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SYMBOLS
ACTH
ADH
ALT
AST
BD
BSA
BTPS
BUN
CA
cAMP
cGMP
ChE
CHIBIS
CO
CPK
D
DBH
DPB
ECG
EDV
EF
ESA
ESV
HR
HGH
GDH
GGTP
ICDH
adrenocorticotropic hormone
antidiuretic hormone
alanine aminotransferase
aspartate aminotransferase
body density, g/ml
body surface area
standard barometric pressure and
temperature
blood urea nitrogen
catecholamine
cyclic adenosine monophosphate
cyclic guanylate monophosphate
cholinesterase
Soviet equivalent for lower-body negative
pressure suit
cardiac output
creatine phosphokinase
density of water
dopamine beta-hydroxylase
diastolic blood pressure
electrocardiogram
end diastolic volume
ejection fraction
erythroid stimulating activity
end systolic volume
heart rate
human growth hormone
glutamate dehydrogenase
glutamate transpeptidase
isocitrate dehydrogenase
IVCT
KS
LBNP
LDH
LVET
MDH
MVR
NS
OHCS
25-OHD3
PEP
PP
PTH
RER
RV
SBP
SDH
STH
STI
SV
TSH
T3,T4
VCF
VCG
VCO2
VE
VO2 max
Wa
Ww
isometric ventricular contraction time
17-kerosteroids
lower-body negative pressure
lactic dehydrogenase
left ventricular ejection time
malate dehydrogenase
maximum ventilatory rate
nonsignificant
hydroxycorticosteroid
25-hydroxycholecalciferol
pre-ejection period
pulse pressure
parathyroid hormone
respiratory exchange ratio
residual lung volume, liters
systolic blood pressure
sorbital dehydrogenase
somatotropin
systolic time interval
stroke volume
thyroxine stimulating hormone
thyroxine
velocity of circumferential fiber
vectorcardiogram
carbqn dioxide production
ventilatory volume
maximal oxygen uptake, ml/kg/min
body weight in air, kg
body weight in water, kg
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PREFACE
This report represents the compilation of results for a pioneering effort accomplished by two teams of investigators
from the United States and the Soviet Union while participating in the first joint U.S./U.S.S.R. bed-rest study in 1979. In
magnitude it compares to the Apollo/Soyuz joint flight test project of 1975 by cooperatively bringing together numbers
of Soviets and Americans in a ground-based, medically related effort. Scientifically it allowed for both qualitative and
quantitative comparisons of methods and results on human experimentation which continue to bear results for each
country.
It is never possible to completely acknowledge and give thanks to all participants in such a large task, which literally
numbered in the hundreds of persons. Yet, the project could never have been accomplished without the support of
Dr. David Winter, then director of Life Sciences for NASA, Washington, DC, and his replacement Dr. Gerald Soften,
and Dr. Oleg Gazenko, their then Soviet counterpart at the Institute of Medical and Biological Problems (IMBP) in
Moscow. Drs. Amauld Nicogossian, NASA Headquarters; Richard Johnston, Lyndon B. Johnson Space Center (JSC);
and Joseph Sharp, Ames Research Center (ARC) provided guidance and the enabling financial and manpower resources
on the U.S. side. Final scientific evaluation of the data was accomplished by an editorial team which consisted on the
American side of Carolyn S. Leach, Ph.D., Paul Rambaut, D.Sc., and Philip Johnson, M.D. (JSC), and Danielle Goldwa-
ter, M.D. (ARC); Leonid I. Kakurin, M.D., Rupert A. Tigranyan, Ph.D., Valerie M. Mikhailov, M.D., and
Boris S. Geogievskii, Ph.D., filled the same role for the IMBP. Special thanks is also given to Dee O'Hara, R.N. (ARC),
and Andrei N. Nazin, M.D. (IMBP), for their management of respective bed-rest facilities over the course of the studies
and to Mrs. Mary Phares for editorial assistance and to Mrs. Doris M. Furman for typing of the manuscript. Specific
thanks are also given to particular investigators and their teams: Lester D. Montgomery, Ph.D. (plethysmographic stud-
ies), Victor Convertino, Ph.D. (body composition studies and exercise testing), Richard Popp, M.D. (echocardiography),
Alvese Polese, M.D. (systolic time intervals, LBNP), Anatoli A. Savilov (echocardiography), Gregori V. Machinskii
(LBNP), Galina I. Kozirevskaya (renal studies), and Victor I. Lobachik (radio-isotope studies). Finally, dedication of this
work is made in the memory of Dr. Philip Johnson who served as principal U.S. investigator for hematologic studies and
Dr. Leonid I. Kakurin, chief project scientist, U.S.S.R. Both have died in the time interval since completion of the study
and this report.
Harold Sandier, M.D., Ames Research Center
Anatoli I. Grigoriev, M.D., Director IMBP, U.S.S.R.
Coeditors

JOINT U.S./U.S.S.R. STUDY:
COMPARISON OF EFFECTS OF HORIZONTAL AND HEAD-DOWN BED REST
SUMMARY
An account is given of results obtained from hypo-
kinesia studies conducted in the Soviet Union (May-June
1979) and the United States (July-August 1979). Both
studies were conducted under identical conditions and
provided a basis for comparing physiologic reactions and
standardizing procedures and methods. Each experiment
consisted of three periods: 14 days of pre-bed-rest control,
7 days of bed rest, and a 10- to 14-day recovery period.
Ten male subjects used for both the Soviet and Amer-
ican studies consisted of volunteers with ages ranging
from 30-40 years. They were also matched with regard to
height, weight, ability to withstand lower body negative
pressure (LBNP) and VO2 max. These groups were sub-
sequently divided into two matched groups of five sub-
jects each, with one group (group "A") subjected to bed
rest in a horizontal (0 °) body position and the other
(group "B") to head-down bed rest (-6°). Daily caloric
intake was regulated to 2800-3000 kcal in the control
period and 2000-2500 kcal during bed rest, with a return
to 2800-3000 kcal during recovery.
Biochemical and hormonal measurements were made
of blood and urine, with particular attention given to elec-
trolyte metabolism and kidney function; cardio-pulmonary
changes at rest and exercise; influence of LBNP; and
incremental exercise using a bicycle ergometer while
supine and sitting.
Results of the study allowed us to conclude that a
7-day bed-rest period caused moderate changes to occur in
various measured physiologic parameters. Clinical evi-
dence pointed to the fact that head-down bed rest, when
compared to the horizontal condition, more closely
matched the conditions seen after manned spaceflight. For
the most part, statistically significant differences between
the two body positions were not observed.
Data from this joint bed-rest study allowed for stan-
dardization of baseline conditions for conducting such
procedures; established the usefulness of bed-rest proce-
dures for the study of weightlessness; identified those
clinico-physiologic parameters most sensitive to change at
rest, or with provocation; and provided a means to share
future research results, thus reducing duplication by the
two countries, through standardization of methods and
uniform presentation of results. These investigations also
identified a number of new questions applicable for future
research projects. The solution to these latter problems
will depend on the possibilities of future joint U.S.S.R.
and U.S. studies in the areas of space biology and
medicine.
The study was accomplished in two parts: A Soviet
part (May to June 1979) and an American part (July to
August 1979).
The Soviet experiment was conducted at the Institute
of Medical and Biological Problems of the Ministry of
Health U.S.S.R. (Moscow) from 14 May to 22 June 1979.
The chief scientist for the Soviet experiment was Dr. L. I.
Kakurin; the Science Manager was Dr. V. M. Mikhailov.
Two American investigator-observers were present at the
Soviet experiment, Dr. H. Sandier from Ames Research
Center (ARC) (20 May to 14 June 1979) and Dr. C.
Alexander from the Lyndon B. Johnson Space Center
(28 May to 9 June 1979).
After completion of the first part, agreement was
reached that the recovery period after bed rest would be
lengthened from 10 days to 14 days and was implemented
during the U.S. part of the experiment.
The American experiment was conducted at ARC,
Moffett Field, during the period 10 July to 15 August
1979. The chief scientist for the American experiment
was Dr. H. Sandier, ARC, and the Science Manager was
Dr. C. Alexander, JSC. Two Soviet special observers
(Dr. V. M. Mikhailov and Dr. A. I. Grigoriev) were pres-
ent during this latter test period from 18 July to 5 August
1979.
Results of the Soviet and American experiments were
presented by each side at the 10th Joint U.S.S.R. and U.S.
Working Group Meeting on Space Biology and Medicine
(Houston, TX, October 1979). At that meeting an agree-
ment was also reached for a fuller exchange of informa-
tion by each side which included individual subject
responses for each subject during all tests conducted over
the course of the studies. This was transferred to each side
as a supplement to the project data at the subsequent 1 lth
Joint Working Group Meeting on Space Biology and
Medicine (Moscow, October 1980). A report on the
results of the study was jointly prepared by a team of
Soviet and American scientists who participated in the
study and was presented at the 12th Joint U.S./U.S.S.R.
Working Group Meeting on Space Biology and Medicine
(Washington, DC, October 1981).
This report represents a summary of the findings
given in this final report.
I. INTRODUCTION
Sincehumansfirstenteredspacewiththeflightof
Yuri Gagarin in 1961, U.S. and U.S.S.R. space crews
have successfully completed more than 200 missions. In
all of these flights, crews have adapted surprisingly well
to the weightless environment, with the most notable
physiological changes being an unloading of weight bear-
ing; a headward shift of body fluids with resultant facial
edema; sensations of blood rushing to the head, and head
fullness; and the presence of space motion sickness.
Despite associated symptoms, both astronauts and
cosmonauts have consistently been able to perform their
assigned tasks in space. However, return to Earth has pre-
sented problems, with crews of both space programs time
after time exhibiting cardiovascular deconditioning, as
evidenced by orthostatic intolerance, loss of exercise
capacity, increased heart rates, decreased systolic blood
pressure, narrowing of and decrease of pulse pressure, and
decreased red cell mass. There has also been significant
loss of body weight and muscle mass; instability of gait
and coordination; and, in some cases, loss of skeletal
mass. These responses have caused considerable concern
among aerospace medical personnel of both nations con-
cerning the possibility that prolonged spaceflights may
cause health-related problems in participants.
Numerous studies have been conducted using
ground-based simulations of weightlessness to seek
answers to the mechanisms underlying the observed phys-
iological changes. These have utilized two principal
means of simulation: water immersion or bed rest (hori-
zontal and/or head-down). Such studies have been utilized
in both countries to uncover mechanisms used by the body
to adapt to weightlessness and to test various countermea-
sures for their subsequent use during spaceflight.
Although it recognized that these procedures do not
represent an exact duplication of weightlessness condi-
tions, each model in turn provides distinct changes which
mimic conditions regularly seen after actual flight. How-
ever, comparisons between ground-based studies con-
ducted between the U.S. and the U.S.S.R. have not been
possible because procedures and methods used have not
been standardized. By accomplishing this standardization,
the data base will be broadened considerably, since it is
realized that individual subject differences and time of
exposure can markedly influence research results. For
example, reported bed-rest studies in the literature have
now varied from a few days to a half year or more. Also,
different body positions have been reported for bed rest
and have varied from horizontal (0 °) to -12 ° or more.
Variables measured or tested in a given study have also
varied significandy, as have the methods for calculating
and presenting results, even when the same procedure is
used.
Therefore, it was proposed that a principal goal for
this first Joint Soviet-American study would be a stan-
dardization of baseline conditions for the conduct of such
ground-based studies, an accurate definition of the best
model for use in simulating the early changes occurring
with weightlessness, and a listing of those clinico-
physiologic parameters most sensitive to change. This was
also to include unification of methods for working
between the two countries, particularly with regard to
techniques and procedures for data handling, calculation,
and presentation of results, and the dealing with any other
applicable procedures and parameters as various inves-
tigators may see fit.
Conducting comparative studies and obtaining solu-
tions to presented problems would allow investigators to
obtain primary and derived data and would help in future
joint work between the Soviet Union and the United
States in the areas of space biology and medicine. In par-
ticular overall results would have a significant impact in
lowering future costs in conducting bed-rest studies in the
two countries by preventing duplication of effort and
allowing subsequent exchange of information.
Prior to the present studies, regular contact between
biomedical specialists in the U.S. and the U.S.S.R. took
place within the framework of the International Federation
of Aeronautics, International Academy of Aviation and
Space Medicine, Conference Committees on Space Sci-
ence associated with UNESCO, the "Man in Space" Inter-
national symposia, and the Joint Working Group on Space
Medicine and Biology. These interactions provided the
needed contacts to build trust and, finally, the realization
of a series of joint medical-biological programs on space
medicine and biology which have included animal
spaceflight experiments as well as collaboration in human
research.
The first important step leading to a cooperative
agreement for a joint hypokinesia study took place at the
8th U.S./U.S.S.R. Joint Working Group (Washington,
Wallops Island, 1977). The final investigative program
was formalized, including the protocol, at the 9th Joint
Working Group meeting (Leningrad 11-17 October 1978).
The plan consisted of two phases and provided for alter-
nate conduct of an identical study first in the Soviet Union
and then the United States. This study stands as a pioneer-
ing effort which allowed for the verification of method-
ology between the U.S. and the U.S.S.R. and future stan-
dardization of approaches for such research projects.
Through these studies it was possible to compare the
physiological effects of horizontal (0 °) and head-down
(-6 °) body positions as experimental models for
weightlessness.
Moreimportantly,thejointprojectallowedfordirect
comparisonof experimentalproceduresandmethods
betweenthesides,includingthemannerofdatacollection
anditsanalysisandpresentation.Thisfinalreportwas
precededbypreparationa dexchangeofpreliminarydata
bybothsides.Thisjointventureprovedusefulandserves
asanexcellentbasisfor futurecooperativefforts
betweentheU.S.S.R.andtheU.S.in thefieldof Space
MedicineandBiology.
II. BACKGROUND
This study utilizes bed-rest techniques that maintain
the body in the horizontal and head-down positions as a
means of simulating weightlessness.
Both the U.S.S.R. and the U.S. have had a significant
number of manned spaceflights which have allowed col-
lection of a large body of information concerning phys-
iological changes under conditions of weightlessness.
This information has been collected under medically con-
trolled conditions in flight, and has allowed comparisons
of physiologic states before and after flight. These results
have shown that weightlessness exposure does result in
specific human body adaptations such as (ref. 1):
1. Space motion sickness syndrome (symptoms and
signs)
2. Cardiovascular changes, in particular decreases
in orthostatic stability and physical work
3. Alteration in fluid/electrolyte balance resulting in
decreased circulating blood volume and blood and tissue
electrolyte content changes
4. Decreased bone mineral
5. An anemic syndrome manifest by a decrease in
red cell mass and thrombocytes and a decrease in red cell
lifespan
6. A change in immunological reactivity with a
decrease in naturally occurring defense mechanisms
Detailed analysis has shown that the most prominent
factor responsible for initiating change was loss of gravity
(ref. 2). This is an occurrence unique to spaceflight and
must be kept in mind when one gauges the adequacy and
experimental usefulness of any model used for its simula-
tion, particularly in assessing mechanisms, magnitude of
change, prognostication of crew findings, or evaluation of
various countermeasures used during spaceflight.
Medical biological investigations conducted during
the Soyuz and Apollo programs and in the Salyut, Mir,
and Skylab orbital stations have shown a need for a beuer
understanding of an operant mechanism, particularly for
longer-duration exposures and for readaptation following
return to Earth (ref. 2).
The single most important occurrence with insertion
into orbit is a physical one--the loss of the otherwise
normal pull of gravity and a resultant acute absence of
normally present hydrostatic pressure columns for the cir-
culation. Blood and body fluid go through a phase of
redistribution which is different from conditions on Earth,
with increases in flow to organs and parts of the body
which are above heart level. This is followed by develop-
ment of compensatory processes which involve changes
in neurohumoral influences and muscle and metabolic
processes (refs. 1 and 2). Problems of gravitational redis-
tribution of blood continue to be studied intensively and
still pose many unsolved questions regarding their magni-
tude and need, and means for prevention.
Another important change not usually encountered
while on Earth is a loss of muscle activity due not only to
the absence of gravity, but to hypokinesia and hypody-
namia (ref. 1).
Both of the above weightlessness factors can be stud-
ied during ground-based experiments and are the basis for
developing various simulation models of weightlessness
(ref. 2).
Most work has been devoted to using two experimen-
tal models: water immersion and strict bed rest. The
rationale for these approaches and their scientific validity
have been widely reviewed in both the U.S.S.R. and the
U.S. (ref. 2).
Original investigations for modeling long-term
weightlessness effects on healthy humans using bed rest
started in the Soviet Union and the United States around
1961, the first publications occurring in 1963 (ref. 2). This
was followed by many experiments investigating different
approaches and exposure durations. These investigations
focused on the process of change during the early period
of weightlessness and on the evaluation of the effective-
ness of different prophylactic drugs.
Analysis of medical data obtained during manned
spaceflight has shown that weightlessness changes are
variable and are dependent on individual subject reactions
(refs. 3 and 4). Nonetheless, the continued need to
increase the number of individuals who might participate
in a given spaceflight venture and prolonged duration of
stay stimulated investigations of drug effects and other
countermeasure procedures directed toward supporting
higher mental and physical work ability, preventing
cardiovascular system problems, and correcting changes
in metabolic processes, particularly with regards to fluid/
electrolyte and other functional disorders. Changes noted
post-flight and following ground-based simulation of
weightlessness have demonstrated that ground-based
methods can accurately reproduce many weightlessness
effects, as well as evaluate different prophylactic drugs
and treat disorders. These procedures have returned indi-
vidual responses to within physiological limits, while
otherchangeshavebeenobservedtoremainbelowaclin-
icalthresholdjudgedtorequiretreatment (ref. 5).
Analysis of previously published material in the
Soviet Union and the United States shows that progress
has been parallel in the two countries. Nonetheless, there
has been a distinct difference in the goals for the studies,
with some directed toward answering specific spaceflight-
related problems: the Soviet Union accomplishing long-
duration spaceflights on the orbital Salyut and Mir space
stations, including programs conducted under the spon-
sorship of lntercosmos; and in the United States for the
preparation and accomplishment of manned spaceflights
using the Space shuttle. As a result, ground-based studies
using bed rest in the Soviet Union have increasingly
emphasized the use of longer-duration studies (up to 1 yr)
with attention to effectiveness of countermeasures and
rehabilitation procedures, while U.S. studies have concen-
trated on shorter periods (1-2 wk).
There has been interest in both countries regarding
untoward physiologic effects during the acute period of
adaptation to weightlessness and/or hypokinesia (ref. !).
Information of interest has been gained from selective
catheterizations of the heart and great vessels (ref. 6).
These studies have provided new information on the car-
diovascular effects of body positional change in otherwise
healthy individuals. Results have had direct applicability
to problems of space, aviation, and clinical medicine.
In the U.S. a large number of bed-rest studies have
been conducted in men and women of different ages as a
means of uncovering potential problems in their participa-
tion in the Space Shuttle program (refs. 1 and 2). Results
have shown that bed rest induces a more severe loss in
physiological capability in women than in men as mani-
fested in responses to LBNP, +Gz tolerance, and physical
work capacity. Most interesting has been the finding that
the magnitude of loss does not increase with age in either
sex and tends to stabilize in older individuals.
In spite of making significant allowances for the use
of horizontal bed rest as a simulator of weightlessness,
predictive results from investigations compared to medi-
cal investigations in both cosmonauts and astronauts
convincingly showed only a fair prognosis. This was par-
ticularly the base with regard to postflight orthostatic sta-
bility and physical work capacity, deterioration of regula-
tory posture mechanisms when upright and coordination
during walking movements, tone of antigravity muscles
and deterioration of metabolic processes, particularly
fluid/electrolyte balance. This led to a search for uncover-
ing other approaches and finally to the use of head-down
positioning examined under conditions of strict bed rest.
This kind of study was started with a 30-day period at a
-4 ° angle (head below the legs) conducted in 1970, and
evaluated the effects of prophylactic drugs recommended
for the crew of Salyut- 1 (ref. 7).
Use of the head-down model has also provided addi-
tional information not readily available from the strict
horizontal approach and has pointed to changes more
closely approximating those reported during actual flight,
such as the sensation of increased blood flow to the head,
which slowly equilibrated; hyperemia and swelling of the
face; instances of illusions where the body seemed to be
upside down when the eyes were closed, and so on. Physi-
ological effects were also more pronounced during such
ground-based gravity-induced redistribution of blood and
paralleled clinically observed data (ref. 8), rheoen-
cephalographic studies (ref. 9), studies of visual and
vestibular end-organ responses, and changes of cardiac
output (ref. 9), to name a few.
In a 5-day study with subjects bed rested at 0 °, -4 °,
-8 °, and -12 °, Kakurin and his associates found that the
-4 ° and -8 ° positions most accurately duplicated heart
rate changes with 70 ° tilt following 5-day spaceflight
(ref. 10). Subjective findings have increased with greater
head-downward angulation and have consisted of com-
plaints of blood rushing to the head, heaviness of the
head, and temporal vessel pulsation, which are similar to
complaints by space crews. Objective findings have
included neck vein engorgement, increased venous disten-
tion of the retinal veins, and increased central and jugular
venous pressures. Most of these changes reached maxi-
mum intensity within 3 hr of assumption of the head-
down position.
Both invasive and noninvasive methods have been
used with head-down subjects to study the hemodynamic
changes that occur in this position so that results could be
compared with those obtained with subjects in the hori-
zontal or upright body position. Mean femoral blood pres-
sure tends to decrease as head-down angulation is
increased because of a decrease in both systolic and dia-
stolic blood pressure caused by loss of hydrostatic column
lengths, but heart rate (HR) changes very little. Unlike
head-up tilt in which central venous, jugular, and left ven-
tricle filling pressures drop significantly, with head-down
positioning, central venous pressure increases by about
9 mmHg and jugular pressure increases to more than
30 mmHg. In a 24-hr study with five subjects in the -5 °
head-down position, Nixon et al. saw a sharp increase in
central venous pressure during the first 40 min of bed rest,
with a return to baseline values by 90 min, followed by a
gradual decline to significantly below baseline by 12 to
16 hr (ref. 11).
In a more recent study by Katkov et al., which placed
eight subjects in a -15 ° head-down position for 7 days,
right atrial pressure showed no significant change until the
second day, when it began to drop; it continued to drop to
the end of the study (ref. 6). At the same time, mean pul-
monary artery pressure increased gradually over the first
7 hr and then decreased gradually until the third day. The
difference in changes in right atrial and pulmonary pres-
sure, which are as yet unexplained, raise questions
because these changes occurred during the period of bed-
rest-induced diuresis. Heart rate, cardiac output (CO), and
stroke volume (SV) did not change significantly through-
out this latter study.
Echocardiography has not revealed a significant
increase in left ventricular end diastolic volume during the
first few hours of -5 ° or --6 ° head-down bed rest over that
measured with horizontal bed rest. In canine studies,
Avasthey and Wood, using X-rays of intact dogs, found
no increase in heart size when the animals were placed in
the -90 ° position (ref. 12), and Rushmer found that left
ventricular dimensions in dogs were greater with animals
in the 0° position than with those in either the +30 ° or
-30 ° positions (ref. 13). These findings may have resulted
from such factors as a shift of the heart and diaphragm
within the chest to accommodate headward fluid shifts
and a possible shift in the hydrostatic indifference point
for right-heart circulation. Gauer and Thron pointed out
originally that this point determines the zero reference
level of the low-pressure side of the circulation when the
measured pressure shifts from positive to negative
(ref. 14). In the supine position, this level occurs at
midatrium; in the head-down position, it shifts cephalad to
the superior vena cava-atrial junction. These changes help
to explain the potential for a decrease in heart size in the
head-down position. Nixon et al. did observe some
increase in left ventricular dimensions during hourly
echocardiographic measurements of subjects in the -5 °
head-down position, but the changes occurred when cen-
tral venous pressure had decreased; the cause remains
unexplained (ref. 11).
Most hemodynamic changes with head-down bed rest
have either paralleled or exceeded findings in the horizon-
tal position, but results have been variable. Kakurin
observed exaggerated heart rate responses in head-down
subjects during 70 ° upright tilt (ref. 10). Convertino et al.
found that exercise responses following bed rest were
more significant with head-down exposure than horizontal
(ref. 15). In a 30-day bed-rest study, Katkovskiy and his
co-workers saw a greater decrease in exercise capacity
following head-down bed rest than in horizontal bed rest
(ref. 16). Goldwater et al. found that subjects bed-rested in
the head-down position for 7 days exhibited a signif-
icantly greater increase in left ventricular and diastolic
volume than horizontal subjects, as well as a greater
pooling in the legs and pelvis (ref. 17). Hyatt and West,
on the other hand, saw no evidence of significant physio-
logical change in eight male subjects bed-rested for 7 days
in the horizontal and -5 ° head-down positions (ref. 18).
Neither did Katkov et al. note significant resting hemody-
namic changes (HR, CO, and SV) over the course of
7 days of -15 ° bed rest (ref. 6).
U.S.S.R. investigators have not observed regular
increases in resting HR during the first month of head-
down bed rest, but have noted significant increases there-
after. Increases in CO during such studies were attributed
to increased SV. Changes in CO were usually most
prominent by the 6th to 9th day of bed rest and returned to
baseline values after 15 to 20 days. Although such
changes have occurred in both horizontal and head-down
subjects, they occur earlier and are more pronounced in
the head-down position. Cardiac output was measured
noninvasively in these studies by using CO2 rebreathing
techniques or mechanoeardiography; as a result, the find-
ings may be open to question since they differed from
those of Katkov et al. who used the indicator dilution
method (ref. 6). Changes in blood redistribution with sig-
nificantly greater headward shift of volume have been
documented in the head-down position, with these shifts
persisting throughout the bed-rest period. These results
were obtained using radioactive iodinated serum albumin
and impedance plethysmography, but the quantitative
accuracy of these measurements has been questioned
(refs. 19 and 20).
U.S.S.R. investigators have used head-down bed rest
extensively to test various countermeasures, particularly
use of physical exercise, exposure to lower-body negative
pressure (LBNP), and electrostimulation of muscles.
Before the long-duration flights of U.S.S.R. crews, inves-
tigators exposed 18 male subjects to 182 days of --4 °
head-down bed rest (ref. 21). The subjects were divided
into three groups: one group served as controls; a second
received daily or weekly exercise regimens; and the third
received muscle electrostimulation. Twenty-minute pas-
sive stand tests (75 ° back angle) performed 11 times dur-
ing the study indicated that the subjects who received
exercise and muscle stimulation exhibited fewer presynco-
pal symptoms during testing than the untreated controls.
Moreover, systolic time intervals (STI) for the untreated
group showed prolonged isometric contractions (pre-
ejection period, PEP) and shorter left ventricular ejection
time (LVET). Oxygen consumption also was better in the
treated subjects. These findings were similar to flight
experience in both the Salyut 6 and Skylab missions.
In both the horizontal and head-down positions, bed
rest is associated with fluid and electrolyte changes--salt
and water diuresis and stimulation of the renin-
angiotensin, aldosterone system (ref. 1). Volicer et al.
reported that plasma renin activity and plasma aldosterone
levels did not differ significantly between horizontal and
head-down subjects during the fLrSt 6 hr of bed rest, but
were significantly increased in head-down subjects (-5 ° )
by the end of 24 hr (ref. 22). In contrast, Nixon et al.
reported that plasma renin activity and aldosterone tended
to be depressed over the first 12 hr and to return to base-
line levels by the end of 24 hr (ref. 11). In this latter study,
bloodvolumealsodecreasedsignificantlyby0.6liters.
Thedifferenceinthesefindingsisasyetunexplained.
Thepresentstudy,performedjointlyby U.S.and
U.S.S.R.investigators,soughttoclarifysomeoftheques-
tionsconcerninghorizontalndhead-downbedrest.
III. GENERAL PROCEDURES AND METHODS
Subject selection was accomplished in three stages.
Stage 1 (screening) when the subjects were ambula-
tory included a complete physical examination, including
psychological testing, routine hematology and urinalysis,
urine tests for renal calculi, SMA-12 (routine blood elec-
trolytes), and blood hormone analysis (24-hr urine and
8-hr blood samples). Subjects were also screened for drug
use.
Stage 2 (preliminary) included a 3-hr glucose toler-
ance test as well as testing for tolerance to exercise
(bicycle ergometer) and LBNP.
Stage 3 (final) in which anthropometric data were
derived and LBNP tolerance and VO2 max were com-
pared and subjects were divided into two comparable
groups of five persons each.
A total of 60 persons were screened on the Soviet
side with 16 individuals subsequently chosen for physio-
logical (Stage 2) testing; 40 individuals volunteered for
the American experiment with 20 of these accepted for
further evaluation.
The studies consisted of a 14-day control period,
7 days of bed rest, and 14 days of recovery, as shown in
figure 1. During the bed-rest segment, five subjects were
bed rested in the horizontal position (0 °) and five in the
head-down (--6 °) position.
The U.S.S.R. study was conducted at the Institute for
Medical and Biological Problems of the Soviet Ministry
of Public Health from May 14 to June 22, 1979; the U.S.
study was conducted at the Human Research Facility of
NASA Ames Research Center from July 11 to August 15,
1979. Each study was observed by members of the other
team.
The subjects selected (ages 31-40 yr) ranged in height
from 159 to 185 cm and in weight from 55 to 87.5 kg.
Anthropometric data for the subjects are shown in table 1
for the U.S. subjects and in table 2 for the U.S.S.R. sub-
jects; tables 3 and 4 provide cardiovascular baseline data
for the two groups, respectively.
DAYS
DAYS
CONTROL
1 2 3 4 5 6 7 8 9 10 11 12 13 14
L B W B L B
X ! X
BED REST
DAYS 1 2 3 4 5 6 7
E B B B
x3
E E I
RECOVERY
0 1 2 3 4 5 6 7 8 9 10 11 12 13 :14
L B L B L
X
Bt W X I X
LEGEND:
L = LBNP
X = EXERCISE
B = BLOOD SAMPLE
W = WATER LOAD
Ex3 = ECHO, THREE TIMES AT 4-hr INTERVALS
E = ECHO, SINGLE
Bt = BLOOD SAMPLE. 1 hr AFTER BECOMING VERTICAL
I = ISOTOPES
Figure 1.- Study schedule.
All subjects were maintained in facilities providing
controlled temperature, noise, and access. The subjects
were fed the diets consumed by their national space
crews--the Shuttle diet for the U.S. subjects (table 5) and
the Salyut orbital station diet for the U.S.S.R. subjects
(table 6). Three or four meals a day were provided: break-
fast, lunch, dinner, and a late snack, which was optional.
The foods were evaluated for content of protein, carbohy-
drates, fat, sodium, potassium, magnesium, and calcium.
The menus were rotated every 4 days in the U.S. study
and every 3 days in the U.S.S.R. study. Table 7 compares
nutritional values for the two studies. The mean caloric
intake for U.S. subjects was 2919 kcal; it consisted of
l18g protein, 429 g carbohydrates, and 81.5 g fat.
U.S.S.R. subjects ate 2832 kcal, with 112 g protein, 370 g
carbohydrates, and 109 g fat. The U.S. diet differed from
that used in previous bed-rest studies in that it included a
number of foods (banana, pineapple, chocolate, vanilla,
and caffeine-containing beverages) that could produce by-
products of metabolism that might interfere with urine test
chemistries. Diet samples were not analyzed daily for
caloric and mineral content, and true balance studies were
not performed. Instead, samples taken of food lots before
the study were chemically analyzed for caloric content,
moisture, protein, carbohydrates, fat, ash, calcium, iron,
phosphorus, magnesium, zinc, potassium, sodium, and
TABLE 1.- ANTHROPOMETRIC DATA ON U.S. SUBJECTS
Subjects,
by number
Horizontal
108
111
115
118
119
Mean
Head-down
103
105
106
110
113
Mean
4O
38
39
40
38
39
40
39
36
36
39
38
Height,
cm
175
165
171
171
185
173
180
159
179
175
179
174
Weight,
kg
74.7
55.2
66.0
70.2
68.7
67.0
70.3
58.3
75.0
67.3
74.1
69.0
TABLE 2.- ANTHROPOMETRIC DATA ON U.S.S.R. SUBJECTS
Subjects,by
designation
Horizontal
S-ev
S-ov
P-ov
Sh-ov
K-ko
Mean
Head-down
A-ev
P-iy
T-in
Zh-ov
L-iy
Mean
Age,
yr
4O
33
33
31
32
34
30
36
34
35
38
35
Height,
cm
183
170
173
170
170
173.2
173
174
176
172
185
176
Weight,
kg
81.5
81.0
74.8
72.0
65.0
74.9
86.5
73.3
87.5
81.0
83.3
82.3
oo
TABLE 3.- BASELINE RESPONSES TO LOWER BODY NEGATIVE PRESSURE AND EXERCISE STRESS: U.S. STUDY
Subjects
Horizontal
108
111
115
118
119
Mean
Head-down
103
105
106
110
113
Mean
BSA, Resting heart rate,
LBNP tolerance at -50 mmH_
Max heart rate, Duration, Blood pressure, Max V02, I Body fat,
m 2
1.89
1.59
1.76
1.81
1.90
1.79
1.89
1.59
1.92
1.81
1.92
1.80
beats/min
68
58
66
78
86
71
beats/min
76
86
96
92
122
94
61
54
80
76
64
67
64
56
108
100
90
84
min
11
15
15
15
15
14
15
8
15
15
15
13
mmHg
120/70
140190
118/78
120/80
120/80
124/80
120/80
120/70
130/70
140/90
120/82
126/78
ml/k_min
44.5
44.6
37.0
28.4
40.5
39.0
38.4
45.2
31.4
35.4
41.4
38.4
%
18.9
17.1
27.0
29.2
18.9
22.2
26.7
16.1
21.3
29.2
17.4
22.1
TABLE 4.- BASELINE RESPONSES TO LOWER BODY NEGATIVE PRESSURE AND EXERCISE STRESS:
U.S.S.R. STUDY
[LBNPfFolerance at -50 mmHg]
Subjects
Horizontal
S-ev
S-ov
P-ov
Sh-ov
K-ko
Mean
Head -down
A-ev
P -iy
T-in
Zh-ov
L-iy
Mean
Heart rate,
beats/rain
68
120
112
74
82
91.2
80
94
87
108
97
93.2
Pulse pressure,
mmHg
20
3O
3O
25
20
25
40
25
45
20
30
32
Maximum VO2,
ml/kg/min
38.5
34.8
40.0
42.2
48.0
40.7
34.9
46.9
37.2
33.0
34.2
38.3
Work performed,
kg.M
13,600
10,500
10,500
13,600
13,600
12,360
13,600
15,300
15,300
13,600
12,000
13,960
TABLE 5.-S[tUqYFLE-TYPE DIET USED IN U.S. STUDY
Day I I Day 2 ] Day 3 I Day 4
Breakfast
Peach slices (T)
Scrambled eggs (R)
Bran flakes (R)
Bread (toast) (NF)
Butter and jelly (NF)
Cocoa (B)
I Orange drink (B)
Applesauce (T)
Granola (R)
! Breakfast roll (NF)
Bread (toast) (NF)
Butter and jelly (NF)
Chocolate instant breakfast (B)
Orange-grapefruit drink (B)
Dried peaches (IM)
Scrambled eggs (R)
Cornflakes (R)
Bread (toast) (NF)
I Butter and jelly (NF)
Cocoa (B)
Orange-pineapple drink (B)
Dried apricots (IM)
Granola with blueberries (R)
Bread (toast) (NF)
Butter and jelly (NF)
Vanilla instant breakfast (B)
Grapefruit drink (B)
Lunch
Frankfurters (T)
Bread (2 slices) (NF)
Bananas (FD)
Almond crunch bar (NF)
Apple drink (2 servings)(B)
Corned beef (I)
Asparagus (R)
Bread (2 slices) (NF)
Pear halves (T)
Peanuts (NF)
Lemonade (2 servings) (B)
t lam (T)
Cheese spread (T)
Bread (2 slices) (NF)
Green beans and broccoli (R)
Pineapple (T)
Shortbread cookies (NI:)
Cashews (NI0
Tea w/lemon and sugar
(2 X) (B)
Diced beef and gravy (T)
Noodles and chicken (P)
Stewed tomatoes (T)
Pears (FD)
Almonds (NF)
Strawberry drink (B)
Dinner
Shrimp cocktail (R)
Beef steak (I)
Rice pilaf (R)
Broccoli au gratin (R)
Fruit cocktail (T)
Grape drink (B)
Beef with BBQ sauce (q)
Cauliflower w/cheese (R)
Green beans w/mushrooms (R)
Lemon pudding (T)
Cocoa (B)
Cream of mushroom soup (R)
Smoked turkey (1)
Mixed Italian vegetables (R)
Vanilla pudding (T)
Strawberries (R)
Tropical punch (b)
Tuna (T)
Macaroni and cheese (R)
Peas w/butter sauce (R)
Pecan cookies (NF)
Chocolate pudding (T)
Lemonade (B)
Notes: Coffee was available with meals, as desired. B = beverage; FD = freeze-dried; I = irradiated; IM = intermediate
moisture; NF = natural form; R = rehydratable; T = thermostabilized. Snacks available in all cases consisted of beverage
(coffee, punch, and/or milk); toast; cookies; pudding.
TABLE 6.- U.S.S.R. MENU USED IN STUDY
Day 1 Day 2
Breakfast
Day 3
Steak
Borodinskiy bread
Coffee with milk
"Lcdokol" toffee
Veal
Borodinskiy bread
Coffee with milk
"Ledokol" toffee
HAITI
Moscow rye bread
Cocoa with milk
"Ledokol" toffee
Lunch
Curds with apple jam
Walnut wafers
Plums and cherries
Curds with cranberry jam
"Sakharnoye" pastry
Fruit stick of apples-plums
Curds with black currant jam
Pastry with cheese
Prunes
Dinner
Beet soup
Beef tongue galatine
Prunes with walnuts
Table bread
Sweetened apple-cherry juice
Sauerkraut soup
Russian cheese
Table bread
Prunes with walnuts
Black currant juice with pulp
"Kharcho" soup
Choice sausage
Rye bread
Plum cake
Sweetened cherry juice
Supper
Sweet and sour meat
Honey cake
Candied fruit
Tea with sugar
Meat and vegetables
"Artika" biscuit
Plums and cherries
Tea with sugar
Pickled mutton
"Sakhamoye" cake
Fruit stick of apples-plums
Tea with sugar
TABLE 7.- COMPARISON OF NUTRITIONAL VALUES OF U.S.AND U.S.S.R. DIETS
Calories
U.S. diet
Day 1
Day 2
Day 3
Day 4
Mean
U.S.S.R. diet
Day 1
Day 2
Day 3
Mean
2906
305O
3043
2678
2919
2839
2810
2846
2832
Proteinr g
107.6
117.4
124.1
123.0
118.0
111.3
112.3
111.6
111.7
Carbohydrates_ g
430.1
477.3
432.0
375.6
428.8
378.0
366.3
367.0
370.4
FatT g
84.1
74.6
91.3
76.0
81.5
105.1
109.0
114.0
109.3
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TABLE8.-CONSTITUENTSOFSHUTTLE-TYPEDIETUSEDINU.S.STUDY
Constituent
Calories
Protein,g
Carbohydrates,g
Fat,g
Calcium,mg
Phosphate,mg
Potassium,g
Sodium,mg
Iron,mg
Magnesium,g
Day1
2906
107.5
430.13
84.06
1088.0
1871.0
3350
4373
28.2
399
Day2
3050
117.35
477.M
74.61
1362.0
1801.0
3900
3673
_.1
464
Day3
3043
124.05
432.00
91.29
1099.0
2223.0
4161
6865
24.8
435
Day4
2678
122.96
375.64
75.99
1565.0
2067.0
4136
4353
49.6
752
Mean
2919
117.98
428.80
81.49
1278.5
1990.5
3887
4816
34.18
513
iodine according to the analytical methods of the Associa-
tion of Agricultural Chemists. Variations in food lots were
not known. Uneaten portions of food were weighed and
their nutrient values estimated. On this basis it was esti-
mated that the mean intakes of calories and minerals for
U.S. subjects were as given in table 8. All subjects drank
bottled water throughout the study except during water-
load testing when they drank distilled water. Mineral
intake for the two types of water was adjusted using
information provided by the supplier.
Nutrient intake values were analyzed using a two-
way analysis of variance, with one factor representing
intake of the subjects and the other representing the time
phase of the study. Upon completion of this analysis,
means of all significant main effects were compared,
using the Newman-Kuels method of testing differences
between ordered pairs.
The U.S.S.R. bed-rest subjects were fed a diet similar
to that provided the cosmonauts on the Salyut space
station (table 6). During the control period that preceded
the bed rest period and during the recovery period that
followed it, the diet consisted of 2800 kcal/day, composed
of 111.7 g protein, 109.4 g fat, and 371.1 g carbohydrates
(see table 7). During bed rest, the subjects were fed only
2550 kcal/day consisting of 104.4 g protein, 95.1 g fat,
and 317.4 g carbohydrates. The three menus consisted of
four meals a day and were rotated every fourth day (see
table 6). The subjects consumed all the food provided at
each meal. Water was permitted ad libitum, but the intake
was recorded.
Throughout the studies, all subjects were monitored
twice each day for vital signs (heart rate, blood pressure,
and oral temperature) and once a day for body weight.
Body weight was measured in the upright position during
the control and recovery periods, but on a horizontal bed
scale during the bed-rest period. Emunctory functions also
were performed in the bed-rest positions.
All subjects lost weight during the study. In the first
few hours of bed rest, the horizontal subjects experienced
no unpleasant sensations, but the head-down groups expe-
rienced sensations of heat, blood rushing to the head and
chest, nose stuffiness, difficulty breathing through the
nose, and facial puffiness. By the end of 3 days, these sen-
sations disappeared except for the facial puffiness in the
head-down subjects, which persisted throughout the bed-
rest period. Following bed rest, all subjects suffered from
orthostatic intolerance and pains in the back and leg mus-
cles. These symptoms disappeared within 2-3 days for the
horizontal subjects and within 3-4 days for the head-down
groups. No health problems were noted as a result of the
study.
To assess cardiovascular changes, the subjects in the
present study were given electrocardiograms (ECGs) and
vectorcardiograms (VCGs), both at rest and under stress
using LBNP, echocardiography at rest and when stressed,
changes in body geometry and leg volume, and STIs. The
methods and results are discussed in the following sec-
tions; a comparison of U.S. and U.S.S.R. results is given
at the end of each chapter.
IV. HEMODYNAMIC STUDIES
Electrophysiology
U.S. study- U.S. investigators recorded 12-lead
ECGs and VCGs for both the horizontal and head-down
subjects. The measurements were performed 11 times dur-
ing the study--2 times during the control period, 6 times
during the bed-rest period, and 3 times during recovery.
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Twelve-leadECGmeasurementswereperformedwitha
three-channelinstrument(Hewlett-PackardModel1517A)
with recordingsat paperspeedsof 25 mm/secand
50mm/sec.Variablesmeasuredwereheartrate,P-R
intervals,durationof theQRScomplex,QTinterval,
maximumvoltageof theT-wavein precordialleads,
maximumamplitudeofprecordialRandprecordialS,and
themagnitudeofRinV5andSinVI. Thesemagnitudes
wereused,respectively,todeterminechangesinelectrical
activityof theleftandrightventricles.QTcwascalcu-
latedbytheequation:
QT
QTc= R_-_-S_R (1)
MeanECGvaluesfor theU.S.horizontalndhead-
downsubjectsareshownintables9 and10.Nostatisti-
callysignificantchangeswereobservedineithergroup
usingpairedorunpairedt-teststhroughoutthestudy,nor
wasthereanyevidenceof changesin theSTsegmentor
conductionabnormalities.OnlytwoabnormalECGfind-
ingswererecordeduringtheentirestudy.Onehorizon-
tallybed-restedsubject(No. l l l) experiencedseveral
ectopicbeats(supraventricular)duringeachLBNPses-
sion,but investigatorsfeltthatthearrhythmiawasnot
causedbythebed-restexperience.Onehead-downsubject
(No.103),on theotherhand,exhibiteda prominent
Uwavein leadsV2andV3,buttheelectricalvoltageof
thiswavedecreasedprogressivelythroughoutthebed-rest
periodandreturnedtobaselinebydayl0ofrecovery.
Vectorcardiogramswererecordedusinga system
similartothatusedinSkylabin-flightstudies(Hewlett-
PackardModel1520A).Leadswereplacedoneachleg,at
thebackof theneck,andat fivepositionsonthechest
(rightandleftmidaxillaryline,fifthinterspacemidlineon
thefrontandbackof thechest,andfifthinterspacemid-
nippleline).Two-tothree-minuter cordingsweremade
onanalogtapeandsubsequentlyreplacedforvectorloop
display;resultsandcalibrationvoltageswererecordedon
polaroidfilm. OrthogonalX, Y, andZ voltageswere
recordedonstripchartsandlaterusedtocreateoscillo-
scopepresentations:X andY to formthefrontalplane
projection,YandZ toformsagittalplaneprojections,and
X andZ to formhorizontalprojections.All threeloops
wereregisteredin eachPolaroidrecording(frontaltop
right,horizontalbottomleft,andsagittalbottomleft).The
individualserialtracingstakenthroughoutthestudy
showednosignificantchangesinP,QRS,orT loopsand
agreedwiththeECGresultsreportedabove.
U.S.S.R.study- U.S.S.R.investigatorsrecorded
ECGsatrestseventimesduringthestudy--threetimes
duringthe14-daycontrolperiod,threetimesduringthe
7-daybed-restsegment,andagainon thefirst dayof
recovery.Recordingsweremadeusinga 12-lead,eight-
channelECG(Minograph-81),withhorizontalsubjectsin
the0° positionandhead-downsubjectsin the-6° posi-
tion.Leadswereplacedusingregularclinicalprocedures:
threestandardleads(I, II, andIII); threelimbleads(ayR,
ayL,andayFO);andsixthoracicleads(V1throughV6).
Controlandbed-restrecordingsshowednormalsinus
rhythms.AlthoughHR decreasedduringthebed-rest
period,therewerenosignificantchangesintheduration
ofPQ,QRS,orQRSTintervalswhencorrectedforcorre-
spondingchangesin thelengthof theR-Rinterval.Abso-
lutevaluesof theQRSTintervalandQTcdidnotdeviate
fromnormalbymorethan0.04secand5%,respectively.
A slightdecreasewasobservedin theamplitudeof the
T-waveinsomecasesduringbedrest.Tables11and12
showtheECGfindings.Therewasnoevidenceofsignifi-
cantSTdepression(i relationtotheisoelectricline)orof
T-wavedeformities.TheECGfindingsforboththehori-
zontalandhead-downsubjectsalsoshowednoevidence
to indicatemetabolicdisturbance,interferencewith the
myocardialbloodsupply,or significantdifferences
betweentimeintervalsorwaveforms.Theslightdropin
amplitudeoftheT-wavethatwasobservedinboth groups
of subjects was attributed to a change in position of the
heart within the chest.
Echocardiography at Rest
U.S. study- Echocardiograms were recorded before
and after both the Skylab 4 flight and the U.S.S.R. long-
term (96, 140, 175, 185, and 211 days) spaceflights. Most
data on cardiac functional and structural changes have
been obtained from ground-based studies, primarily bed-
rest studies. In the present study, both teams sought to
characterize changes in cardiac size and function in order
to compare such responses in horizontal and head-down
subjects. U.S. investigators performed echocardiographic
measurements at rest on both groups of subjects twice
during the control period (days 2 and 13), four times on
the first day of bed rest, and twice during the remainder of
the bed-rest period (days 2 and 4), and twice during
recovery (days 5 and 10).
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TABLE 9.- ELECTROCARDIOGRAPHIC RESPONSES OF HORIZONTAL (0 °) SUBJECTS: U.S. STUDY
M :t:SE HR, PR, QRS, QT, QTC, T, SMAX, RMAX, R + S, Rv1 + Sv5, Sv1 + RV5,
[mats/min sec sec sec sec mV mV mV mV mV mV
Prebed rest
Day 2
Day 13
Bed rest
Day 1, 0800
Day 1, 1300
Day 1, 1600
Day 1, 1900
Day 2
Day 4
Postbed rest
Day R + 0
Day R + 5
Day R + 10
71 :t3.9
69 :V.2.1
65 +1.9
69 _+.3.3
63 5.-4.5
67 _+.2.4
70 _+_2.2
70 :t2.9
70:1:2.0
69_+_2.1
72 +1.8
0.17 i-0.01
0.17 i-0.01
0.17 :£0.01
0.17 i-0.01
0.18 i-0.01
0.18 :t0.01
0.17 :£0.01
0.18 :i-9.01
0.18 L_0
0.08 i-O
0.08
0.08 i-0
0.08 :t0
0.08 :tO
0.08 :t0
0.09 :tO
0.08 :k-0
0.08 _+0
0.08
0.08 :tO
0.38 _-_-t-0
0.48 _+0
0.38 L'0.01
0.38 i-0.01
0.37 i-0.01
0.38 i-0.01
0.37 -20
0.38 x0
0.37 _+0
0.39 :t0.01
0.40 :t0.01
0.38 i'0.01
0.40 5_-0.01
0.39 i-0.01
0.40 i-0.01
0.40 :x_0.01
0.40 ::L0.01
0.41 :i-O.01
0.8 5_'0.2
0.7 £-0.2
0.6 L,-0.1
0.6 :t--0.1
0.7 5.-0.1
0.7 i-0.1
0.7 x_0
0.7 5.-0.1
0.6 :L-0.1
1.6 :£--0.4
1.7 i-0.3
1.4 :g-0.1
1.2 :L--0.3
1.7 _+0.2
1.7 £-0.3
1.8 i--0.2
1.9 _-+0.2
1.3 5.-0.3
1.8:1.-0.2
1.7 -t-0.3
1.8 xL0.3
1.9 i'0.3
1.8 i'0.3
1.8:1.-0.3
1.7:1_-0.3
1.8 x'-0.3
1.7 :tO.2
3.6 :L-0.4
3.4 i-0.5
3.1 :L-0.4
2.6 _+0.4
3.5 :t0.4
3.5 -t-0.5
3.6 x'-0.4
3.3 :_0.5
3.0 _+0.4
0.9 !0.3
1.0 _+0.3
1.1 :h0.4
0.7 _+0.1
0.9 :if).3
1.1 2-0.3
0.8 i-0.3
0.8 :tO.3
0.9 -20.3
3.1 -t-0.5
2.6 +0.4
2.6 x'-0.3
2.4 £-0.2
2.6 £-0.3
2.9 :L-0.4
2.7 :_.3
2.6 i-0.3
2.5 i'0.3
TABLE10.-ELECTROCARDIOGRAPHICESPONSESOFHEAD-DOWN(--6 °) SUBJECTS: U.S. STUDY
M +SE HR, PR, QRS, QT, QTC, T, SMAX, RMAX, R + S, Rv1 + SV5, Sv1 + Rv5,
beats/min sec sec see see mV mV mV mV mV mV
Prebed rest
Day 2
Day 13
Bed rest
Day 1, 0800
Day 1, 1300
Day 1, 1600
Day 1, 1900
Day 2
Day 4
Postbed rest
Day R + 0
Day R + 5
Day R + 10
64 :L--4.2
66 5:5.6
59 +_.6
64 :L-4.6
65 :L-4.8
64 :L-4.8
69 :t5.4
80:1.5.4
75 _+.3.9
0.16 :L-0.01
0.15 -.L-0.01
0.18 :L-0.01
0.17 -20.01
0.17 -&0.01
0.16 i-0.01
0.16 :L-0.01
0.16 _+0.01
0.16 :L-0.01
0.09 i'O
0.09 :tO
0.08 -2-13.01
0.09 _+0
0.09 :L-0
0.08 :t-0
0.08 :L-0
0.08 :L-0
0.08 :_
0.08 :tO
0.08 i-O
0.38 i_0.01
0.38 2-0.01
0.38 _+0.01
0.38 _.01
0.37 i-0.01
0.37 :L-0.01
0.37 :k0.02
0.36 i-0.02
0.37 :L-0.02
0.38 i'O.01
0.41 iO.01
0.39 -20.01
0.39 -24).01
0.38 :t0.01
0.38 i'0.01
0.39 i-0.01
0.38 i-0
0.39 "20.01
0.39 i-O.01
0.41 :L-'0.01
0.9 _+0.1
0.9 :L-O.1
1.0i-0.1
0.8 :L-0.1
0.8 :L-0.1
0.8 :L'0.1
0.7 _+0.1
0.6 :L-0.1
0.6_+0.1
1.6 :L-0.3
1.6 _+0.3
1.1 :L-0.2
1.1 _-t-0.2
1.4 :L-0.3
1.5 i-0.3
1.5 +0.3
1.5 !'0.3
1.5 :L-0.3
2.1 i-0.2
2.0 -1-0.2
2.0 :L-0.3
1.9 :L-0.3
1.9 :L-0.3
1.8 :L-0.2
1.9 i-0.2
1.7 i0.2
1.7 :L-0.3
3.5 i-0.4
3.1 :L--0.3
3.1 iv0.5
3.0 :L-0.2
3.0 :L-0.3
3.1 :L-0.3
3.3 :L'0.3
3.1 :L-0.3
3.0 :L-0.4
1.9 :L-0.7
1.6 :L-0.6
1.6 i-0.6
1.6 i-0.6
1.5 i-0.7
1.6 :L-0.7
2.6 -20.3
1.6 i_0.7
1.5 _+0.7
3.2 :L-0.4
3.1 _-0.4
2.7 :L-0.5
2.8 i-O.3
2.7 i-0.4
3.0 :k-0.4
2.9 :L-0.3
2.8 _'0.3
2.9 :L-0.3
TABLE11.-ELECTROCARDIOGRAPIIICESPONSESOFHORIZONTAL(0°)SUBJECTS:U.S.S.R.STUDY
Variable C-13 Control Bed restC-14 Av_. BR-1
0.91 0.95 0.99
66 63 61
0.18 0.18 0.19
0.08 0.08 0.08
0.39 0.39 0.40
0.35 0.36 0.37
+0.04 +0.03 +0.03
42 40 40
38 37 37
4 3 3
0.28 0.26 0.20
0.28 0.27 0.27
0.05 0.05 0.10
0.29 0.26 0.24
0.09 0.11 0.06
0.17 0.16 0.17
0.11 0.06
0.51 0.51
0.73 0.77
0.83 0.80
0.37 0.36
0.27 0.22
BR-2
1.16
52
0.18
0.08
0.42
O.39
+0.03
36
34
2
0.27
0.31
0.05
0.25
0.10
0.16
0.10
0.68
0.87
0.91
0.45
0.30
BR-4
1.12
54
0.18
0.08
0.41
O.39
+0.02
36
34
2
0.20
0.29
0.11
0.26
0.08
0.16
0.10
0.60
0.89
0.80
0.38
0.26
Recover]/
R-R, sec 1.01
FHC, beats/min 60
!PQ, sec 0.18
QRS, sec 0.08
QRSTu, sec 0.39
QRSTg, sec 0.37
QRST, sec +0.02
SLR, % 38
SLRQ, % 37
SL, % I
Ti, mV 0.23
TII, mV 0.26
Til l, mV 0.04
Tay R, mV 0.23
Tay L, mV 0.12
Tay F, mV 0.14
Ty 1, mV 0.09 0.12
Ty2, mV 0.50 0.51
Ty30 mV 0.82 0.63
Ty4, mV 0.84 0.82
Ty 5, mV 0.36 0.39
Ty 6, mV 0.26 0.28
Note: C = control; BR = bed rest = recovery.
R+0
1.0
5
0.I
0.0
0.4
0.3
+0.0
37
35
3
0.1
0.2
0.0
-0.1
0.0
0.1
0.1
0.5
0.4
0.6
0.2
0.1
TABLE 12.- ELECTROCARDIOGRAPtlIC RESPONSES OF ANTIORTHOSTATIC (-6 °) SUBJECTS:
U.S.S.R. STUDY
Variable
R-R, sec
FHC, beats/min
PQ, sec
QRS, sec
QRSTu, sec
QRSTg, sec
QRST, sec
SI r, %
Slrq, %
SI, %
TI, mV
TII, mV
Til l, mV
Tay R, mV
Tay L, mV
Tay F, mV
Ty 1, mV
Ty2, mV
Ty 3, mV
Ty4, mV
Ty 5, mV
Ty 6, mV
Note: C = control
Control
C-13 C-14
0.99 1.01
61 60
0.16 0.17
0.08 0.08
0.41 0.40
0.37 0.37
+0.04 +0.03
42 39
37 36
+5 +3
0.20 0.20
0.22 0.29
0.02 0.11
-0.24 -0.21
0.07 0.04
Av[_.
1.00
60
0.17
0.08
0.41
0.37
+0.04
41
37
+4
0.20
0.25
0.07
-0.23
0.06
BR-1
1.01
61
0.17
0.08
0.39
0.37
+0.02
39
37
+2
0.20
0.26
0.03
-9.22
Bed rest
BR-2
1.08
56
0.17
0.08
0.41
0.38
+0.03
38
35
+3
0.20
0.29
0.12
-0.23
BR-4
1.06
57
0.16
0.08
0.41
0.38
+0.03
39
36
+3
0.19
0.25
0.10
-0.23
0.13 0.20
0.06 0.06
0.42 0.32
0.64 0.59
0.66 0.70
0.28 0.33
0.19 0.28
BR = bed rest; R = recovery.
0.17
0.06
0.37
0.62
0.68
0.31
0.24
0.06
0.18
0.01
0.29
0.60
0.69
0.29
0.22
0.05
0.18
0.07
0.33
0.66
0.78
0.38
0.28
0.06
0.17
0.11
0.48
0.72
0.64
0.26
0.23
Recovery
R+10
1.14
53
0.17
0.09
0.41
0.39
+0.02
36
34
+2
0.14
0.18
0.07
-0.16
0.02
0.13
0.10
0.44
0.58
0.59
0.24
0.17
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The instrument used (Smith-Kline Ekosector I) had
both M-mode and scanner capabilities. Transducers of
either 1.90 or 2.25 MHz were used for the M-mode, with
recordings made on ultraviolet paper (Kodak Lina-
graph 1895) with a recorder (Honeywell Model 1856A
Visicorder) at a paper speed of 50 mm/sec with 7-cm cali-
bration marks. Sector scanner results were recorded
(Smith-Kline Model UTC-7100) on magnetic tape. Bipo-
lar sternal electrographic leads were used to record all
tracings simultaneously to determine the HR and timing
of cardiac events. To obtain the most representational
echoes of the anterior and posterior left-ventricle walls, all
subjects were placed in the right anterior, oblique chest
position (rotated 30o-40 ° around the longitudinal axis of
the body to rest on the left side). For each recording,
transducers were positioned in the same interspace and
chest location (left fourth and fifth intercostal spaces) to
ensure acquisition of reliable and reproducible data. The
position of the mitral valve was determined first, and the
transducer was then moved toward the cardiac apex until
acceptable recordings were obtained of the interventricu-
lar septum and rear wall of the left ventricle at the level of
the mitral valve chordae. This same approach was also
used by both teams of investigators when preparing sub-
jects for echocardiography during LBNP.
The following measurements were obtained from the
echocardiographic tracings:
1. Left ventricular end diastolic volume (EDV)
diameter: distance from the septal to posterior wall endo-
cardium with the peak of the QRS complex.
2. Left ventricular end systolic volume (ESV)
diameter: distance from septal to posterior wall endo-
cardium measured at the point of maximal anterior excur-
sion of the left ventricular posterior wall.
3. Left ventricular ejection time (LVET): from the
beginning of anterior motion of the posterior wall to the
point of maximal anterior displacement.
4. End systolic and end diastolic ventricular vol-
umes: calculated by the Teichholz formula
( 7.0 "_r_3
EDV or ESV = t 2.4 q5_((d ors) J_(d ors) (2)
5. Mean velocity of circumferential fiber shortening
(VCF) was calculated by
Dd - Ds / LVET (3)
VCF = Dd
fx
lated by
Left ventricular stroke volume (SV) was calcu-
SV = EDV - ESV (4)
7. Ejection fraction (EF) was calculated by
EF - SV / EDV (5)
8. Cardiac output (CO) was calculated by
CO = SV x HR (6)
where HR is heart rate. Mean values were obtained from
5-10 complete cardiac cycles and used for statistical anal-
yses. The results of echocardiography at rest are shown in
table 13 for the U.S. horizontal and head-down subjects.
Heart rate: No significant changes in resting HR
occurred in either group during echocardiography, and
differences between the two sets of subjects were not sig-
nificant. Average mean HR was 67.5 +2.5 for the horizon-
tal group and 65.2 +5.9 for the head-down subjects. The
maximum reduction occurred in the horizontal group on
the first day of bed rest (at 1900) when they exhibited an
average value of 58.8 +1.1; the comparable value for the
head-down subjects was 61.2+7.1. Thereafter, HR
increased progressively in both groups throughout the
bed-rest period and into recovery.
Mean arterial pressure: Although mean arterial
pressure (MAP) did not differ significantly between the
two subject groups, values were consistently higher for
the head-down subjects during both the bed-rest and
recovery periods. The highest MAP value for this group
(93.3 +3.4) occurred with the first measurement on the
first day of bed rest. This reading was significantly higher
(p < 0.05) than the baseline value (77 +3.1) and remained
elevated throughout the remainder of bed rest. Mean arte-
rial pressure also increased in the horizontal subjects, but
not significantly, with the highest value (86 +3.9) occur-
ring on the first day of bed rest. In both groups, values
returned to baseline by the fifth day of recovery.
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TABLE 13.-DYNAMICS OF ECHOCARDIOGRAPHY AT REST: U.S. STUDY
Control a Bed rest a Recover_ a
Parameter B R- 1 B R- 1
0800 1300 BR-2 BR-4 R + 0 R + 5 R + 10
Heart rate, beats/min
Horizontal Mean
SD
SE
Head-down Mean
SD
SE
Mean arterial pressure, mmHg
Horizontal Mean
SD
SE
Head-down Mean
SD
SE
End diastolic volume, ml
Horizontal Mean
SD
SE
Head_lown Mean
SD
SE
End systolic volume, ml
Horizontal Mean
SD
SE
Head-down Mean
SD
SE
C-2 C-13
67.8 67.5
7.7 3.3
3.8 1.7
63.0 67.2
16.0 11.0
7.4 4.9
73.3 77.5
6.0 13.9
3.0 7.0
79.0 77.0
11.4 6.8
5.1 3.1
103.3 96.3
21.3 26.3
10.7 13.1
116.2 118.6
4.9 33.1
2.2 14.8
31.5 29.0
7.9 10.9
3.9 5.5
30.2 35.6
10.8 17.1
4.8 7.7
63.3
6.5
3.3
62.6
10.8
4.8
86.0
7.8
3.9
93.3
7.7
3.4
108.0
19.1
9.6
108.4
14.9
6.6
43.5
15.5
7.7
37.2
13.4
6.0
65.0
5.8
2.9
62.0
16.3
7.3
86.0
7.8
3.9
93.0
7.9
3.5
104.0
26.8
13.4
106.4
19.6
8.8
32.5
4.9
2.5
33.0
11.8
5.3
BR-1 BR-1
1600 1900
64.3 58.8
8.2 2.2
4.1 1.1
59.2 61.2
14.5 15.8
6.5 7.1
85.3 83.8
10.1 8.9
5.1 4.5
87.4 87.6
11.1 11.1
4.9 5.0
103.0 99.8
20.6 27.0
10.3 13.5
106.7 102.8
9.5 16.7
4.2 7.5
33.3 32.0
5.3 6.7
2.6 3.3
36.0 34.0
9.3 12.0
4.1 5.5
64.3
2.6
1.3
60.4
6.8
3.1
84.0
7.5
3.8
86.0
7.1
3.2
108.8
8.1
4.0
97.0
14.8
6.6
33.3
5.7
2.8
33.0
8.9
4.0
64.5
2.9
1.4
68.4
10.4
4.6
78.8
8.3
4.1
90.4
9.9
4.5
105.7
20.3
10.1
124.2
30.4
13.6
36.5
3.0
1.5
41.6
16.8
7.5
67.0
2.5
1.2
68.3
9.7
4.3
80.1
9.3
4.6
85.4
9.9
4.4
97.0
29.8
14.9
116.0
36.5
16.3
37.0
17.8
8.8
40.6
24.8
11.1
70.0
4.2
2.1
68.0
11.1
5.3
72.5
10.4
5.0
80.0
5.2
2.3
112.8
28.0
14.0
124.0
29.0
13.0
44.0
24.8
12.4
39.4
17.6
7.8
72.5
3.4
1.7
67.0
7.9
3.6
76.5
4.4
2.2
78.0
10.7
4.7
105.7
20.3
10.1
123.0
29.6
13.2
38.5
9.6
4.8
39.6
13.3
5.9
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End diastolic volume: Baseline values of EDV were
not significantly different between the two groups,
although they tended to be slightly higher in the head-
down subjects than in the horizontal subjects
(118.6 +14.8 ml and 96.3 +13.1 ml, respectively). Values
for the two groups were similar on the first day of bed rest
(108 +9.6 ml versus 108 +6.6 ml), but decreased progres-
sively until 1900 (99.8 +13.5 ml for the horizontal sub-
jects and 102.8 +7.5 ml for the head-down). On day 2 of
bed rest, EDV declined further in the head-down group
(97.6 +6.6 ml) and increased slightly in the horizontal
subjects (108.8 +4.0 ml), which created a significant dif-
ference between the two groups (p < 0.05). These trends
were reversed on day 4 of bed rest when four of the five
head-down subjects showed an increase in EDV
(124.2 +13.6 ml) whereas the horizontal subjects showed
a slight decrease (105.7 +10.1 ml), but the difference
between the two was not significant. Throughout the
remainder of the bed-rest period, the head-down subjects
consistently exhibited a higher EDV. By day 5 of recov-
ery, however, both groups showed signs of returning to
normal, although the horizontal subjects exhibited a sig-
nificant increase (from 97+14.9 to 112.8+14 ml;
p < 0.05).
End systolic volume: End-systolic-volume responses
of the horizontal and head-down groups did not differ sig-
nificantly. On the first days of bed rest, ESV increased in
both groups (horizontal to 43.5 +7.7 ml; head-down to
37.2 ml), but decreased toward baseline values in both
groups by 1300 that day. During the remainder of bed
rest, ESV tended to increase slightly, but became signifi-
cantly higher for the horizontal group (p < 0.01) by day 4
of bed rest. It continued to increase during the recovery
period and became significantly higher (p < 0.05) in the
head-down group by the end of the recovery period, rela-
tive to baseline values.
Stroke volume: Baseline values of SV tended to be
higher in the head-down subjects (85.6 +3.8 ml on con-
trol-day 2 (C-2) and 83.4 +8.2 ml of C-13) than in the
horizontal group (72 _+9.8 and 67.3 +8.4 ml, respectively).
By 0800 on day 1 of bed rest, this variable had decreased
significantly in the head-down group (p < 0.05), but the
change in the horizontal group was not significant. It was
further reduced in the head-down group (to 63.4 +4.8 ml),
but increased slightly in the horizontal group (to
75.8 +2.9 ml). Throughout the remainder of bed rest, rest-
ing SV tended to decrease in both groups, but it returned
to baseline values by the fifth day of recovery.
Cardiac output: Changes in CO were closely related
to stroke-volume changes since HR did not change sig-
nificantly in either group during the study. Cardiac
output values for the horizontal subjects (mean control
value = 4730 +749 ml/min) did not change significantly
throughout the study, with only slight decreases observed
on the first day of bed rest and on the first day of
recovery. The head-down group, on the other hand,
exhibited a significant progressive decrease during the
first 2 days of bed rest (p < 0.05) over their base-line
values (mean control value = 5462 +384 ml/min;
decreased to 3833 +321 ml/min). By day 4 of bed rest,
however, CO had increased significantly in this group
(p < 0.05; 5568 +398 ml/min), but decreased again signif-
icantly (p < 0.05) by the end of bed rest. From then until
day 5 of recovery, both groups showed increases in CO,
but the changes were not significant.
Ejection fraction: Both groups exhibited a reduction
in EF on day 1 of bed rest, with the head-down group
showing a significant decrease (p < 0.01) and the horizon-
tal group showing a similar, but not significant, reduction.
By 1300 of day 1, EF in both groups had returned to the
range of baseline values. Thereafter, the horizontal sub-
jects showed a steady decrease in EF, which was signifi-
cant by the end of bed rest (p < 0.05). After the initial
decrease in EF early in the bed-rest period, the head-down
group stabilized at a lower value and did not change fur-
ther. Mean EF values in both groups remained depressed
during the recovery period.
Velocity of circumferential fiber shortening:
Changes in VCF were similar to those shown for the ejec-
tion fraction. During the first measurement on day 1 of
bed rest, both groups showed a reduced VCF compared
with baseline values, with the head-down subjects show-
ing a significant decrease (p < 0.05). Throughout the
remainder of bed rest, both groups exhibited wide varia-
tions in VCF, which were similar in magnitude to changes
observed in SV and CO. By the end of bed rest, both
groups showed values of VCF that were lower than base-
line values, but the change was significant only in the
horizontal group (p < 0.01). Values continued to differ
between the two groups during the recovery period, but
not significantly.
U.S.S.R. study- Echocardiograms at rest were
recorded in the U.S.S.R. study two times during the con-
trol period (days 13 and 14), three times on the first day of
bed rest, two times during the remainder of bed rest
(days 2 and 4), and two times during the recovery period
(days 0 and 5). M-mode measurements were made using
an Echoline-80 C (Picker Company) concurrent with the
ECG (bipolar chest levels) and recorded on ultraviolet
paper (Kodak 1895). The transducer was placed in the left
fourth or fifth intercostal spaces and positioned in a man-
ner identical to that described above for the U.S. study.
All studies were performed with subjects in the right ante-
rior oblique chest position (subjects rotated 300-40 ° about
the longitudinal axis of the body to rest on the left side).
Subjects were maintained in their respective bed-rest
positions (0 ° and -6 °) during echo studies. The two
investigative teams measured the same echocardiographic
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variables,exceptfortheVCF,whichwasnotderivedby
U.S.S.R.investigators.AsintheU.S.study,thesamepro-
cedurewasusedbyU.S.S.R.investigatorsforboththe
restingechocardiogramsndduringLBNP.
Baselinemeanechocardiographicdatafor both
groupsofsubjectsweresimilarandaregivenin table14.
Onesubjectineachgroupdemonstratedrelativelyhigh
controlvaluesofEDVandESV.Inthefirst4daysofbed
rest,thehorizontalsubjectsexhibitedecreasesinEDV,
ESV,andSVof 11%,6%,and14%,respectively,withan
attendantdecreasein CO(24%).Conversely,thehead-
downgroupshowedincreasesin thesevariablesof 10%,
19%,and3%,respectively,withCOreducedbyanaver-
ageof7%.Duringtheremainderof bedrest,thehorizon-
talsubjectsdemonstratedlowerEDV,ESV,andSVthan
did thehead-downgroup,for whichthesemeasured
valuesremainedclosetobaselinelevels.Bytheendof
bedrest(day7),andrelativetoday4 of bedrest,both
groupshowedecreasesinEDVandESV,whereasCO
hadincreasedalmosttobaseline.
Theincreasein HR,resultingin decreasedEDV,
ESV,andSVandincreasedCOonthefirstdayof recov-
ery,couldhaveresultedfrompsychologicalstressassoci-
atedwithanticipatingthesubsequentLBNPtestwhich
followedthesemeasurements.Theresponseof thehead-
downsubjectsatthistimecouldalsobeassociatedwith
decreasedvenousreturnsincethesubjectshadbeen
movedfromthehead-downtohorizontalpositionshortly
beforetherestingechomeasurements.It houldbenoted,
however,thatthehead-downgroupwasalsotested
2-2.5hr beforethepositionalchangein thehead-down
positionandshowedresponsesinEDV,ESV,SV,andCO
closetothoseseenonday4ofbedrest,indicatingthatthe
observedchangeshadpersistedthroughoutthebed-rest
period.
Afterthehead-downsubjectswerechangedto the
horizontalposition,theyexhibitedtheirlargestdecreases
inEDVandESV,butthiswasalsoassociatedwithsignif-
icantincreasesinHRresultinginamaintenanceof CO.
Forexample,onesubject,whenmovedfromthehead-
downto horizontalposition,showedadecreasein SV
(93ml to78ml),butbecauseofanincreaseinHR(48to
57beats/min)COremainedunchanged.Similarchanges
wereobservedinthehorizontalsubjects.
All resting echocardiographic variables returned to
baseline values in both groups by the fifth day of recov-
ery. No clinically significant changes in heart activity
occurred as the result of either horizontal or head-down
bed rest, and the changes that were noted were moderate,
functional, and reversible. The difference in heart volume
changes between the two groups of subjects deserves
some comment. It was felt that the slight decreases in
EDV, ESV, SV, and HR during bed rest in the horizontal
subjects were adaptive and directed toward maintaining
adequate cardiac output. The decreases in heart volumes
in these subjects were best explained by a reduction in
circulating blood volume. In the head-down group, the
tendency toward increases in EDV and ESV was thought
to result from the headward shift of body fluids, which is
characteristic of head-down bed rest.
The small number of subjects in the study, the limited
duration of bed rest, and significant individual variations
among subjects made it difficult to reach valid conclu-
sions concerning patterns of heart-volume changes and
alterations in myocardial contractile function.
Lower-Body Negative Pressure
A decrease in orthostatic tolerance has been a consis-
tent finding following exposure to weightlessness, bed
rest, immersion, and inactivity. To date, crews in Skylab
and Soyuz/Salyut missions have been subjected to ortho-
static testing (LBNP) during flight, and all of those tested
showed altered responses similar to those seen during
ground-based studies. Exposure to LBNP at -50 mmHg
has been demonstrated to produce changes in HR and
blood pressure, following weightlessness or immobiliza-
tion, similar to those produced by 70 ° passive tilt. The
observed changes are believed to result primarily from a
redistribution of the blood from thoracic reservoirs to
pools in the pelvis and vasculature of the legs. However,
this hypothesis has not been supported by findings from
all research studies (refs. 1 and 2).
The LBNP study compared physiological responses
of horizontal and head-down subjects to determine
whether either of these bed-rest modes would elicit
greater responses than the other. Echo ultrasound was
used during LBNP testing to measure total CO and
changes in left ventricular volumes with orthostatic stress
and to seek answers to the role of myocardial factors in
observed orthostatic responses to bed rest.
U.S. study- U.S. investigators used a standard LBNP
suction box device for orthostatic stress testing. All sub-
ects were placed in the device in the supine position. A
vacuum hood covered the lower extremities and was
sealed by a rubber diaphragm at the level of the umbilicus.
The LBNP procedures consisted of (1) a 5-min resting
control period; (2) 2 min at -25 mmHg, 3 min at
-35 mmHg, 5 min at --40 mmHg, 5 min at -50 mmHg;
and (3) 5 min of resting recovery. LBNP tests were
performed on days 2 and 13 of the study control period,
the last day of bed rest (day R + 0), and days 5 and 10 of
the study recovery period.
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TABLE 14.- CONCLUDED
Parameter
Cardiac output, liters
Horizontal
Head-down
Ejection fraction, %
Horizontal
Head-down
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Control a
C-13 C-14
5.7 6.0
1.3 1.6
0.6 0.8
5.9 5.3
1.1 0.8
0.5 0.4
66 66
5 4
2 2
64 66
4 1
2 1
BR-1 BR-1 + 3 hr
5.8 4.6
1.4 1.1
0.5 0.4
5.7 5.0
1.0 0.7
0.3 0.3
66 64
4 4
1 1
65 60
3 5
1 2
Bed rest a
BR-1 +6hr
5.0
1.3
0.6
5.3
0.6
0.3
64 64
2 6
1 3
59 62
4 2
2 1
BR-1 + 9 hr
4.8
1,1
0.5
5.8
0.3
0.2
BR-2
4.7
1.3
0.6
5.3
1.1
0.5
64
5
2
62
2
1
BR-4
4.4
1.0
0.5
5.2
0.9
0.4
64
5
2
61
2
1
Recovery a
R+0 R+5
5.4 5.3
1.4 1.2
0.6 0.5
5.8 7.0
1.1 0.5
0.5 0.2
66 65
4 4
2 2
65 68
3 5
1 3
aLetter-number combinations identify test period (e.g., C = control) and day of period.
DuringLBNP,thefollowingphysiologicalvariables
weremeasured:HR(sternalECGleads),bloodpressure(cuffandultrasonicsensor),andEDV,ESV,SV,CO,EF,
andVCF(allusingechoultrasound).Wideangle(82°),
two-dimensionalsectorscanswerealsomadeduring
LBNP,andthevelocityoftemporalrteryflowwasmea-
suredbothat restandduringLBNP(transcutaneous
Dopplerultrasonicflowmeter)todeterminecerebralper-
fusion.Orthostaticoleranceofthesubjectswasevaluated
onthebasisof changesinHR,bloodpressure,andCO
duringtesting.
TheU.S.investigatorsu edunpairedt-teststoassess
differencesinresponsesbythehorizontalndhead-down
subjects.Theusedpairedt-teststoevaluateheorthostatic
effectsofbedrestandrecoveryonindividualsubjects.In
evaluatingtheirfindings,particularattentionwaspaidto
differencesbetweenresponsesat peakLBNPstress
(-50 mmHg)andin therestingstate,to comparing
ambulatorycontrolresponseswiththoseattheendofbed
rest,andto changeseenduringtherecoveryperiod
(daysR+5andR+ 10).Theresultsaregivenintables15
through18.
Heartrate:HeartrateresponsesduringLBNPdid
notdiffersignificantlybetweenthehorizontalndhead-
downsubjects,asshownin table15.Beforebedrest,
averagemean HR during LBNP increasedby
21beats/minbothgroups,withthechangebeingsignif-
icantinboth(horizontal= +30%;head-down= +31%;
p< 0.01).Afterbedrest,bothgroupsexhibitedaneven
greaterincreaseduringLBNP(horizontal=+49%;head-
down= +51%;p<0.01).Responsesduringtherecovery
periodwereslightlydifferentforthetwogroups.Onday
5ofrecovery,thehorizontalgroupexhibitedagreaterHR
responseto peakLBNP,whichpersisteduntilday10
(+38%;p<0.01).OndayR+ 10,onehorizontalsubject
experiencedbradycardia(35beats/min)andvasopressor
syncopewithpeakLBNP.MeanHRincreasesduringthis
testweregreaterandmoresignificant(p < 0.05)than
thoseseenin thehead-downgroup,probablybecauseof
theresponseofthesubjectmentionedabove.
Systoliebloodpressure: Systolic blood pressure
(SBP) responses during LBNP are given in table 16. As
would be expected, SBP tended to decrease in both sub-
ject groups during LBNP and to increase to baseline
values when LBNP was stopped. Throughout the bed-rest
period, there was little difference in responses between
the two groups. During the recovery period, however, on
days R + 5 and R + 10, the horizontal subjects exhibited a
significant (p < 0.05) decrease in systolic pressure during
--40 and -50 mmHg LBNP, with decreases of 8 and
12 mmHg, respectively, compared with decreases of 3 and
7 mmHg, respectively, in the head-down subjects. Again,
the difference may have resulted from the response of the
subject described above.
Diastolic blood pressure: Diastolic blood pressure
(DBP) (table 17) was generally higher in both groups of
subjects at every level of LBNP following bed rest. In the
recovery period, the horizontal subjects exhibited a signif-
icantly greater increase in resting DBP (10.6%, p < 0.05)
than did the head-down group (+3.3%, p < 0.05).
Mean arterial pressure: In general, MAP
(DBP + (SBP - DBP)/3) tended to follow the same
patterns as diastolic blood pressure, both during LBNP
and after bed rest. With release of LBNP, this variable
remained higher than the baseline values in both groups,
particularly on the last day of bed rest (p < 0.05) and on
recovery days R + 5 and R + 10 (p<0.05) for the
horizontal subjects.
Throughout most of the LBNP test sessions, MAP
was lower in the horizontal subjects, except on day R + 10
of the recovery period. However, it was significantly
higher (p < 0.05) in the head-down group on day 13 of the
control period and on day 5 of recovery. On the last day
of bed rest, it was consistently higher (although not signif-
icantly so) in both groups of subjects during all LBNP
phases. Although there appeared to be a tendency toward
recovery in both groups on day R + 5, by day R + 10, the
horizontal group exhibited higher MAP, especially at
--40 mmHg LBNP (p < 0.05). The difference between the
two groups was significant, both during -40 mmHg
(p < 0.01) and after release of pressure (p < 0.05).
Pulse pressure: As LBNP stress progressed, both
subject groups consistently exhibited decreases in pulse
pressure (PP, SBP - DBP) as a result of a decrease in
systolic blood pressure and compensatory increase in dias-
tolic blood pressure. The decrease in PP with LBNP paral-
leled a decrease in SV and CO, which occurred with this
procedure. With the removal of LBNP, PP continued to
remain lower than baseline values. Pulse pressure at rest
and during LBNP showed no consistent trend after bed
rest in either group when compared with their respective
baseline values. However, the two groups differed signifi-
cantly (p < 0.05) in the direction and magnitude of change
following bed rest, with the horizontal group showing a
decrease in PP (-4%) and the head-down subjects show-
ing an increase (+16%).
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TABLE15.-AVERAGEHEARTRATERESPONSESTOLOWERBODYNEGATIVEPRESSUREINHORIZONTAL(0°)ANDHEAD-DOWN(-6°)SUBJECTS:U.S.STUDY
Group
Horizontal
-60tilt
Horizontal
-6 ° tilt
Horizontal
-60 tilt
Horizontal
-60 tilt
Horizontal
-60 tilt
Horizontal
-60 tilt
LBNP oeriod
Control
Control
-25 mmHg
-25 mmHg
-35 mmHg
-35 mmHg
--40 mmHg
--40 mmHg
-50 mmHg
-50 mmHg
Recovery
Recovery
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Control
2 13
68.7 68.9
7.3 2.4
3.3 1.1
65.5 69.3
10.3 11.4
4.6 5.1
73.6 76.2
7.6 5.3
3.4 2.4
70.3 75.2
12.9 14.9
5.8 6.7
81.7 81.5
10.4 5.7
4.7 2.5
73.7 79.7
11.8 15.8
5.3 7.1
83.0 85.4
13.2 5.6
5.9 2.5
79.1 84.4
11.5 17.2
5.1 7.7
89.9 91.0
13.3 7.4
6.0 3.3
84.7 92.0
15.4 19.0
6.9 8.5
67.6 66.1
10.0 4.4
4.5 2.0
63.0 69.6
10.2 11.2
4.6 5.0
Heart rate, beats/min
Averase 0
68.8 68.9
4.4 2.7
2.0 1.2
67.4 66.7
10.1 9.6
4.5 4.3
74.9 76.3
5.4 2.4
2.4 1.1
72.7 75.4
13.3 14.3
6.0 6.4
81.6 84.9
7.0 4.2
3.1 1.9
76.7 82.1
13.1 16.3
5.8 7.3
84.2 92.6
8.6 6.1
3.8 2.7
81.8 89.3
13.2 18.1
5.9 8.1
90.4 102.7
9.5 6.1
4.2 2.7
88.4 101.7
15.8 23.9
7.1 10.7
66.9 69.0
7.0 3.6
3.2 1.6
66.3 71.1
10.0 14.1
4.5 6.3
Recovery day
67.3
5.2
2.3
66.8
10.9
4.9
75.9
7.7
3.5
72.2
13.4
6.0
82.0
9.0
4.0
76.5
14.0
6.2
86.3
13.1
5.9
79.9
13.8
6.2
93.8
11.4
5.1
87.5
17.2
7.7
66.1
6.1
2.7
66.9
11.4
5.1
10
74.0
4.1
1.9
68.2
10.7
4.8
80.6
6.0
2.7
75.5
13.1
5.9
88.2
7.2
3.2
78.8
14.2
6.4
95.9
8.8
3.9
82.9
16.8
7.5
93.8
21.6
9.7
90.2
17.6
7.8
71.4
5.8
2.6
67.9
11.1
4.9
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TABLE16.-SYSTOLICBLOODPRESSURESPONSESTOLOWERBODYNEGATIVEPRESSUREIN
HORIZONTAL(0°)ANDHEAD-DOWN(.-6°)SUBJECTS:U.S.STUDY
Grout)
Horizontal
-6° tilt
Horizontal
-6 ° tilt
Horizontal
-6 ° tilt
Horizontal
-6 ° tilt
Horizontal
-6 ° tilt
Horizontal
-6 ° tilt
LBNP oeriod
Control
Control
-25 mmHg
-25 mmHg
-35 mmHg
-35 mmHg
-40 mmHg
-40 mmHg
-50 mmHg
-50 mmHg
Recovery
Recovery
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
2
111.5
11.8
5.3
120.2
16.2
7.2
105.4
12.1
5.4
116.9
19.3
8.6
105.0
12.2
5.5
115.2
18.6
8.3
105.2
12.4
5.5
117.1
19.3
8.6
102.3
13.2
5.9
114.3
21.5
9.6
111.6
11.1
4.9
121.7
14.1
6.3
Systolic blood
Control day
13
109.2
9.2
4.1
120.9
10.8
4.8
106.6
8.7
3.9
119.0
11.0
4.9
106.3
6.7
3.0
117.6
13.1
5.9
105.2
8.7
3.9
115.0
10.0
4.5
101.7
7.6
3.4
111.7
12.7
5.7
108.6
10.1
4.5
118.5
11.3
5.1
pressure r
Averal_e 0
110.3 112.1
10.4 14.2
4.6 6.4
120.5 123.6
11.8 17.7
5.3 7.9
106.0 106.8
9.7 8.9
4.3 4.0
118.0 119.2
13.2 19.3
5.9 8.6
105.6 106.3
9.0 10.8
4.0 4.8
116.4 120.2
13.8 18.8
6.2 8.4
105.2 108.1
10.1 10.2
4.5 4.6
116.1 121.9
14.1 21.2
6.3 9.5
102.0 104.9
9.8 9.9
4.4 4.4
113.0 116.4
16.4 19.2
7.3 8.6
110.1 115.4
10.5 15.5
4.7 6.9
120.1 124.2
11.9 19.9
5.3 8.9
mmH_
Req9v_rv _,_y
5
107.4
12.3
5.5
119.0
13.6
6.1
103.2
10.7
4.8
117.2
13.8
6.2
103.0
13.3
6.0
118.6
16.3
7.3
99.8
13.2
5.9
117.4
16.7
7.5
99.7
14.5
6.5
116.3
16.3
7.3
109.0
13.3
6.0
119.5
13.9
6.2
10
108.8
10.7
4.8
116.7
9.8
4.4
105.6
11.6
5.2
112.5
13.9
6.2
104.2
8.2
3.7
113.4
14.0
6.3
106.5
10.0
4.5
113.1
9.6
4.3
97.0
16.7
7.5
109.5
13.1
5.9
109.3
9.5
4.3
111.7
14.1
6.3
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TABLE17.-DIASTOLICBLOODPRESSURESPONSESTOLOWERBODYNEGATIVEPRESSUREIN
HORIZONTAL(0°)ANDHEAD-DOWN(--6°)SUBJECTS:U.S.STUDY
Group
Horizontal
-6°tilt
Horizontal
-6o tilt
Horizontal
-6o tilt
Horizontal
-6o tilt
Horizontal
-6 ° tilt
Horizontal
-6 ° tilt
LBNP period
Control Mean
SD
SE
Control Mean
SD
SE
-25 mmHg Mean
SD
SE
-25 mmHg Mean
SD
SE
-35 mmHg Mean
SD
SE
-35 mmHg Mean
SD
SE
-40 mmHg Mean
SD
SE
-40 mmHg Mean
SD
SE
-50 mmHg Mean
SD
SE
-50 mmHg Mean
SD
SE
Recovery Mean
SD
SE
Recovery Mean
SD
SE
ap < 0.05 change compared to C-2 or R + 0
Diastolic blood pressure, mmH 8
Control day
2 13 Avera/_e
55.3 54.9 55.1 60.9
4.1 5.2 4.2 6.4
1.8 2.3 1.9 2.9
60.3 61.7 61.0 63.1
7.8 7.1 4.6 6.0
3.5 3.2 2.0 2.7
58.0 58.6 58.3 61.4
4.8 6.7 5.0 5.8
2.2 3.0 2.2 2.6
62.0 63.7 62.8 65.6
6.9 5.9 4.1 5.9
3.1 2.6 1.8 2.6
57.9 56.2a 57.1 61.6
5.2 3.8 4.3 4.9
2.3 1.7 1.9 2.2
63.8 65.6 a 64.7 67.9
9.8 8.3 6.3 7.2
4.4 3.7 2.8 3.2
59.2 58.9 59.0 64.5
5.4 3.4 4.3 5.4
2.4 1.5 1.9 2.4
64.1 65.8 65.0 70.7
8.5 6.6 6.2 6.9
3.8 3.0 2.8 3.1
60.6 59.4 60.0 66.3
6.0 6.0 5.6 7.6
2.7 2.7 2.5 3.4
64.0 66.2 65.1 70.6
9.9 5.6 6.9 8.7
4.4 2.5 3.1 3.9
59.7 59.7 59.7 67.3
4.6 5.3 4.9 9.4
2.1 2.4 2.2 4.2
64.2 64.5 64.3 71.0
7.9 5.1 5.9 8.2
3.5 2.3 2.6 3.7
test.
Recovery day
5 10
56.1 60.4
6.9 4.4
3.1 2.0
60.6 59.8
3.5 7.9
1.6 3.5
57.2 a 62.2
5.3 7.0
2.3 3.1
64.5 a 59.8
1.7 8.8
0.8 3.9
60.4 63.5
8.9 6.8
4.0 3.0
64.1 63.5
2.3 6.6
1.0 3.0
59.7 65.2
7.7 8.4
3.4 3.7
65.5 64.6
3.9 6.5
1.7 2.9
61.5 62.7
8.1 10.8
3.6 4.8
66.0 65.9
3.8 8.5
1.7 3.8
61.6 66.2
8.5 9.0
3.8 4.0
62.8 63.1
5.8 8.2
2.6 3.7
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TABLE 18.- DYNAMICS OF ECHOCARDIOGRAPHY DURING LBNP: U.S. STUDY
P_ametet
Control-_-iod da_¢ Recover_-_5od da_
C-2 C-13 Average C-2 + C-13 R + 0 R + 5 R + 10
Peak Peak Peak Peak Peak Peak
Cont. LBNP, Recov. Cont. LBNP, Recov. Cont. LBNP, Recov. Cont. LBNP, Recov. Cont. LBNP, Recov. Cont. LBNP, Recov.
mmHg mmHg mmHg mmHg mmHg mmHg
End diastolic volume, ml
Horizontal Mean 103.3 59.0 101.7 96.3 61.8 102.0 99.5 65.5 103.5 97.0 58.7 95.5 112.8 57.0 111.0 105.7 63.0 117.0
SD 21.3 21.2 17.6 26.3 27.5 28.7 5.8 24.6 8.5 29.8 13.3 30.4 28.0 13.0 37.5 20.3 179 34.3
SE 10.7 15.0 8.8 13.1 16.7 16.6 2.9 12.3 4.3 14.9 6.6 15.2 14.0 6.0 18.8 10.1 8.6 17.2
Head-down Mean 116.2 72.0 126.0 118.6 81.8 110.0 117.4 77.0 118.0 116.0 51.8 116.0 124.0 68.0 122.0 123.0 74.6 127.6
SD 4.9 21.8 6.5 33.1 23.1 27.4 18.0 16.0 10.7 36.5 35.8 38.2 29.0 37.6 34.0 29.6 20.7 15.6
SE 29 9.8 2.9 14.8 10.4 12.2 8.0 7.2 4.8 16.3 16.0 17.1 13.0 16.8 15.3 13.2 9.3 7.0
End systolic volume, ml
Horizontal Mean 31.5
SD 7.9
SE 3.9
14.0 29.0 29.0 20.5 33.0 30.8 20.5 31.8 37.0 22.5 38.0 44.0 23.2 44.8 38.5 20.2 42.5
0 8.2 10.9 9.9 13.5 3.1 9.8 7.8 17.8 8.6 13.7 24.8 13.0 27.1 9.6 8.6 18.7
0 4.1 5.5 4.9 7.8 1.5 4.9 3.9 8.8 4.3 6.9 12.4 6.5 13.5 4.8 4.3 9.3
Head-down Mean 30.2
SD 10.8
SE 4.8
18.0 32.2 35.6 21.8 34.4 33.0 20.0 33.6 40.6 19.4 43.0 39.4 24.8 42.8 39.6 27.6 43.6
8.1 8.3 17.1 6.2 13.3 13.5 6.3 10.0 24.8 15.4 26.0 17.6 20.1 20.5 13.3 14.5 13.2
3.6 3.7 7.7 2.8 5.9 6.0 2.8 4.5 11.1 6.9 11.4 7.8 9.0 9.2 5.9 6.5 5.9
Stroke volume, ml
Horizontal Mean 72.0 45.0 73.0 67.3 413 69.0 69.7 45.2 68.0 59.0 37.0 57.3 68.2 34.0 66.2 67.2 43.0 74.8
SD 19.6 21.2 21.1 16.8 18.5 18.5 6.4 15.9 6.2 14.2 6.7 18.0 15.7 13.4 17.0 16.0 10.2 18.5
SE 9.8 15.0 10.5 8.4 9.3 10.7 3.2 7.9 3.1 7.1 3.3 9.0 7.9 6.7 8.5 8.0 5.1 9.3
Head-down Mean 85.6 54.2 94.0
SD 8.4 22.9 11.7
SE 3.8 10.2 5.2
83.4 60.0 77.0 85.0 57.4 85.8
18.2 19.9 17.8 9.3 16.2 4.9
8.2 8.9 8.0 4.6 7.2 2.2
85.4 32.4 73.0 84.6 43.2 79.6 83.6 47.0 83.8
13.5 21.0 14.2 12.1 19.8 16.0 16.6 6.9 3.6
6.0 9.4 6.4 5.4 8.8 7.2 7.4 3.1 1.6
to
.,,d
TABLE 18.- CONCLUDED
Pm'_lllctet
Cardiac output,ml/min
Horizontal Meaa
SD
SE
Head.down Mean
SD
SE
Ejection fraction, %
Horizontal Mean
SD
SE
Head-down Mean
SD
SE
VCF, circlsec
Horizontal Mean
SD
SE
Head-down Mean
SD
SE
Conlrol-imriod da_/ Recovery-period da_'
C-2 C-13 Average C-2 + C-13 R + 0 R + 5 R + 10
Peak Peak Peak Peak Peak Peak
Cont. LBNP, Recov. Cont. LBNP, Recov. Cont. LBNP, Recov. Cont. LBNP, Recov. Cont. LBNP, Recov. Cont. LBNP, Recov.
mml _ mmH mmlq mmHg mmltg mmHg
48_ 35_ 44q 46 363 3& 4595 4017 3790 3583 4811 3031 4160 4847 4345 5058
12z 16t 14z 11: 173 15 1039 816 481 930 1159 1556 960 1010 818 745
62 lOi, 72 5q 86' 7-'_ 520 408 240 465 580 778 480 505 409 372
54: 43( 53" 54, 521 47 5181 4935 2972 4608 5737 3602 4747 5646 3990 5443
16' 22( 14: 75 105 13 636 728 1141 408 1086 1564 1020 1516 972 1227
75 101 05 3:47 5: 284 326 510 182 485 7_ 456 678 434 549
, 069 062 062 061 062 060 061 063 069 065
C 0.05 0.08 0.07 0.04 0.14 0.18 0.13 0.07 0.07 0.07
C 0.02 0.04 0.03 0.02 0.07 0.09 0.07 0.04 0.03 0.03
0.73 0.67 0.63 0.65 0.69 0.65 0.66 0.68 0.65 0.66
1 0.05 0.09 0.08 0.08 0.06 0.09 0.00 0.04 0.09 0.06
( 0.02 0.04 0.04 0.04 0.02 0.04 0.03 0.02 0.04 0.03
c 1.73 1.51 1.73 1.45 1.48 1.68 1.46 1.53 2.08 1.67
0.18 0.31 0.38 0.21 0.51 0.77 0.48 0.30 0.30 0.40
, 0.09 0.15 0.19 0.11 0.26 0.38 0.24 0.15 0.16 0.18
l
1.84 1.73 1.82 1.59 1.73 1.79 1.63 1.70 1.82 1.59
0.17 0.29 0.36 0.20 0.22 0.37 0.21 0.08 0.28 0.14
0.08 0.13 0.16 0.09 0.10 0.16 0.09 0.04 0.13 0.06
End diastolic volume: Mean values of EDV
(table 18) did not differ significantly between the hori-
zontal and head-down subjects during the pre-bed-rest
control period, with all subjects exhibiting a decrease
(-34% to -35%) at -50 mmHg LBNP. Following bed rest
(day R + 0), the horizontal subjects showed a decrease in
EDV of 38 ml (-37%) at peak LBNP, whereas the head-
down group experienced a decrease of 64 ml (-58%;
p < 0.01), which was significantly greater (p < 0.05) than
their control period responses. During the recovery period
(days 5 and 10), both groups continued to exhibit greater
decreases in EDV with LBNP than they had before bed
rest.
End systolic volume: No significant differences in
mean values of ESV were seen in the two sets of subjects
at rest in the control period. When subjected to LBNP dur-
ing this period, both groups exhibited a 30%-36%
decrease (table 18). With peak LBNP after bed rest, how-
ever, the horizontal subjects showed a decrease in ESV of
15 ml (30%), and the head-down subjects experienced a
decrease of 21 ml (-52%; p < 0.05). During peak LBNP
on recovery days 5 and 10, the horizontal group exhibited
a greater decrease than they had before bed rest, although
resting values were higher and resting ejection fractions
lower. At the same time, the head-down subjects exhibited
lesser decreases in ESV.
Stroke volume: Stroke volume decreased with
-50 mmHg LBNP in both groups during the control
period (table 18). Average values for the two LBNP tests
during that period (days 2 and 13) showed that the head-
down subjects had a significantly higher mean value of
resting SV (85 ml) than the horizontal group (70 ml).
Following bed rest (day R + 0), the head-down group
exhibited a significantly greater decrease in SV, with peak
LBNP, of 43 ml (-59%; p < 0.01) than the horizontal
group with a decrease of 22 ml (-36%). During the recov-
ery period, both groups continued to exhibit SV decreases
compared to the baseline values. The horizontal group,
however, returned more rapidly to the values that were
measured before bed rest. With peak LBNP on day 5 of
recovery, these subjects showed a decrease in SV of 34 ml
(nonsignificant) and the head-down subjects showed a
41-ml decrease (p < 0.01). This trend persisted in the
head-down subjects to day 10 of recovery, when they
exhibited a 37-ml decrease in SV with peak LBNP stress,
whereas the horizontal subjects showed a decrease of only
24 ml. At this testing, the horizontal subjects also
displayed increased HR, EF, and VCF during peak LBNP
and, consequently, maintained CO.
Cardiac output: There was a consistent decrease in
CO during peak LBNP in both groups despite LBNP-
induced tachycardia, primarily because of marked
decreases in EDV and SV resulting from LBNP
(table 18). Following bed rest (day R + 0), the head-down
subjects showed a much greater decrease in CO (p < 0.05)
with peak LBNP than did the horizontal group----decreases
of 1963 ml/min and 228 ml/min, respectively. Between
day 13 of the control period and the end of bed rest
(day R + 0), the head-down group showed a drop in CO
with LBNP from 5210 ml/min to 2972 ml/min, but the
horizontal subjects showed no significant change (from
3633 ml/min to 3790 ml/min). Thus, there was a signifi-
cant difference (p < 0.05) between the magnitude and
direction of changes in the two groups. The observed
changes in CO were primarily a result of changes in SV,
since HR increased proportionately (by 56% in the hori-
zontal group and 53% in the head-down group).
By day 5 of recovery, the horizontal subjects exhib-
ited a greater decrease in CO with LBNP than was seen
between the control period and the end of bed rest, possi-
bly because of a lesser decrease in HR (-17 beats/min on
day R + 5 and -38 beats/min on day R + 0). These
subjects also had a greater decrease in SV on day R + 5
(-34 ml) than on day R + 0 (-22 ml). The head-down
subjects, on the other hand, exhibited no change in CO in
response to LBNP, indicating that deconditioning per-
sisted. However, HR responses during peak LBNP were
reduced significantly (-17%) on day R + 5 relative to
R + 0, while control-to-peak-LBNP changes on day R + 5
were similar to average responses in the pre-bed-rest con-
trol period. It is interesting to note that the head-down
subjects experienced this reduction in HR even though
their peak LBNP COs and SVs were significantly
(p < 0.05) lower than pre-bed-rest values.
Ejection fraction and VCF: With LBNP testing fol-
lowing bed rest (days R + 0 and R + 5), the horizontal
subjects did not show evidence of LBNP-induced changes
in EF and VCF. The head-down subjects, on the other
hand, did exhibit greater decreases in EF and VCF (see
table 18). The head-down subjects showed changes that
were less significant following bed rest. Although MAP
in the horizontal subjects at -50 mmHg LBNP on
day R + 10 was 6 mmHg lower and diastolic blood pres-
sure was 5 mmHg lower than comparable values for the
head-down group, the differences between the two groups
probably did not account for the difference in EF and
VCF responses between them.
U.S.S.R. study- The LBNP equipment used by the
U.S.S.R. investigators differed from that used by the U.S.
and consisted of pants worn by the subjects which would
support an applied vacuum as shown in figure 2. The
device, called the CHIBIS suit, was developed for prophy-
lactic purposes during flight. The pants cover the lower
half of the body and contain a waist vacuum seal. The
trousers are accordion pleated and held in place, during
application of negative pressure, by shoulder suspenders
and pressure on the soles of the feet of the outstretched
legs.
29
STRAP
PR ESSU R E
UNIT
ACCORDION
PLEATED
PANTS
Figure 2.- U.S.S.R. lower-body negative pressure
equipment.
All subjects were tested in the supine position and
were exposed to the following levels of LBNP: (I) 5 min
of resting control; (2) 2 min at -25 mmHg, 3 min at
-35 mmHg, 5 min at -40 mmHg, and 5 min at
-50 mmHg; and (3) a 5-min recovery period. After the
application of peak stress (-50 mmHg), pressure was
returned to atmospheric. The tests were administered at
the same time each testing day, twice during the study
control period, at the end of bed rest (day R + 0), and on
days 5 and 10 of the study recovery period (for one sub-
ject, the last test had to be postponed until day 13 because
of the subject's toothache). Heart rate and blood pressure
changes at peak LBNP before and after bed rest are given
in table 19.
During the study control period, all of the horizontal
subjects and four of the head-down subjects were able to
tolerate LBNP at all levels; one head-down subject, how-
ever, was able to tolerate only 4.5 min of -50 mmHg
LBNP during the first test in the study control period, but
tolerated the second test without difficulty. During LBNP
testing, the head-down group exhibited higher HR and
lower arterial pressure than the horizontal subjects. How-
ever, the differences between the two groups were not
significant, as shown in table 19.
Following bed rest, HR and arterial pressure before
LBNP were practically identical for the horizontal and
head-down subjects, which negated a slight discrepancy
between the two observed in the control period. After bed
rest, LBNP tolerance decreased in all subjects, and they
complained of feelings of weakness, sweating, and dizzi-
ness. Frank syncope was not observed on R + 0, but pulse
rate increased and arterial pressure decreased to a greater
degree than before bed rest. The horizontal subjects
demonstrated a significant (p < 0.01) decrease in PP,
caused primarily by a decrease in systolic arterial pressure
during vacuum. Systolic pressure of the horizontal sub-
jects decreased from 121 +1.0 mmHg before bed rest
to 101 +4.0 mmHg afterward, and it decreased from
122 +1.0 to 113 +4.0 mmHg in the head-down subjects.
Changes in diastolic arterial pressure with LBNP were
very similar in the two groups, with increases of 12% in
the horizontal subjects and 14% in the head-down
subjects.
By days 5 and 10 of recovery, LBNP tolerance had
improved substantially in most of the subjects. One head-
down subject who had been unable to tolerate a full period
of -50 mmHg during control-period testing, however, was
still unable to tolerate more than 280 sec of-50 mmHg on
day 5 of recovery.
U.S.S.R. investigators were able to obtain usable
echocardiograms of only four horizontal subjects and
three head-down subjects because of subject heart dis-
placements during LBNP, particularly at suctions greater
than -35 mmHg. The data are given in table 20. Since the
number of suitable measurements was so small, the results
were not analyzed statistically.
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TABLE 19.- HEART RATE, ARTERIAL PRESSURE, AND PULSE PRESSURE WITH LBNP IN HORIZONTAL (0") AND HEAD-DOWN (-6 o) SUBJECTS: U.S.S.R. STUDY
Pm'ameter
Heart ram, be_shnin
Horizontal Mesa
SD
SE
Head-down Meaa
SD
SE
Pulse pressure, mmHg
Horizontal Mema
SD
SE
Head-down Mean
SD
SE
Systolic blood pressure, mmHg
Horizontal Mean
SD
SE
Head-down Mema
SD
SE
Diastolic blood pressure,
mmHg
Horizontal Meaa
SD
SE
Head-down Mean
SD
SE
Rest
65.0
12.11
5.42
69.0
9.06
4.05
41.0
8.94
4.00
37.0a
5.70a
2.55a
127.1
9.8
4.4
125.7
11.4
5.3
77.5
7.7
3.5
81.6
10.2
4.8
asignificant difference from U.S. findings.
.Controlperiod
-50 mm/-Ig
LBNP
A
26.0
6.7
3.04
29.0
12.2
5.54
19.0 a
4.2 a
1.9 a
18.0
7.2
3.27
12.7
9.9
11.1
5.3
%A
40
5.8
2.63
42
18.1
8.22
47"
7.9a
3.59 a
47 a
17.0 a
7.72 t
10
7.8
14.3
6.4
Rest
67.0
14.65
6.55
68.0
8.44
3.78
44.0
4.15
1.86
46.0
9.62
4.30
122.4
3.0
1.3
123.2
13.2
5.9
R+0
-50 mmHg
LBNP
A
43.0
12.3
5.59
46.0
13.6
6.18
30.0 a
6.6 a
3.0 a
20.0
7.9
3.59
20.2
15.6
%A
66
22
10
68
16.9
7.68
68 a
11.8 a
5.36 a
46a
13.9 a
6.31 a
16.5
12.6
9.2
14.1
Rest
65.0
11.13
4.98
76.0
8.86
3.96
38.0
6.71
3.0
45.0
11.72
5.24
114.4
6.0
2.7
118.2
12.7
5.7
Rec_e_ _fiod
R+5
Rest
69.0
13.22
5.91
76.0
13.33
5.96
42.0
6.71
3.0
43.0
12.04
5.39
109.2
7.6
3.4
177.2
12.7
5.7
78.0
5.6
2.5
76.1
11.3
5.1
7.2
10.7
74.0
6.1
2.7
72.4
9.1
4.2
-50 mmHg
LBNP
A %A
26.0 40
6.2 7.9
2.81 3.59
34.0 45
11.3 17.4
5.13 7.90
16.0 41 a
6.6 10.6 a
3.0 4.81 a
21.01 48 m
4.2a 9.6a
1.90a 4.36a
8.4 7.3
10.3 8.7
4.0 5.4
9.0 12.4
67.6
4.0
1.8
74.6
8.6
3.8
R+I0
-50 mmHg
LBNP
A
24
5.6
2.54
27.0
7.0
3.18
23.0
8.4
3.81
19.0
6.6
3.0
12.6
70.6
5.8
3.0
%A
35
13
6
36
1
7
5.5
1
6
44
9
4
11.5
39.8
8.5
4.0
L,O
TABLE 20.- ECHOCARDIOGRAPHIC DATA DURING LBNP FOR HORIZONTAL (0 °) AND
ANTIORTHOSTATIC (-6 °) SUBJECTS: U.S.S.R. STUDY
Parameter
End diastolic volume, ml
End systolic volume, ml
Stroke volume, ml
Heart rate, beats/min
Cardiac output, liters/min
Ejection fraction, %
Group
0o
_6°
0o
_6°
0o
_6 °
0o
_6 °
0o
_6 °
Control period
Rest
138.0
132.0
46.0
47.0
920
85.0
67.0
66.0
6.2
5.6
0o
-6o
67.0
64.0
Peak
LBNP
86.0
95.0
32.0
38.0
Recovery period
Day R-0
Peak
Rest LBNP
122.0 71.0
127.0 84.0
45.0 33.0
40.0 39.0
Day
Rest
128.0
133.0
44.0
43.0
R-5
Peak
LBNP
84.0
83.0
28.0
31.0
54.0
57.0
91.0
94.0
4.9
5.4
64.0
60.0
77.0
87.0
67.0
66.0
5.2
5.7
63.0
69.0
38.0
45.0
102.0
112.0
3.9
5.2
54.0
54.0
84.0
90.0
79.0
65.0
6.6
5.9
66.0
68.0
56.0
52.0
104.0
92.0
5.8
4.8
67.0
63.0
During the study control period, echocardiography
during LBNP showed that HR at peak LBNP increased by
36% in the horizontal subjects and by 42% in the head-
down subjects, as shown in table 20. In the horizontal sub-
jects, EDV decreased by 38%, ESV by 31%, and SV by
28%. In the head-down group, EDV decreased by 28%,
ESV by 28%, and SV by 43%. Cardiac output also
decreased in both groups, but to a greater degree in the
head-down subjects (-19.3%) than in the horizontal sub-
jects (-3.4%).
Immediately following bed rest (day R + 0), LBNP
responses during echocardiography were intensified in all
subjects, particularly HR, which increased by 52% in the
horizontal subjects and by 70% in the head-down subjects.
In the horizontal group, EDV decreased by 42%, ESV
decreased by 27%, and SV decreased by 37%. The head-
down group showed decreases of 34% in EDV, 33% in
ESV, and 46% in SV. Cardiac output and EF were con-
siderably greater both before and after bed rest in the
head-down subjects.
By day 5 of recovery, all variables had returned
almost to baseline values, except that the horizontal group
exhibited a somewhat greater decrease in CO (-17%) than
seen during the control-period testing.
Although fewer in number, the U.S.S.R. echocardio-
graphic findings demonstrated changes similar to those
found by the U.S. team in both magnitude and direction.
Left Ventricular Systolic Time Intervals
U.S. investigators recorded left ventricular systolic
time intervals (STI) at rest and during LBNP, both before
and after bed rest. Measurements of STI made during
LBNP were obtained at peak stress (-50 mmHg) and
during recovery (release of suction). First and second
heart sounds were obtained with a microphone (Elma-
Schonander EMT 25) placed over the precordium at the
fourth right interspace near the sternum. Carotid pulse
was recorded (Sanborn APT/16/1 transducer), and tempo-
ral artery pulse was measured with a continuous-wave
Doppler velocity system (L&M Directional Ultrasonic
Flowmeter Model 1012). Because no difference was
found between carotid and temporal artery pulses, LVET
was determined from the more technically definitive trac-
ings of the Doppler fiowmeter with the value determined
from the beginning upstroke of the velocity trace to the
trough of the incisura. The interval between the first
and second heart sound (S1S2) was measured from the
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beginningof thefirst soundto theonsetof theaortic
componentof thesecondsound.Thedurationof total
electromechanicalsystolewasmeasureddirectlyfromthe
onsetof theQ-waveof theECGtothebeginningof the
secondheartsound(QS2).All datawererecordedusing
aneight-channelink recorder(GouldBrush200)at a
paperspeedof 100mm/sec.
Thepre-ejectionperiodwascalculatedbysubtracting
LVETfromQS2;theQS1intervalwascalculatedbysub-
tractingS1S2fromQS2;andtheisovolumnicwascalcu-
latedbysubtractingLVETfromS1S2.Observedvaluesof
QS2,LVET,andPEPwerecorrectedforHRresponses
usingthefollowingequationsdevelopedbyWeisslertal.(ref.22):
QS_= 2.1HR +QS 2 (7)
LVET' = 1.7 HR + LVET (8)
PEP' = 0.4 HR + PEP (9)
All intervals were calculated from the mean of five con-
secutive beats, with each beat measured to the closest
5 msec. Results are shown in table 21. Changes within
each group were analyzed by using a paired t-test and
changes between the two groups were analyzed by using
an unpaired t-test.
This noninvasive technique has become widely used
for clinically evaluating left ventricular function under a
variety of conditions (ref. 23). In several previous investi-
gations, in which the technique was used with bed rest, it
was consistently found that LVET is shortened and that
the PEP is lengthened, resulting in an increase in
PEP/LVET. The mechanisms underlying these changes
are not yet understood, but appear to be related to
decreased myocardial contractility or to changes in car-
diac function, because of decreases in plasma volume
regularly seen with immobilization.
However, differences in resting STI measurements
between the horizontal and head-down subjects before
and after bed rest were not significant. As would be
expected, LBNP affected both groups. During control-
period measurements with LBNP, the two groups
exhibited similar decreases in LVET intervals (hori-
zontal = -40 msec, p < 0.05; head-down = -34 msec,
p < 0.05). PEP intervals and PEP/LVET, on the other
hand, increased in both groups, with the horizontal
subjects showing increases of +19 msec in PEP intervals
(p < 0.05) and an increase of +0.19 in PEP/LVET
(p < 0.05); the head-down subjects showed increases of
+20 msec in PEP interval (p < 0.05) and +0.18 in
PEP/LVET (13 < 0.05). Values following bed rest did not
differ significantly within either group or between the two
groups from control (pre-bed-rest) values. Therefore,
there was no evidence of a change in myocardial
contractility following bed rest using these methods.
Plethysmography and Body Composition
Many LBNP studies have dealt with the redistribution
of blood and fluids during bed rest in attempts to clarify
whether such changes are responsible for the cardiovascu-
lar deconditioning seen after actual spaceflight and after
bed-rest and other ground-based simulations. Despite dif-
ferences in methods and conditions in the various investi-
gations, the findings have been similar--that is, the vol-
ume of the lower leg increases in proportion to the level of
suction applied and the volume rate of blood flow to the
forearm is decreased. It has also been suggested that
orthostatic intolerance following restricted muscular activ-
ity is associated with altered blood vessel tone (both arte-
rial and venous) and increased distensibility of the vascu-
lar bed of the lower extremities. To date, no conclusive
data supporting such hypotheses have been obtained in
ground-based studies. Some investigations, in fact, have
indicated that prolonged immersion, chair rest, and bed
rest do not significantly change the distensibility of the
lower extremity vascular bed, but, rather, may even
increase the tone of blood vessels (ref. 2). Even less is
known about volume changes in subjects bed-rested in the
head-down position. Toward this end, impedance and
occlusion plethysmography were used to estimate the
blood rate and distensibility of extremity vessels for sub-
jects in this study (ref. 24).
U.S. study- Headward shifts of body fluids have
been observed consistently during initial exposure to
weightlessness, but as yet the physiological consequences
of this change have not been explained. U.S. investigators
used plethysmography for the following purposes:
1. To determine volume changes that occur in vari-
ous segments of the body during bed rest
2. To determine the temporal course of such
changes
3. To correlate segmental fluid shifts with changes
in anthropometric volume that occur during bed rest
4. To compare the redistribution of body fluids that
occurs in horizontal and head-down subjects with bed rest
The plethysmography tests were conducted between
1400 and 1600 on days 2, 8, and 14 of the control period;
days 1, 4, and 7 of bed rest; and days 0, 8, and 9 of recov-
ery. On the last testing day, an additional test was con-
ducted between 0700 and 0800, before the subjects had
risen, to determine whether fluid redistribution occurred
during the sleep period. All measurements were made
with the subjects in the supine position.
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TABLE 21.- SYSTOLIC TIME INTERVALS
Control a
Horizontal
Mean
SD
SE
-6 ° flit
Mean
SD
SE
128
7.3
3.3
125
15.2
6.9
PEP interval, msec
Before bed rest After bed rest
Peak
LBNP
147 b
10.9
4.9
145 b
18.5
8.4
Be_bedrest
Peak
Recover_a Control a
138 133
5.3 9.6
2.4 4.4
124 132
15.2 17.6
6.9 8
QS Z interval, msec
Peak
LBNP
146 b
28.1
12.7
145 b
67.2
30.6
After bed rest
Peak
Recover_ a
137
16
7.3
138
18.5
8.4
Control a
67
4.4
2
63
17.6
8
Before bed rest
Peak
LBNP
69
12.9
5.9
58
14.4
6.6
Qs 1 interval, msec
Recover_ a Control a
70 51
6.8 20.2
3.1 9.2
60 52
18.4 16.8
8.4 7.6
After bed rest
Peak
LBNP
64
8.4
3.8
56
8.4
3.8
LVET interval, msec
Before bed rest After bed rest
Peak Peak
Recover_
69
30.2
13.7
66
33.6
15.3
Horizontal
Mean
SD
SE
-6 ° tilt
Mean
SD
SE
Con_ol a
529
7.3
3.3
525
16.8
7.6
LBNP
510
14.4
6.5
510
20.2
9.2
Recover_ a
526
12.2
5.6
514
20.2
9.2
Control a LBNP
518 523
20.2 7.8
9.2 3.6
525 510
16.4 20.2
7.4 9.2
Recover_a
526
30.2
13.7
515
28.1
12.7
Control a LBNP
402 362 b
13.7 13.7
6.2 6.2
400 366 b
9 18.5
4.1 8.4
Re£ove/_
389
11.6
5.2
39O
7.3
3.3
Control a LBNP
408 368 b
65.6 25
29.8 11.4
384 363 b
29.2 19.3
13.2 8.8
Recov eladta
381
10.9
4.9
371
24
10.9
TABLE21.-CONCLUDED
Horizontal
Mean
SD
SE
-6 ° tilt
Mean
SD
SE
Con_o_
33
4.4
2
35
4.8
2.2
IVCT interval, msec PEP/LVET interval, msec
Before bed rest After bed rest Before bed rest After bed rest
Peak
LBNP
39
12.2
5.6
39
7.3
3.3
Recover_ Control a
38 35
5.8 9.6
2.6 4.4
37 33
4.4 4.4
2 2
Peak
LBNP
39
3.6
1.6
40
11.6
5.2
Recover_ a
38
6.2
2.8
35
4.8
2.2
Con_o_
0.356
0.04
0.02
0.346
0.09
0.04
Peak
LBNP
0.546 b
0.09
0.04
0.524 b
0.16
0.07
Recov_
0.404
0.16
0.07
0.352
0.01
0.0
Controla
0.394
0.36
0.16
0.400
0.09
0.04
Peak
LBNP
0.55#
0.09
0.04
0.520 b
0.36
0.16
Recover_ a
0.410
0.09
0.04
0.430
0.04
0.02
aQS 1 - time interval from onset of Q-wave to first heart sound.
b Difference from the control value of the same LBNP phase significant at p < 0.05.
Baseline resistance of the calf, thigh, total leg, pelvis,
torso, and midthigh were measured during each test
sequence, using an impedance rheograph (Princeton
Applied Research). Disposable ECG electrodes (Hewlett-
Packard) were placed in the same position for each test
and attached to the foot, ankle, knee, and midthigh
(opposite the groin) of each subject's dominant leg; to the
wrist and shoulder of the dominant arm; and at the iliac
crest on the same side of the body. The ankle, thigh, and
midthigh electrodes defined the extent of the calf, thigh,
and whole-leg segments. The midthigh and iliac crest
electrodes defined the pelvic segment, and the iliac crest
and shoulder electrodes defined the torso segment. The
wrist and shoulder electrodes defined the arm segment.
Whole-body measurements were made from values
obtained between the wrist and ankle electrodes, and
those for the total leg came from measurements between
the ankle and midthigh electrodes.
Before each impedance test, the subject was mea-
sured to determine the geometric dimensions of the leg,
pelvis, and area between the electrodes defining those
segments. Leg and arm circumferences were measured at
3-cm intervals according to the procedure used in the
Skylab experiments. Pelvic circumferences were mea-
sured at the iliac crest, midthigh position, and midway
between the two. The circumferences and lengths of the
various segments were then averaged, and the cylindrical
volume of each segment was calculated from the results.
The segmental length was considered to be the conductive
length for each segment, with the whole-body conductive
length being the sum of the leg, pelvic, and arm lengths
plus the distance between the iliac crest and shoulder
electrodes. Segmental geometric volumes were calculated
for the calf, thigh, whole-leg, pelvic, and arm segments,
but not for the torso and whole-body segments. The
results were then correlated with electric impedance vol-
umes calculated from the corresponding Ro values for
each segment.
A two-tailed, paired Student's t-test was used to
compare the responses of each subject on the various test
days, and a two-tailed Student's t-test for independent
data was used to compare findings for horizontal and
head-down subjects. A rejection criterion of p < 0.05 was
used throughout. Resting geometric and electric volume
changes for the forearm are shown in table 22; changes
for the whole leg are shown in table 23. Segmental elec-
tric volumes and whole-body water values were calculated
using the resistivity for blood of 150 ohm.cm. In the
recovery period, the horizontal subjects showed an
increase in volume in all segments except with testing on
recovery day 8 and the first test on day 9 when they lost
volume. Aside from these occasions, the day-to-day seg-
mental volume changes in the horizontal group were
gradual and not significant, the greatest changes occurring
in the ambulatory control period. It should also be noted
that the tests on the mornings of recovery days 8 and 9
were separated by 8 hr of ambulation and 8 hr of sleep,
which suggests that fluid shifts occurring in the body
require 4-6 hr to become significant. Comparison of the
results of individual tests, however, showed that the hori-
zontal subjects exhibited a significant decrease (p < 0.05)
in electric volumes of the lower extremities during the
14-day control period, but did not change significantly in
this regard during bed rest.
In the head-down group, segmental electric volumes
of the calf and thigh did not change to the degree
observed in the horizontal group. Although this group
exhibited significant decreases (p < 0.05) in these seg-
ments during the control period, they remained fairly
stable throughout the rest of the study and did not show
notable differences on the mornings of recovery days 8
and 9. Changes in whole-leg electric volume in this group
were similar to those seen in the horizontal subjects. Elec-
tric pelvic volume decreased significantly in the head-
down group during the control period, increased signifi-
cantly on day 4 of bed rest, and again decreased during
the last 3 days of bed rest. Electric volume of the arm
segment also decreased significantly between control test-
ing and the first 4 days of bed rest. Electric torso volume
changes in the head-down subjects were substantially
different from those seen in the horizontal group, with the
head-down subjects showing a significant decrease
between tests on days 8 and 14 of the control period, a
significant increase on the first day of bed rest, a slight
increase between days 1 and 4 of bed rest, and a signifi-
cant increase between days 4 and 7 of bed rest.
U.S. investigators also calculated whole-body water
responses for each subject during the study, using whole-
body resistance values according to Bernard et al.
(ref. 25):
Whole - body water (liters) = 0.62 × 10-4-_o 2 (10)
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TABLE22.-VOLUMECHANGESINTHEFOREARMDURINGPLETHYSMOGRAPHYATREST---COMPARISONOFGEOMETRIC
ANDELECTRICALVALUES:U.S.STUDY
Control-periodday Bed-restday Recoveryday
C-2 C-8 C-14 BR-1 BR-4 BR-7 R+0 R+ 8
Geometricvolumerml
Horizontal (N = 5)
Head-down (N = 5)
Mean
SD
SE
Mean
SD
SE
2369.6
288.4
218.9
2415.6
514.2
230.0
2234.3
204.7
91.5
2441.5
408.8
182.8
2297.9
315.6
141.2
2440.3
396.9
177.5
2231.7
304.9
136.4
2407.3
412.6
184.5
2234.7
311.0
139.1
2396.5
561.9
251.3
2279.3
299.1
133.8
2406.6
449.6
201.1
2269.5
276.5
123.6
2299.9
467.3
209.0
2_2.6
_6.7
132.7
2353.9
512.3
229.1
Horizontal (N = 5)
Head-down (N = 5)
Mean
SD
SE
Mean
SD
SE
1718.9
228.5
102.2
1709.3
429.9
192.3
Electrical volume_ ml
1481.4
82.3
36.8
1662.3
318.1
142.3
1491.4
195.7
87.5
1590.6
328.2
146.8
1458.2
205.9
92.1
1553.6
298.8
133.6
1459.3
199.6
89.3
1599.6
329.3
147.3
1437.1
170.8
76.4
1619.9
435.2
194.6
1448.9
127.3
56.9
1361.7
309.6
138.5
1503.9
146.2
65.4
1492.7
430.6
152.3
Note: Regression equations of comparison: horizontal, Vg = 1.12 Ve + 603.47; r = 0.79 and n = 50; head-down, Vg = 1.21 Ve + 495.88; r = 0.92
and n = 50; combined, Vg = 1.19 Ve + 510.01; r = 0.89 and n = 100.
--..I
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TABLE 23.- VOLUME CHANGES IN THE WHOLE LEG DURING PLETHYSMOGRAPHY AT REST--COMPARISON OF GEOMETRIC
AND ELECTRICAL VALUES: U.S. STUDY
Horizontal (N = 5)
He_d-down (N = 5)
Horizontal (N = 5)
Head-down (hi = 5)
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Control-period (ay Bed-rest day Recover 7 day
C-2 C-8 C-14 BR-1 BR-4 BR-7 R + 0 R + 5
6984.1
1217.8
544.6
7369.0
1526.8
682.8
6761.9
930.1
415.9
7550.4
1525.9
682.4
6676.7
867.9
388.2
7340.7
1321.9
591.2
Geometric volume, ml
6374.4
1169.6
523.1
7090.4
1378.1
616.3
6354.4
1064.9
476.2
7101.9
1456.4
651.3
6463.6
1108.5
495.7
7086.9
1219.3
545.3
6605.8
1213.8
542.8
7108.7
1396.9
624.7
6447.6
1044.9
467.3
7152.3
1447.3
647.3
3492.5
312.2
139.6
3728.7
920.8
411.8
Electrical volumer ml
3263.0
663.8
296.9
3466.9
805.3
360.1
3056.9
434.8
194.4
3368.8
708.4
316.8
2877.6
509.8
227.9
3067.4
619.9
277.2
2789.8
495.4
221.6
3129.5
833.2
372.6
2783.3
474.9
212.4
3080.1
619.2
276.9
3056.4
616.9
275.9
3170.4
608.5
272.2
3063.0
505.8
226.2
3235.3
640.2
_6.3
Note: Regression equations of comparison: horizontal, Vg = 1.62 Ve + 1686.30; r ---0.86 and n = 50; head-down, Vg = 1.73 Ve + 1534.48;
r = 0.91 and n = 50; combined, Vg = 1.72 Ve + 1468.38; r = 0.90 and n = 100.
whereT =subjectheight(meters),andRo= whole-body
resistance(ohms).Meanvaluesareshownin figure3.
Boththehorizontalandhead-downsubjectsexhibited
significantdecreasesinwhole-bodywaterduringthecon-
trolperiodandthroughday1ofbedrest,withresponses
of thetwogroupsbeingsimilar.Meanvaluesfor the
horizontalgroupstartedlowerandremainedlower
throughouttheperiodof observation.In thehorizontal
subjects,whole-bodywaterdecreasedinaregularmanner
throughoutthebed-restperiodandincreasedslightly
duringrecovery.Thehead-downgroup,ontheotherhand,
exhibiteda decreaseduringthefirstdayof bedrest,an
increaseonday4,andadecreasethereaftertotheendof
thebed-restperiod.Bothgroupsshoweda decrease
betweentestsonthemorningsof recoverydays8and9
andanincreasebetweenthetwotestsonrecoveryday9,
with the horizontalsubjectsexhibitingthe greater
decreaseoverthatperiod.
Bodycompositiondatafor horizontalandhead-
downsubjectsaregivenin tables24-26.Duringthecon-
troiperiod,U.S.investigatorsmeasuredthepercentbody
fat of eachsubject,usingthedensiometricmethod
describedbyKeysandBrozek.Withthistechnique,body
weightis firstmeasuredin air(towithin5g)andthen
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Figure 3.- Whole-body water responses: U.S.
with the subject seated on an aluminum weighing seat and
suspended in a tank of water (temperature, 36°C). At a
signal from the testing personnel, the subject expels all air
possible from the lungs, and lowers his head to his legs
until his body is in a tucked position and fully immersed.
Underwater body weight of each subject was measured
repeatedly until the maximal reading was maintained.
Residual lung volume was calculated from previously
measured vital capacity values, and body density was cal-
culated by the following equation:
Wa
BD = (Wa - Ww) / D- RV (11)
where
BD body density, g/ml
Wa body weight in air, kg
Ww body weight in water, kg
D density of water, g/ml
RV residual lung volume, liters
Percent body fat was calculated using the following
equation:
% Body fat = [4.570 / BD- 4.142] × 100 (12)
The weights (kg) of body fat and of lean body mass were
calculated from the body weight in air and the percent of
body fat. Body density was measured on day 14 of the
control period and on days R + 0 and R + 10 of recovery.
Both groups of subjects had a slight increase (NS) in
mean body weight during the 14-day ambulatory control
period. Following bed rest, the horizontal subjects exhib-
ited a decrease in mean body weight of 2% (p < 0.01) and
the head-down group a decrease of 2.9% (p < 0.01). Mean
body weight of the horizontal subjects remained
unchanged on day R + 10, but in the head-down group it
was 2.2% lower than baseline values (p < 0.01).
Percent body fat increased during the ambulatory
control period by 2.2% (p < 0.05) in the horizontal sub-
jects and by 3.2% (p < 0.05) in the head-down subjects.
Following bed rest (between days R + 0 and R + 10), per-
cent body fat decreased in both groups, but the change
was not significant.
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TABLE 24.- MEAN BODY WEIGHT AND FAT
Group Orientation
Day
C-14
Mean Body Weight
R+0 ] R+IO
Horizontal
Mean
SD
SE
-6 ° tilt
Mean
SD
SE
67 kg
7.3
3.3
69 kg
6.7
3
68.3 kg
7.5
3.4
69.7 kg
6.8
3
66.8 kg a
7.1
3.2
67.7 kg a
7.1
3.2
68.8 kg a
7.1
3.2
68.2 kg a
7.5
3.4
Mean Body Fat
Horizontal
Mean
SD
SE
_.6 ° tilt
Mean
SD
SE
5,
15 kg
4.3
1.9
15.3 kg
4.2
1.9
< 0.01 versus control day 14 value.
15.4 kg
4.6
2.1
15.3 kg
4
1.8
15.4 kg 15.3 kg
4.5 4.3
2 1.9
15.4 kg 15.3 kg
4.3 4
1.9 1.8
TABLE 25.- MEAN LEAN BODY WEIGHT AND FAT
Group Orientation C- 14
Horizontal
Mean
SD
SE
-6 ° tilt
Mean
SD
SE
Day
Mean Lean Bod_t Weil]ht
52 kg 52.9 kg
6.1 5.6
2.7 2.5
53.7 kg 54.4 kg
6.1 6.5
2.7 2.9
R+0 R+10
51.4 kg a
5.4
2.4
52.3 kg a
5.8
2.6
51.5 kg a
5.3
2.4
52.9 kg a
6.5
2.9
Horizontal
Mean
SD
SE
--6° tilt
Mean
SD
SE
22.2%
5.5
2.4
22.1%
5.7
2.6
Mean Body Fat
22.4%
5.3
2.4
21.9%
5.4
2.4
22.9%
5.4
2.4
22.6% b
5.6
2.5
22.7%
5
2.2
22.4%
5.3
2.4
ap < 0.01 versus control day 14 value.
bp < 0.05.
4O
TABLE 26.- MEAN BODY WEIGHT: U.S.S.R. SUBJECTS
Group
Horizontal
Mean
SD
SE
-6 ° tilt
Mean
SD
SE
Day
Orientation C- 14 R+0 R+ 10
74.8 kg
6.9
3.4
82.4 kg
6.9
3.4
70.8 kg
7.2
2.3
75.5 kg
8.4
2.7
70.2 kg
7.0
2.2
73.9 kg a
8.8
2.8
70.2 kg
7.0
2.2
74.1 kg
8.4
2.7
ap < 0.01 versus control day 14 value.
Lean body weight increased slightly (NS) in both
groups during the control period, but decreased following
bed rest by 2.9% (p < 0.01) in the horizontal subjects and
by 3.9% (p < 0.01) in the head-down group. On day
R + 10, both groups exhibited a significantly lower
(p < 0.01) lean body weight, with decreases of 2.6% for
the horizontal group and 2.8% for the head-down group.
From the foregoing results, it can be concluded that
1. The observed significant decreases in body weight
over the study resulted from a significant decrease in lean
body weight, probably because of a loss of body water.
2. The significant increase in percent body fat
occurred because absolute body fat (kg) remained con-
stant, whereas total body weight decreased.
3. The larger relative decreases in body weight and
lean body weight in the head-down group resulted from
the head-down bed-rest position.
U.S.S.R. study- Change in body weight for U.S.S.R.
subjects is given in table 26. A significant decrease in
body weight occurred for all subjects from the time of ori-
entation until they entered the study. The reasons were not
totally clear other than a desire on the part of a number of
subjects to engage in more physical activity prior to par-
ticipating in a study of bed rest effects and its known
associated marked hypodynamia. At the end of the pre-
bed rest control period there was a significant 4.7-kg
difference in body weight between the horizontal and
head-down subject groups. This was a much greater
response than the 2-kg difference between the same
respective groups in the U.S. study. The U.S.S.R. head-
down subjects also lost significantly more weight than the
horizontal subjects over the course of bed rest and had not
regained this weight by the end of the study. This also
occurred for U.S. subjects.
Soviet investigators measured volume changes in the
arm and leg using occlusion plethysmography (ref. 26).
For the procedures, Whitney strain gauges (mercury in
rubber sensors) were applied to the forearm (3 cm below
the elbow joint) and to the calf at the largest perimeter.
Occlusion was produced by aneroid cuffs capable of
increasing pressure to 50 mmHg in 2 to 3 sec; the cuffs
were applied to the arm and thigh. Venous occlusion was
continued until the resultant curve reached a plateau.
Before plethysmography, all subjects were measured for
length of the extremities, perimeters of the forearm at
spacings of 3 cm, and perimeters of the calf at spacings of
6 cm. Measurement positions were marked with paint so
the measurements could be obtained for the same seg-
ments in subsequent tests. To further ensure consistency
of measurements, they were generally performed by the
same investigator (except for forearm measurements on
days 5 and 10 of recovery and leg measurements on
day 10 of recovery). Piethysmography was performed on
day 12 of the control period; on days 2, 4, and 6 of bed
rest; and on days 1, 5, and 10 of recovery.
During the procedures, the following data were
recorded or measured:
1. Plateau level of the plethysmogram for 2-3-min
duration
2. Index of blood flow as determined by the slope
of the curve during the first 5 sec (rapid component of
volume increase)
3. Blood flow index was expressed in milliliters per
minute per 100 ml of tissue
4. Amplitude of the curve from the resting baseline
level to the plateau established during occlusion, which
was used to determine an index of venous distensibility
5. Rate of volume increase within the first 30 sec of
occlusion until the plateau was reached (slow component
of volume increase)
6. Extent of volume restoration within 30 sec after
the removal of venous occlusion
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Plethysmography results are shown in table 27 for
both subject groups. Findings during the control period
indicated that the horizontal subjects had 157 ml less vol-
ume in the forearm and 261 ml less volume in the calf
than the head-down subjects. During bed rest, arm volume
tended to decrease progressively in both groups and did
not vary significantly between them; calf volume on the
average decreased by 4.4% in the horizontal subjects and
by 6.6% in the head-down group. Both groups showed a
significant (p < 0.05) decrease in lower leg volume on
days 4 and 6 of bed rest and on day 0 of recovery.
Although the change was more pronounced in the head-
down group, the difference between the two groups was
not significant. During the recovery period, leg volumes
returned to baseline values in both groups, although arm
volumes remained slightly decreased. The decrease in leg
volume in both groups by the end of bed rest was similar
to changes seen on the fifth day of the Skylab experiment
(ref. 2).
Volume rate of blood flow: Baseline values for fore-
arm volume rate of blood flow were somewhat higher for
the horizontal subjects than for the head-down subjects,
but the difference was not significant (table 28). Flow in
the lower legs was essentially the same in both groups.
During bed rest, the horizontal subjects exhibited a grad-
ual decrease in forearm and lower-leg rate of blood flow
so that by day 6 of bed rest, this variable was substantially
lower than baseline values. The head-down subjects also
exhibited a decrease, but to a lesser degree, and the
change was not significant. This latter group showed a
significant decrease in flow to the forearm only on day 0
of recovery, which returned to baseline values by recovery
day 10. The findings of decreased peripheral flow in the
horizontal subjects correlated with the known decrease in
muscular activity during bed rest. By the fifth day of
recovery, the head-down subjects exhibited a significantly
greater increase in lower leg blood flow than the horizon-
tal group.
Limb volume change with venous occlusion: With
venous occlusion during the control period, limb volume
increased on the average by 1.7-1.8 ml/100 ml of tissue
for the forearm and by 1.9-2.0 ml/100 ml of tissue for the
lower leg, with little difference seen between the two
groups (table 29). Forearm values for both groups showed
little change from baseline levels over the course of bed
rest or recovery. The groups showed no significant differ-
ence between each other. Lower-leg volume changes,
however, were quite different. During bed rest, volume
tended to decrease in both groups and was significantly
lower (p < 0.05) in the horizontal subjects beginning on
the second day of bed rest. By the first day of recovery,
the decrease in lower-leg volume became significant in
both groups. These changes with venous occlusion were
thought to reflect reduced venous tone (capacity) associ-
ated with restricted mobility. In addition, it was felt that
the observed findings might be indirectly related to extra-
vascular fluid reabsorpfion in leg tissues. By the second
day of bed rest, lower-leg findings in the horizontal sub-
jects significantly decreased toward normal and tended to
decrease in the head-down group. This apparent reduction
in filtration processes (loss of extracellular fluid reabsorp-
lion) agrees with previous findings for humans and ani-
mals that the number of perfused capillaries is reduced
during restricted muscular activity.
On termination of venous occlusion, volume was
restored to baseline levels in both groups within 30 sec or
less, both during and after bed rest.
A number of investigators have demonstrated that the
regulation of vascular tone is clearly associated with the
level and magnitude of intravascular pressure and the
magnitude of transmural pressure (refs. 2 and 27). These
findings would suggest that vascular tone should be
decreased in head-down subjects since hydrostatic (hence
transmural) pressure for the lower extremities is reduced
in this body position. It is hypothesized that basal arterial
tone is reduced to facilitate lower extremity blood flow.
As a result of the body's adaptation to reduced muscular
activity, the volume rate of blood flow to the lower
extremities is also reduced. The interaction of these two
processes could explain the less pronounced lowering of
the volume rate of blood flow to the lower legs in the
head-down subjects than was seen in the horizontal group.
Finally, recumbency in the head-down position
should create the following physiologic responses:
(1) reduced venous pressure in the veins of the lower
limbs, (2) increased drainage of blood from the limbs, and
(3) reduced pressure between the tissues. As a result of
these changes, large-vessel tone should be reduced. How-
ever, restricted muscular activity is usually accompanied
by an increase in large-vessel tone of the lower leg. In the
present study, the interaction of these various effects
resulted in a less pronounced lowering of vessel tone in
the head-down subjects than in the horizontal group.
Comparison of U.S. and U.S.S.R. Findings
Electrophysiology at rest- The electrocardiographic
findings of the two teams of investigators were in com-
plete agreement. Neither team observed any significant
changes in either the horizontal or head-down subjects.
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TABLE27.-VOLUMECHANGESINTHE FOREARM AND LOWER LEG (ml) DURING PLETHYSMOGRAPHY AT
REST: U.S.S.R. STUDY
Forearm
Horizontal
Head-down
Lower leg
Horizontal
Head-down
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Control -
period
mean 2
1025.8 1015.3
109.2 106.9
48.8 47.8
1183.0 1203.3
92.4 103.5
41.3 46.3
2415.9 2343.8
236.3 265.3
105.7 118.6
2677.4 2578.2
268.5 245.8
120.1 109.9
Bed-rest day
4
1010.4
88.5
39.6
1185.7
118.8
53.1
2382.2
253.2
113.2
2588.5
263.4
117.8
1019.5
91.1
40.8
1162.6
110.2
49.3
2309.4
231.8
103.6
2508.3
226.9
101.5
R+0
1008.1
87.6
39.2
1168.9
114.8
51.3
2300.1
224.4
100.4
2534.6
265.4
118.7
Recovery day
R+5
987.8
84.3
37.7
1163.5
108.5
48.5
2398.0
217.2
97.1
2602.8
241.6
108.0
R+10
1013.9
83.3
37.3
1150.8
101.4
45.4
2412.2
269.0
120.3
2609.6
306.4
137.0
TABLE 28.- CHANGES IN VOLUME RATE OF BLOOD FLOW (ml/100 ml tissue) IN THE FOREARM AND LOWER
LEG DURING PLETHYSMOGRAPHY AT REST: U.S.S.R. STUDY
Forearm
Horizontal
Head-down
Lower leg
Horizontal
Head-down
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Control -
period
mean
6.99
3.63
1.63
6.3
3.44
1.54
2.43
0.57
0.25
2.48
1.07
0.48
5.40
4.14
1.85
6.00
1.64
0.74
2.21
0.43
0.19
2.40
0.85
0.38
Bed-rest day
4
3.79 a
2.90
1.30
5.64
2.19
0.98
0.66 a
0.26
0.12
1.77
0.57
0.25
3.36a
1.57
0.70
4.23
0.95
0.43
1.41a
0.91
0.41
2.08
0.46
0.21
R+0
4.08
3.16
1,41
2.16 a
0.91
0.41
1.54a
0.53
0.24
2.04
0.68
0.31
Recovery day
R+5
3.96
1.97
0.88
5.52
5.27
2.36
2.26
0.32
0.14
3.73
1.18
0.53
aSignificant difference.
R+10
7.32
2.56
1.15
7.50
5.21
2.33
2.35
0.60
0.27
3.95
1.64
0.73
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TABLE29.-VOLUMEINCREASEINTHE FOREARM AND LOWER LEG (ml/100 ml tissue) WITH
OCCLUSION (50 mmHg) OF THE VEINS: U.S.S.R. STUDY
Forearm
Horizontal
Head-down
Lower leg
Horizontal
Head-down
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Mean
SD
SE
Control-
period
mean
1.70
0.53
0.24
1.79
0.23
0.10
2.08
0.64
0.29
1.87
0.78
0.35
1.49
0.33
0.15
1.87
0.36
0.16
1.22a
0.33
0.15
1.60
0.84
0.37
Bed-rest day
1.42
0.50
0.23
1.82
0.35
0.16
1.15 a
0.33
0.15
1.56
0.74
0.33
6
1.77
0.32
0.14
1.52
0.63
0.28
1.38 a
0.26
0.12
1.51
0.48
0.22
R+0
1.50
0.52
0.24
1.54
0.42
0.17
1.22 a
0.37
0.17
1.23
0.65
0.28
Recovery day
R+5
1.50
0.61
0.27
1.18
0.36
0.16
1.26 a
0.50
0.23
1.94
0.54
0.24
R+10
1.66
0.52
0.23
1.61
0.63
0.28
1.66
0.53
0.24
1.92
0.71
0.32
aSignificant difference.
Echocardiography at rest- Echocardiographic pro-
cedures of the U.S. and U.S.S.R. investigators did not dif-
fer significantly. Variations consisted of
1. U.S. investigators performed baseline echocar-
diographic measurements on days 2 and 13 of the control
period, whereas U.S.S.R. investigators performed them on
control days 13 and 14.
2. U.S. investigators recorded resting echos four
times on the first day of bed rest, whereas U.S.S.R. inves-
tigators recorded them three times on that day.
3. The U.S. study included VCF recordings; the
U.S.S.R. study did not. The U.S. control data obtained
after 11 days of subject confinement showed consistent
decreases in all subjects by the second measurement and
suggested that some degree of deconditioning occurred
during the 14-day ambulatory control period.
U.S. and U.S.S.R. data at rest are compared for the
horizontal subjects in figures 4(a)-4(g) and for the head-
down subjects in figures 5(a)-5(g). U.S. and U.S.S.R. rest-
ing echocardiographic values differed in several areas.
U.S.S.R. calculated values for EDV, ESV, SV, and CO
exceeded U.S. values in all cases and significant
differences were noted as follows:
1. End diastolic volume for the first, second
(p < 0.05), and third readings on day 1 of bed rest and
day 2 of bed rest (p < 0.01) (see figs. 4(c) and 5(c))
2. End systolic volume for day 1 of control
(p < 0.05), the second (p < 0.05), and third (p < 0.01)
readings on day 1 of bed rest, and day 2 of bed rest
(p < 0.01) (see figs. 4(d) and 5(d))
3. Stroke volume for the first (p < 0.05) and third
(p < 0.01) readings on day 1 of bed rest (see fig. 5(e))
4. Cardiac output for the third reading on days 1
and 2 of bed rest and on day 5 of recovery (p < 0.05)' (see
fig. 5(0)
5. Ejection fraction during the second reading
(p < 0.05) on day 1 of bed rest (see fig. 5(g))
Because of the differences between the two sets of
results, it was felt inadvisable to pool data from the two
investigations to obtain mixed (U.S.ALS.S.R.) data for
comparing the two sets of horizontal and head-down
subjects.
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Figure 4.- Dynamics of echocardiography in horizontal subjects at rest: comparison of U.S. and U.S.S.R. findings.
(a) Heart rate. (b) Mean arterial pressure. (c) End diastolic volume. (d) End systolic volume.
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Lower-body negative pressure- Mean values for all
parameters at rest, peak LBNP, and the differences
induced by 50-mmHg negative pressure are given in
table 30. Comparisons of LBNP f'mdings for systolic and
diastolic blood pressure for respective horizontal and
head-down subjects are also given in figures 6(a) and 6(b)
and 7(a) and 7(b). These overall findings, as indicated
earlier, were obtained on the U.S. side by using a lower
body decompression chamber and by wearing a CHIBIS
suit by U.S.S.R. investigators. Heart rate for horizontal
subjects showed little difference between the teams before
and during LBNP stress except for day 5 of recovery
when U.S. values were lower. U.S. values tended to be
lower for all other parameters--SBP, PP, EDV, ESV, SV,
and CO, including DBP, which was significantly lower
(p < 0.05, fig. 6(b)). EF proved to be variable. Head-down
subjects showed no differences for HR or SBP (figs. 7(a)),
but all other parameters again tended to be lower for U.S.
subjects. As was the case for horizontal subjects, DBP
was significantly lower in U.S. subjects (fig. 7(b)).
The reason for the significant differences for PP
between the U.S. and U.S.S.R. subjects related to the con-
sistently lower recorded diastolic blood pressures in the
U.S. study. PP for U.S.S.R. subjects, which tended to
approximate pre-LBNP U.S. values (see table 30),
decreased to approximately 40-50% of resting levels with
peak LBNP. This did not occur for the U.S. study. Thus,
resulting LBNP-induced PP change for U.S.S.R. subjects
was 19-62% greater. Despite the above-noted differences
in diastolic pressure, these values regularly increased with
application of LBNP following bed rest, suggesting that
an elevated peripheral vascular resistance is associated
with the deconditioning process.
Several factors may have contributed to the observed
differences in U.S. and U.S.S.R. blood pressure findings.
First, the two teams used different equipment and tech-
niques for measuring blood pressure. Second, U.S.S.R.
investigators used the single lowest PP obtained during
LBNP in their calculations, whereas U.S. investigators
averaged the data for the final 5-min period of peak LBNP
stress. Finally, the U.S. subjects showed a distinct ten-
dency for lowering of DBP over the pre-bed rest
ambulatory control period, indicating some degree of
change in physiologic state for this group during this
period.
End-diastolic volumes, SV and CO tended to be
higher for U.S.S.R. subjects (see table 30). Still, observed
comparative LBNP-induced differences were not of note
except for the greater fall in EDV for U.S.S.R. horizontal
subjects during control (52 vs 34 mi) and a smaller
decrease for U.S.S.R. head-down subjects immediately
after bed rest (43 vs 63 ml). Similar differences in EDV
were reflected in much greater post-bed rest decreases in
SV (53 vs 38 ml/beat) and CO (1.9 vs 0.4 L/min) for U.S.
head-down subjects. In addition, LBNP induced 1.8 l_/min
and 2.1 L/min decreases in CO for respective U.S.
horizontal and head-down subjects on day 5 of recovery,
while comparable changes for U.S.S.R. subjects were
20% of these values. In the U.S. study, head-down
subjects experienced a significantly greater decrease in
EDV following bed rest than did the horizontal subjects
(64 ml vs 38 ml, see table 30). Since bed-rest-induced
intravascular volume losses were similar in the two
groups, changes suggest that the peripheral vascular
mechanisms affecting venous return may have been
altered because of the head-down bed-rest position. Such
changes did not occur for the U.S.S.R. study.
In the U.S. study the observed immediate post-bed
rest decrease in cardiac output with peak LBNP
(-2 L/min) in the head-down subjects was significantly
larger than that seen in the horizontal subjects. This
decrease, which was more than twice that seen before bed
rest, persisted throughout the recovery period. Horizontal
subjects showed a similar decrease on recovery day 5.
Such changes were of a smaller magnitude (half or less) in
the U.S.S.R. study (see table 30). As would be expected,
with LBNP stress, both sets of investigators found that
EDV and SV decreased with increased HR. Both groups
noted significantly increased heart rates during LBNP
testing which was exaggerated immediately following bed
rest. The large decrements in EDV, ESV, and SV
observed in U.S. subjects between average control-period
values and values measured on day 5 of recovery suggest
that both subject groups may have experienced continued
deconditioning.
The difference in response of EF and VCF for the
two U.S. groups and EF for the U.S.S.R. groups (table 30)
suggests that the head-down group experienced a greater
degree of myocardial deconditioning.
Finally, a change in MAP does not appear to offer a
sufficient explanation for observed changes in EDV, SV,
and CO, since there was hardly any change for U.S. sub-
jects and the value rose only 3 to 4 mmHg for U.S.S.R.
subjects.
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TABLE30.-HEMODYNAMICCHANGESWITH-50mmHgLBNP
U.S. data
Pre-bed rest Post-bexl rest
Day 0 Day 5
0o _6 ° 0 ° _6 ° 0 ° _6 °
Pre-bed rest
Day I0
0 ° -6 ° 0 ° -6 °
U.S.S.R. data
Post-bed rest
Day 0 Day 5
0 o _6 ° 0o _6o
Control
I_ 68 64 68 58 71 68 72 68 67 66 67 66 79 65
EDV 100 117 97 116 113 124 106 123 138 132 122 127 128 133
ESV 31 33 37 41 44 39 39 40 46 47 45 40 44 43
SV 70 85 59 85 68 85 67 84 92 85 77 87 84 90
CO 4.7 5.5 4.0 4.9 4.8 5.7 4.8 5.6 62 5.6 5.2 5.7 66 5.9
EF 0.69 0.73 0.62 0.67 0.62 0.69 _ 0.63 0.68 0.67 0.64 0.63 0.69 0.66 0.68
VCF 1.76 1.79 1.51 1.73 1A8 1.73 1.53 1.70 ......
PP 55 60 51 61 51 58 48 57 41 37 44 46 38 45
MAP 74 81 78 83 73 80 77 79 91 94 93 91 87 87
-50 mmHg LBNP
HR 86 83 102 92 89 83 101 85 91 94 102 112 104 92
EDV 66 77 59 52 57 68 63 75 86 95 71 84 84 83
ESV 21 20 23 19 23 25 20 28 32 38 33 39 28 31
SV 45 57 37 32 34 43 43 47 54 57 38 45 56 52
CO 3.9 4_ 3.8 3_ 3.0 3.6 4.3 4.0 49 5A 3.9 5.2 5.8 4.8
EF 0.69 0.74 0.62 0.63 0.60 0.65 0.69 0_5 0.64 0.60 0.54 0.54 0_7 0.63
VCF 1.99 2.26 1.73 1.82 1.68 1.79 2.08 1.82 ......
PP 42 48 39 46 38 50 34 44 22 19 14 26 22 24
MAP 74 81 79 86 73 83 74 80 95 93 95 94 83 89
IAIdue to -50 mmHg LBNP
I-_ 18 19 34 34 18 15 29 17 24 28 35 46 25 27
EDV 34 40 38 64 56 56 43 48 52 37 51 43 44 50
ESV 10 13 14 9 21 14 18 12 14 9 12 1 16 12
SV 25 28 22 53 34 42 24 37 38 28 39 42 28 38
CO 0.8 0.7 _2 1.9 1.8 2.1 0.5 1.6 1.3 _2 1.3 0.5 0.8 1.1
El:: 0 0.01 0 0.04 0.02 0.04 0.06 0.03 0.02 0.08 0.09 0.15 0.01 0.05
VCF 0.23 0.47 0.22 0.09 0.20 0.06 0.55 0.12 ......
PP 13 12 12 15 13 8 14 13 19 18 30 20 16 21
MAP 0 0 1 3 0 3 3 1 4 1 2 3 4 2
Note: HR - bpm; EDV, ESV, SV - ml; CO - L/min; EF- %; VCF - cm/sec; PP, MAP - mmHg.
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The data in table 30 generally support the conclusion
that head-down subjects showed greater degradations in
response to LBNP than did horizontal subjects, with U.S.
subjects doing so to a greater extent than U.S.S.R. sub-
jects. However, test results were not closely comparable
between the two groups. It appeared that -50 mmHg
LBNP experienced in a CHIBIS suit produced greater
increases in HR and decreases in EDV, yet calculated SVs
were similar to U.S. values. These latter differences may
have been due to difficulties in obtaining good-quality
echocardiographic images and in the ease of making
required measurements. The small number of subjects,
particularly for the U.S.S.R. group, undoubtedly also con-
tributed. As already mentioned, some mild degree of
deconditioning from pre-bed rest confinement may also
have been present for U.S. subjects.
U.S. findings related to resting heart volume data
over the course of bed rest showed that all subjects tended
to exhibit a decrease in EDV and ESV through day 2 of
bed rest, findings consistent with a decrease in plasma
volume. This was followed by an increase in these vari-
ables from day 2 through day 4 of bed rest in head-down
U.S. subjects, whereas the U.S.S.R. head-down subjects
showed a continued increase from day 1 through day 4 of
bed rest. Thereafter, the head-down subjects in both stud-
ies exhibited decreases in EDV through the end of bed
rest.
The findings in the present study did not support
results from previous research related to STIs because bed
rest did not induce significant changes (ref. 2). The pre-
sent findings, however, are consistent with echocardio-
graphic results obtained during this study, which demon-
strated that no significant changes occurred in SV at rest
for either of the subject groups--a change which had been
usually observed in previous studies. Similarly, results of
the present study during LBNP did not agree with previ-
ous findings of significant changes in STI following bed
rest, although again they were consistent with echocardio-
graphic findings of the present study. To date, the reasons
for the differences are unclear.
Plethysmography- Although the U.S. team used
impedance plethysmography and the U.S.S.R. team used
occlusion plethysmography, and although the types of
measurements differed between the two, the findings cor-
related fairly well (r = 0.90 to 0.99; p < 0.05) for the indi-
vidual subjects, for each group, and for all combined.
Comparison of findings for horizontal subjects is given in
table 31 and for the head-down subjects in table 32. In
general, volume increases and blood pooling values were
smaller in the U.S. subjects than in the U.S.S.R. subjects.
Both teams of investigators found that the observed
changes occurred very gradually in all subjects. They also
concluded the following:
1. LBNP increased lower-body volume to similar
degrees.
2. There were generally no consistent differences in
plethysmographic responses during LBNP in the horizon-
tal and head-down subjects, either before or immediately
after bed rest.
3. There were no changes in vascular compliance as
a result of 7 days of bed rest.
4. Leg-volume enlargement persisting for as long as
5 min after release of suction suggested that extravascular
fluid accumulation was a feature of the physiologic
response.
In the U.S. horizontal subjects, there was a tendency
during the second of the control-period measurements for
volume decreases in the upper and lower extremities,
which continued, but at a slower rate, during bed rest. Evi-
dence of such changes in the ambulatory control period
suggests that conf'mement itself may play a role in decon-
ditioning. In this group, on the other hand, pelvic and
torso volumes increased during control and persisted dur-
ing bed rest. Although the increase in pelvic volume in
this group persisted throughout bed rest, torso volume
decreased during the last 4 days of bed rest. The latter
data were consistent with echocardiographic findings of
EDV changes in these subjects. The general trend of
plethysmographic changes during bed rest for U.S. head-
down subjects was consistent with echocardiographic
findings, which initially demonstrated a decrease, then an
increase in EDV in this group. In fact, the differences in
torso volume changes between the horizontal and head-
down groups, as measured by plethysmography, were
generally reinforced by the echocardiographic results.
V. CLINICAL LABORATORY STUDIES
Both U.S. and U.S.S.R. space crews have exhibited
specific metabolic and hormonal changes following expo-
sure to weightlessness. Investigators from the two nations
have conducted numerous ground-based studies using var-
ious simulation techniques in an attempt to identify the
mechanisms underlying these changes. Horizontal bed
rest has been the primary method used to study the causes
of endocrine and hormonal changes occurring during
spaceflight. Although ground-based studies have shown
that hormones play an important part in physiological
changes during bed rest, these studies as yet have not
identified the mechanisms responsible (ref. 29).
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TABLE31.-COMPARISONOF LEG VOLUME FINDINGS IN HORIZONTAL SUBJECTS (0°):
U.S. AND U.S.S.R. STUDIES a
Time r rain
LBNP) mmH 8
Last minute 30 sec 1 min 5 min Regression equations
-25 -35 --40 -50 Release U.S. vs U.S.S.R. data
Control period Control average: day 2 and day 13
U.S.S.R. 1.960 2.720 3.320 3.840 1.480 1.140 0.940
0.780 0.887 0.487 0.627 0.363 0.313 0.397
U.S. 0.74 1.00 1.36 1.74 0.53 0.53
0.21 0.30 0.40 0.50 0.26 0.17
t-test value 3.02 b 3.67 b 6.22 b 5.24 b 4.26 b 1.90
Recovery day 0
U.S.S.R. 1.660 2.420 3.220 4.440 1.960 1.000 0.640
0.196 0.217 0.427 0.635 0.695 0.436 0.351
U.S. 0.79 1.11 1.49 1.95 0.76 0.54
0.21 0.27 0.36 0.40 0.49 0.16
t-test value 6.07 b 7.56 b 6.20 b 6.64 b 2.82 b 0.52
Recovery day 5
U.S.S.R. 2.040 2.800 3.460 4.140 1.760 1.040 0.860
0.921 0.970 1.220 1.113 0.623 0.669 0.319
U.S. 0.73 0.93 1.33 1.79 0.60 0.42
0.20 0.27 0.21 0.27 0.36 0.29
t-test value 2.78 b 3.71 b 3.44 b 4.10 b 3.22 b 2.04
Recovery day 10
U.S.S.R. 2.240 3.160 3.780 4.600 1.640 1.160 0.820
0.518 0.856 0.820 0.731 0.456 0.860 0.867
U.S. 0.88 1.14 1.48 1.81 0.58 0.41
0.18 0.24 0.22 0.17 0.30 0227
t-test value 4.96 b 4.54 b 5.42 b 7.43 b 3.88 b 0.90
U.S. = 0.42R - 0.03
r = 0.97
U.S. = 0.39R + 0.16
r = 0.98
U.S. = 0.41R - 0.07
r -- 0.97
U.S. = 0.38R + 0.03
r= 0.99
Note: Total for all values in this table: U.S. = 0.39R + 0.04, r = 0.97.
aValues shown are milliliters per 100 ml; x +SD.
bp < 0.05 U.S.S.R. values versus U.S. values.
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TABLE32.-COMPARISONOFLEGVOLUMEFINDINGSINHEAD-DOWN(--6° ) SUBJECTS:
U.S. AND U.S.S.R. STUDIES a
Time r min
LBNP r mmHg
Last minute 30 sec 1 min 5 min Regression equations
-25 -30 --40 -50 Release U.S. vs U.S.S.R. data
Control period Control average: day 2 and day 13
U.S.S.R. 1.620 2.680 3.220 4.120 1.520 0.900 0.720
0.482 0.936 1.192 1.472 1.099 0.863 0.801
U.S. 0.81 0.99 1.51 1.90 0.96 0.81
0.35 0.48 0.48 0.53 0.24 0.24
t-test value 2.72 b 3.21 b 2.66 b 2.84 b 1.00 b -0.22
Recovery day 0
U.S.S.R. 2.020 2.740 3.720 4.760 1.760 0.900 0.720
1.158 1.014 0.795 0.945 0.415 0.224 0.421
U.S. 0.99 1.39 1.81 2.28 1.09 1.04
0.55 0.60 0.62 0.68 0.29 0.24
t-test value 1.61 2.29 3.79 b 4.26 b 2.65 b -1.32
Recovery day 5
U.S.S.R. 2.080 2.860 3.520 4.360 1.400 0.860 0.620
0.642 0.888 0.944 1.004 0.600 0.537 0.492
U.S. 0.83 0.95 1.46 1.95 0.79 0.76
0.40 0.60 0.72 0.83 0.44 0.44
t-test value 3.31 b 3.56 b 3.47 b 3.55 b 1.64 -0.42
Recovery day 10
U.S.S.R. 2.500 3.150 3.700 4.400 1.525 1.150 1.000
0.503 0.854 0.931 1.143 1.135 1.320 1.275
U.S. 0.98 1.40 1.86 2.44 1.05 0.92
0.45 0.62 0.76 0.83 0.35 0.41
t-test value 4.50 b 3.32 b 3.06 b 2.78 b 0.80 b 0.13
U.S. = 0.32R + 0.41
r = 0.92
U.S. = 0.34R + 0.55
r-- 0.94
U.S. -- 0.31R + 0.35
r= 0.90
U.S. = 0.42R + 0.30
r= 0.91
Note: Total for all values in this table: U.S. = 0.35R + 0.39, r = 0.89.
aValues shown are milliliters per 100 ml; x +SD.
bp < 0.05 U.S.S.R. values versus U.S. values.
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Theadrenal-pituitarysystem contributes significantly
to maintaining homeostasis during stressful or unusual
situations. Responses of this system to bed rest generally
have been studied by measuring urinary excretion of
17-hydroxycorticosteriod (17-OHCS) and 17-ketosteroid
concentrations. But changes in these variables have been
inconsistent from study to study. Some investigators have
found no change in 17-ketosteroids, but a significant
increase in 17-OHCS; others have found the reverse.
However, studies of urinary cortisol excretion have con-
sistently shown an increase during bed rest and an even
greater increase during ambulatory recovery. Investigators
using serum levels of adrenocorticotropic hormone
(ACTH) and cortisol found that ACTH increased gradu-
ally from the beginning of bed rest, rose sharply after
30 days, and gradually returned to control levels after bed
rest. Conversely, blood cortisol levels were decreased
throughout bed rest (ref. 1).
With spaceflight and bed rest, there is a redistribution
of extravascular fluid to vascular space and a redistribu-
tion of blood volume, accompanied by a compensatory
loss of water, potassium, and sodium as the hormonal and
renal mechanisms are activated to prevent vascular vol-
ume from increasing beyond limits established by the
receptors. Blood-volume shifts are accompanied by
changes in aldosterone and antidiuretic hormone (ADH)
and plasma renin activity. Aldosterone, the salt-retaining
hormone of the adrenal cortex, has been observed to
decrease during bed rest, often almost immediately after
bed rest is begun. This change has been interpreted to be
the initial response to redistribution of blood volume. But
findings on aldosterone change have varied, with some
investigators observing increases, slight decreases, or no
change with bed rest (refs. 1, 29, and 30). Plasma renin
activity increases constitute an early indication of altered
neural and circulatory conditions. Such changes are inter-
preted as the body's attempt to maintain adequate renal
blood flow. But findings on this variable have differed,
with some investigators finding little change and others an
increase. On the other hand, serum measurements have
consistently shown that ADH decreases during bed rest,
and urinary measurements have shown that it varies. Lim-
ited postflight measurements have shown increases in
ADH in both serum and urine.
An early diuresis accompanied by a loss of elec-
trolytes has been observed consistently with bed rest and
immersion. This change occurs as the body attempts to
maintain vascular-extravascular equilibrium. It would
seem that when equilibrium is achieved as bed rest con-
tinues, fluid shifts and loss of vascular fluid volume
would no longer occur. However, investigators have
demonstrated consistently that the loss of vascular fluid
continues (ref. 2). The underlying mechanisms are not
completely understood, but it is hypothesized that any of
three conditions could occur: (1) vascular fluid is
excreted, (2) fluid is transferred from vascular to extra-
vascular space, or (3) fluid transfers through extravascular
space to intracellular space. To evaluate these hypotheses,
investigators have studied changes in plasma volume,
extracellular water, and total body water.
It has long been known that prolonged bed rest is
accompanied by a decrease in circulating plasma volume
(ref. 2). The decrease can range from 5% to 20%, depend-
ing on the length of bed rest and on the study design.
Plasma volume in the normal male is about 40 ml/kg of
body weight; for a male weighing 80 kg, for example, the
loss in plasma volume during prolonged bed rest would
amount to 160-640 ml. Loss of plasma volume begins
during the first 24 hr of bed rest, reaches a mean loss of
10% by 48 hr, and then continues more slowly, reaching a
loss of about 20% after 30 days. During this period of
change, there usually is no change in electrolyte and pro-
tein concentrations. Similarly, blood pressure is main-
tained despite a reduction in circulating blood volume,
suggesting that vascular volume decreases proportionally
to blood volume decrease, which in turn results from a
decrease in plasma volume.
The decrease in circulating blood volume usually
stimulates the vascular tree to release catecholamines.
Therefore, it would be expected that catecholamines
would increase during bed rest. But findings to date have
not demonstrated that catecholamine activity does
increase, although the accelerated HR seen with bed rest
may be an indirect indicator of such occurrence.
Extracellular fluid consists of circulating plasma and
interstitial fluid, with plasma volume amounting to one
half of interstitial fluid. Plasma volume decreases during
bed rest; therefore, extracellular fluid also should decrease
unless the plasma volume decrease represents only a
transfer of water, protein, and electrolytes into the intersti-
tial space. But the diuresis associated with the decrease in
plasma volume argues against such a shift. Extracellular
fluid volume has been measured in only a few bed-rest
studies (ref. 2). Findings have been variable, with some
investigators finding no decrease in extracellular fluid
volumes despite a decrease in plasma volume, others
observing a decrease greater than the plasma volume
decrease, others finding equal decreases in both, and still
others finding that extraceUular fluid volume actually
increased. With regard to the last finding, a decrease in
plasma volume accompanied by an increase in extracellu-
lar fluid volume would indicate that body water was
shifted from the intravascular compartment to the extra-
cellular compartment. In most bed-rest studies, a greater
percentage decrease in plasma volume has been observed
than would be expected from increases seen in peripheral
hematocrit, thus indicating a change in the ratio of total
body hematocrit to peripheral hematocrit (ref. 31).
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Whetherinterstitial fluid changes during bed rest is not
well studied. Findings from spaceflight (refs. 32 and 33)
have indicated that fluid losses during short-term flights
have resulted in a loss of extracellular fluid; in longer
flights, losses in extracellular fluid probably are gradually
restored, but there is still an overall loss because of mus-
cular atrophy.
Total body water also changes during spaceflight and
bed rest. This element consists of extraceUular and intra-
cellular water and is proportional to lean body mass.
Changes in lean body mass and in total body water are
interrelated because adipose tissues contain no water
unless they replace lean tissue. Thus, if lean body mass
decreases, total body water can be expected to decrease.
At present, two bed-rest studies have shown no statisti-
cally significant changes in total body water (refs. 34
and 35). This finding raises the possibility that
immobilization during bed rest is associated with an
increase in intracellular fluid. However, no conclusive
supporting data have been put forward to date; moreover,
the findings conflict with spaceflight results (ref. 29).
U.S. Study
The changes in hormones and electrolytes seen in bed
rest have not shown the magnitude of change observed in
men returning from spaceflight. In recent years, greater
and greater emphasis has been placed on head-down bed
rest as a more accurate analog for weightlessness expo-
sure. Clinical laboratory studies in the joint U.S./
U.S.S.R. investigations were focused on comparing bio-
chemical, hormonal, and hematologic changes in horizon-
tai and head-down bed-rest subjects.
Urine samples were collected throughout the study
and were pooled every 24 hr for analysis. Fasting blood
samples (8-hr fast) were obtained by venipuncture from
all subjects after they had spent 30 min in the supine posi-
tion. Samples were collected between 0700 and 0800,
except on recovery days 0 and 10, when they were col-
lected in the afternoon following cardiovascular testing.
(One unscheduled sample was obtained from one subject
for white cell count and differential.) A complete listing
of all tests conducted and methods of procedure are given
in table 33. Blood sampling schedules are shown in
figure 1.
All subjects were administered a water-load test in
the fasting condition on day 9 of the control period and on
the second day of recovery. For this test, the subjects
drank distilled water equal to 2% of their body weight.
The tests were conducted in the morning following blood
sampling. Urine samples were collected 30 to 60 min
before the test and at 30, 60, 90, 120, 180, and 240 min
after water loading. Samples were analyzed for creatinine,
sodium, potassium, calcium, osmolality, aldosterone, and
ADH. Blood samples (4 ml) were taken immediately
before water loading and again 90 min afterward. The
samples were analyzed for hemoglobin, sodium, potas-
sium, calcium, osmolality, aldosterone, ADH, and pH. All
subjects continued to fast until after the test was
completed.
Radioisotope studies- Radioisotope measurements
were used to evaluate red cell mass, hematocrit, and
extracellular fluid. The radioisotopes used were 1251
human serum albumin (25 _tCi), 35S sulfate (25 I.tCi), and
3H water (25 _tCi). Before administration, each dose was
diluted by saline to exactly 1 ml in volume.
Red cell mass, plasma volume, and extracellular fluid
were determined by the following procedure. Blood
(12.5 ml) was drawn into a special anticoagulant solution
(2.5 ml of acid citrate dextrose) contained in a 20-ml
syringe. An Na251CrO4 solution (37.5 _tCi) was next
injected into the syringe, and the contents were mixed
slowly and continuously for 4 min. Ascorbic acid (50 mg)
was then injected into the syringe, and the contents were
again well mixed. Immediately thereafter, 10 ml of the
tagged blood (25 laciS1Cr) were reinjected into the sub-
ject through the catheter-stopeock system, with the injec-
tion syringe washed with saline solution until no blood
remained. The 51Cr-tagged blood that was not reinjected
was used as the subject's standard. A dose of 125I albu-
min was next injected and the syringe washed with
normal saline. The procedure used to inject the subjects
was used in preparing standard dilutions for each determi-
nation so that they would duplicate each other exactly.
Subjects were also given 35SO4 and 3H20 orally. Red
cell mass and plasma volume values were determined on
the basis of a 30-min blood sample. Extracellular fluid
values were determined by calculating the zero-time
intercept using the least-squares method and the 35S con-
tent of the samples at 30, 60, 90, and 120 min.
Duplicate microhematocrits were performed on all
samples (4-rain centrifugation). Blood samples were used
for determining red cell mass were well mixed, and
0.2-ml aliquots were pipetted into triplicate sample tubes.
Those for determining plasma volume also consisted of
0.2-ml aliquots pipetted into triplicate sample tubes. The
51Cr standards were treated similarly. The 125I albumin
standards were made by diluting 1 ml of stock solution to
1 liter and pipetting 0.2-ml aliquots into sample tubes.
Sulfate space was determined by precipitating the
plasma protein contained in 0.2 ml of plasma with 0.4 ml
of Thanol. Duplicate aliquots (0.2 ml) of the supernatant
were pipetted into an Aquasol counting solution (15 ml).
The standard was obtained by adding 1 ml of 35SO4 to a
25-ml volumetric flask with normal stock plasma. From
this, 0.2-ml aliquots were treated in the same way as
unknown plasmas.
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TABLE33.-LABORATORYANALYSES AND PROCEDURES
Assay
Hematology
RBC
RETIC
RETIC NO.
RPI
HB
HCF
MCV
MCH
MCHC
ZSR
RBC MORPH
PLAT
WBC
DIFF PCT
DIFF NO.
WBC MORPH
Special hematology
RCM
P VOL
BLD VOL
ESA
FERRITIN
HB ELECTROPHORESIS b
A1,A2, F, S
HB A1C
TRANSFERRIN
HAPTOGLOBIN
HEMOPEXIN
CERULOPLASMIN
2,3 -DPG
RETIC PROFILE
Units Sample
101211
%
lo9/1
g/dl
1/1
fl
Pg
g/dl
ml/ml
109/1
109A
%
109A
ml
ml
ml
mg/dl
ng/ml
%
%
mg/dl
mg/dl
mg/dl
mg/dl
lamol/gHb
%
WB
WB
WB
WB
WB
WB
WB
WB
WB
WB
WB
WB
WB
WB
WB
WB
WB
HP
WB
S
S
WB
WB
S
S
S
S
S
WB
Procedure a
Electronic
Microscopic-new methylene blue N
Calculation: relic % x RBC(1012/I) x 103
Calculation: relic % x Hct(l / l) x K
45 x 100
Spectrophotometric-cyanmethemoglobin
Microhematocrit-centrifugation
Calculation: Hct(l / 1) x 1000
RBC(1012 / 1)
Calculation: Hb(g /dl) x 10
RBC(1012 ] 1)
Hb(g/dl)
Calculation: Hct(l / 1) x 1000
_ _ Hct(l/l)
Centrifugation ana caic: Zetacrit (%) x 10,000
Microscopic: light and scanning electron microscope
Electronic; coincidence corrected + KHc t
Electronic
Microscopic: Wright's stain
Calculation: % x WBC
Microscopic: Wright's stain
Isotope dilution: 51Cr
Isotope: 125I-albumin
Calculation: RCM + P Vol
TC: mouse fetal liver; 59Fe incorporation
RIA: 59Fe incorporation
Electrophoresis: Titan III cellulose acetate
Cation exchange column
EID: cellulose acetate-specific antiserum
EID: cellulose acetate-specific antiserum
RID: Mancini technique
EID: cellulose acetate-specific antiserum
Enzymatic: Nygaard and Rorth
Quantitative microphotometry c
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TABLE33.-CONTINUED
Assay
Serology-immunology
HBsAGb
CRP
RPR b
IGG
IGA
IGM
IGD
C3
C4
Cellular immunology
Lymphocyte profile
Chemistry: blood
Glucose
Cholesterol
AST
ALT
BUN
Uric Acid
Alk Phos
CA
Mg
PO4
Bili T
Bili D
Creat
CK
LDH
OSMOL
Na
K
Amylase
O
Trigly
GGTP
Units
Poaneg
Postneg
Pos/neg
mg/dl
mg/dl
mg/dl
mg/dl
mg/dl
mg/dl
%-108_
mg/dl
mg/dl
IU/l
IU/l
mg/dl
mg/dl
IU/l
mg/dl
mg/dl
mg/dl
mg/dl
mg/dl
mg/dl
IU_
IU/I
mOsm/kg
mEq/l
mEM
IU/I
mE_
mg/dl
IU/l
Sample
S
S
S
S
S
S
S
S
S
I-I'WB
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
Procedure a
RIA: ausria H-125I, Rel/CPM
Polystyrene latex agglutination/If pos, RID
Flocculation: cardiolipin-cholesterol reagin
EID: cellulose acetate-specific antiserum
EID: cellulose acetate-specific antiserum
RID: buffered agarose gel with monospecific antibody
RID: buffered agarose gel with monospecific antibody
RID: buffered agarose gel with monospecific antibody
RID: buffered agarose gel with monospecific antibody
Electronic, E. Rosette, surface immunoglobin, Isotope
Incorp.
Coupled enzymatic-hexokinase and glucose-6-phosphate
dehydrogenase; mod. Barthelmai and Czak
Enzymatic utilizing cholesterol esterase and cholesterol
oxidase; Allain
UV-kinetic Wroblewski and Mod. Henry
UV-kinetic Wroblewski and LaDue
Enzymatic with urease and glutamic dehydrogenase;
mod. Talke and Schubert
Hawk--reduction of phosphotungstate in the presence of
cyanide
Kinetic using p-nitrophenyl phosphate; rood. Bessey
ctal.
Willis--atomic absorption spectrophotometry
Willis--atomic absorption spectrophotometry
Fiske and Subbarow---dialyzed; phosphomolybdate--
reduced by 1-amino-2-naphthol 4-sulfonic acid
Formation of azobilirubin after reaction with diazotizcd
sulfanilic acid; Jendrassik
Reaction with diazo in acidic aqueous medium O-1N
HCI; Jendrassik
Alkaline picrate (dialysis); Jaffe
Kinetic-coupled enzymatic of creatine phosphate to
form NADH in the presence of glucose-6-phosphate
dehydro-genase; mod. Oliver and Rosalki
UV---kinetic using lactate to pyruvate; mod. Wacker
Freezing point depression
Flame emission photometry
Flame emission photometry
U-V---kinetic Mod. Henry and Chiamori
Amperometric titration with silver ions
Enzymatic: Bucolo and David
Kinetic-utilizing glycylglycine; mod. Szasz
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Assay
Specialchemistry
VLDLb
LDL b
HDL b
Protein
Alb
AI
A2
B
Gamma
Lipo 1A
Lipo Pre Beta
Lipo Beta
LDH ISO 1-5
CK ISO
pH
pCO2
pO2
3O32
Base Excess
Standard Bicarbonate
TBW
ECF
Endocrinology: blood
T-3
T-4
TSH
PTH
CAL
EPI
NOREPI
DA
ANGLO I
ALDO
ACTH
CORT
INS
HGH
TESTO
25-OH VIT D
1,25 (OH)2 VIT D
VIT B12
FOLATE
DBH
ADH
TABLE33.-CONTINUED
Units
m_l
rag/all
mg/dl
g/dl
g/d_
g/d_
g/di
g/cU
g/d_
%
%
%
%
%
mmHg
mmHg
mmol/!
mmol/l
mmol/1
ml
ml
ng/dl
pe,/cu
I.LIU/ml
ng/ml
ng/ml
pg/ml
pg/ml
pg/ml
ng/ml/hr
pg/ml
pg/ml
_g/d_
taU/l
ng/ml
_Jd_
ng/ml
pg/ml
pg/ml
ng/ml
nm/ml/hr
pg/ml
Sample
S
S
S
S
S
S
S
S
S
S
S
S
S
S
HP
HP
HP
HWB
HWB
HWB
Urine
HP
S
S
S
EP/HP
EPAIP
HP
HP
HP
EP
EP
EP
EP
EP
EP
EP
HP/EP/S
HP
S
S
S/HP
HP/EP
Procedure a
Calculation
Calculation
Extraction/enzymatic
Refractometry
Electrophoresis cellulose acetate with barbital buffer
Electrophoresis cellulose acetate with barbital buffer
Electrophoresis cellulose acetate with barbital buffer
Electrophoresis cellulose acetate with barbital buffer
Electrophoresis cellulose acetate with barbital buffer
Electrophoresis cellulose acetate with barbital buffer
Eleca'ophoresis cellulose acetate with barbital buffer
Electrophoresis cellulose acetate with barbital buffer
Eiectrophoresis cellulose acetate with barbital buffer
Electrophoresis UV fluorescent (cellulose acetate)
pH electrode
pCO2 electrode
pO2 electrode
Calculation Siggaard-Andersen alignment nomogram
Calculation Siggaard-Andersen alignment nomogram
Calculation Siggaard-Andersen alignment nomogram
3HOH radioisotopic dilution
35SO4 radioisotopic dilution
125I RIA solid phase
125I RIA solid phase
125I RIA double antibody; solid phase
125I RIA single antibody; charcoal separation
125I RIA single antibody; dioxane separation
3H Radioenzymatic with TLC separation
3H Radioenzymatic with TLC separation
3H Radioenzymatic with TLC separation
125I RIA single antibody charcoal separation physio-
logical pH
3H RIA with methylene chloride; single antibody char-
coal separation
1251 RIA single antibody; charcoal separation
125I RIA single antibody; solid phase
1251 RIA double antibody; sandwich mechanism
125I RIA double antibody
1251 RIA ether extraction; double antibody
1251 CPB; charcoal separation
HPLC/protein binding
57Co CPB; charcoal separation
125I CPB charcoal separation
14C Radioenzymatic PNNT-enzyme
125I RIA-double antibody
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TABLE 33.- CONCLUDED
Ashy
Routine urinalysis
Nitrite
pH
Prot
Gill
Keto
Urobilin
Bili
Blood
WBC
RBC
Epith
Mucous
Casts
Color
Appearance
Chemistry: urine
Volume
Specific Gravity
Osmolarity
Protein
Na
K
O
Ca
Mg
IPO 4
Uric Acid
Creat
Endocrinology: urine
ALDO
CORT
TESTO
TOT EPI
TOT NOREPI
ADH
Units
pos/neg
neg-3+
neg-3+
neg-3+
normal-
12 mg/dl
neg-3+
neg-about
250 Ery/01
cells/hpf
cells/hpf
cells/hpf
No./hpf
ml
m
mOsm
mg
mEq/Vol
mEq/Vol
mEq/Vol
mEq/Vol
mEq/Vol
mg/Vol
mg/Vol
mg/Vol
_tgrrv
_tgrrv
_tgrrv
_tg/rV
_tgrrv
mlU/'rv
Abbreviations: EID = electroimmunodiffusion
Sample
urine
urine
urine
urine
urine
urine
urine
urine
urine
urine
urine
urine
urine
urine
urine
urine-24 hr
or random
urine
urine
urine
urine
urine
urine
urine
urine
urine
urine
twine
urine
urine
urine
urine
urine
urine
EP = EDTA
Procedure a
3 Hydroxy- 1,2,3,4-tetrohydro-7,8 benzoquinoline
Bromthymol blue
Tetrachlorophenol
Glucose oxidase
Sodium nitroferricyanide
4-methoxybenzene-diazoniumtetrafluoroborate
2,6 Dichlorobenzene
0-toluidine
Microscopy
Microscopy
Microscopy
Microscopy
Microscopy
Visual inspection
Visual inspection
Volumemc
Refractometry
Freezing point depression
Refractometry
Flame emission photometry
Flame emission photometry
Amperometric titration
Atomic absorption
Atomic absorption
Phosphomolybdate
Phosphotungstate with cyanide
Alkaline picrate
3H RIA acid hydrolysis extraction with methylene
chloride
1251 RIA methylene chloride extraction; single antibody;
solid phase
125I RIA ether extraction; glucuronidase hydrolysis;
double antibody
Acid hydrolysis, open column chromatography,
fluorometric
Acid hydrolysis, open column chromatography,
fluorometric
Open column chromatography, 125I RIA single antibody,
charcoal separation
9lasma; FP = sodium fluoride plasma; HP = heparin plasma;
HWB = heparinized whole blood; RIA = radioimmunoassay; RID = radioimmunodiffusion; S = serum; TC = tissue
culture; WB = whole blood.
aNumbers in parentheses refer to sources as they are cited in reference 37 of this report.
bSelection examination only.
CMethylene blue and 1-ethyl-2[3-(1-ethylnaphtho[ 1,2d]-thiazolin-2-ylidene)-2-methyl-prophenyl]naphtho [1,2d]-
thiazolium bromide.
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Radioactivestudiesof totalbodywaterusedthe
3H20contentof backgroundurineandthreespoturines
collected3to8hrafterdosage.Eachsubjectemptiedhis
bladderatleastoncebetweentheinjectionsof3H20and
theemptyingof thespoturines.Urinesamplesweredis-
tilled,andthedistillate(0.5ml)waspipettedintoan
Aquasolcountingsolution(15ml).Thebody-waterstan-
dardwasachievedbydiluting1mlof thestocksolution
to 1literandpipetting,in triplicate,0.5-mlaliquotsinto
15mlofAquasol.
Radioactivitywasmonitoredby measuringbeta
radioactivityina liquidscintillationcounterandgamma
radioactivityinascintillationwellcounter.Inbothmea-
surements,multiplecountswereobtaineduntil a 1%
countingerrorwasachieved.Subjectsreceivedtotal
radioactivedosesof 0.0432rem,whichcomparesfavor-
ablywith thetotalpermissibleoccupationalexposure
of 1.25 rem/quarter,which can be increasedto
3.0rem/quarterif the total for theyearis lessthan
5.0rem.
Cellular immunology-Cellularimmunological
responseswerestudiedin bothgroupsof subjects,with
testsmade3daysbeforebedrest,ontheseventhdayof
bedrest,andonthefirstdayofrecovery.Testswerecon-
ductedfor whitebloodcellcount;lymphocytecount,
Tcell,B cell,andnullcelldistributions;andlymphocytic
responsivenesstothemitogensPHA,ConA,andpoke-
weed.Beforeassay,thesampleswerestoredfor24hr to
lowerthetotalwhitebloodcellcountresultingfromcell
death,whichwouldaffectprimarilytheneutrophiles.
Results of biochemical and endocrine analyses-
Selected 24-hr-mean urinary and serum biochemical and
endocrine results are shown in tables 34 and 35. These
include parameters from the full list of analyses (see
table 33) showing evidence of significant (p < 0.05) or
near-significant change compared to control (pre-bed-rest)
levels. Data for all parameters (table 33) are given in the
original reports submitted for this experiment. Both the
horizontal and head-down subjects exhibited decreased
excretion of sodium, chloride, and potassium during the
bed-rest and recovery periods relative to the baseline val-
ues. But osmolality and specific gravity measurements
indicated a more concentrated urine in both groups. There
also was a significant decrease in 24-hr-urine volume
between the control period and bed rest or recovery
(fig. 8). During bed rest, urinary aldosterone increased
slightly in the horizontal group, but decreased in the head-
down group. During recovery, both groups showed
increased aldosterone. Antidiuretic hormone, on the other
hand, was slightly increased in both groups during bed
rest, except for the head-down group on the first day of
bed rest, when it was lowered. In the recovery period,
both groups showed slight increases in ADH.
Urine creatinine findings (table 34) were variable but,
in general, were slightly increased in both groups during
bed rest. Epinephrine and norepinephrine were decreased
in both groups during the bed-rest period; during recov-
ery, there was a tendency for these substances to increase
back toward the bed rest levels. Testosterone was gener-
ally decreased in both groups. Findings for calcium and
inorganic phosphate excretion were variable, but urinary
levels of these parameters generally increased during bed
rest in both groups. Findings on magnesium excretion
were more consistent, with this electrolyte decreasing
during bed rest and tending to increase during recovery in
both groups.
Plasma and serum biochemistry and endocrine results
(table 35) indicated that both groups experienced losses in
sodium, potassium, chloride, osmolality, cortisol, and
aldosterone concentrations during bed rest; sodium, potas-
sium, chlorine, glucose, cholesterol, osmolality, and
insulin were depressed in the recovery period. Aldos-
terone, which had decreased during bed rest, actually
increased during recovery. Serum norepinephrine
increased in the head-down group during bed rest and
increased in both groups following bed rest; but
epinephrine and dopamine beta hydroxylase (DBH) were
more variable. Plasma ADH tended to decrease in both
groups, except in the head-down group on the fourth day
of recovery. In both groups, FI]-I was decreased on day 2
of bed rest, but increased on day 4. Both 1,25(OH)2 and
25-OHD were decreased during bed rest, but returned to
baseline values or higher after recovery. There were gen-
eral increases in AST and ALT during bed rest and upon
recovery. Both groups exhibited increases in alkaline
phosphatase and LDH early in bed rest, with the horizon-
tal group showing an increase in LDH isoenzyme on
day 7 of recovery. Uric acid (table 35) was decreased in
the horizontal subjects throughout bed rest and slightly
increased in the head-down subjects on day 2 of bed rest.
There was a significant difference in serum uric acid
levels between horizontal and head-down groups, uric
acid being lower in the latter subjects. Again, in both
groups, HGH and T3 were decreased following bed rest,
T4 was slightly increased during the recovery period, and
thyroid stimulating hormone (TSH) showed no consistent
changes.
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Figure 8.- Mean fluid balance: U.S. subjects. (a) Fluid intake, fluid output.
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Figure 8.- Concluded. (b) Intake versus output.
Discussion- Exposure to weightlessness results in a
redistribution of the volume of blood within the vascular
system. The body sensors interpret this redistribution to
be an increase in blood volume and respond by causing a
compensatory loss in water, sodium, and potassium from
the renal tubules. Following spaceflight, both astronauts
and cosmonauts have shown a loss in body weight which
is rapidly regained. Most of this loss is attributed to water
loss; the remainder is thought to consist of fat, protein
(muscle), and bone. The decreased adiposity has been
attributed to a hYtxx:aloric diet eaten during flight (loss of
appetite) and to muscle loss caused by inactivity or lack of
gravitational force, or both.
Fluid balance findings are shown in figure 8 for the
U.S., which compares water intake, urine output, and
resulting balance. A frank diuresis was not evident on the
first day of bed rest. This was also the case for the
U.S.S.R. subjects (see fig. 9). The findings may have been
a result of the fact that the subjects were fed standard
spaceflight diets instead of more usual table food. In both
horizontal and head-down groups, urine excreted during
bed rest was more concentrated and of less volume. On
the first day of bed rest, excreted ADH increased slightly
in the horizontal group and decreased in the head-down
subjects; throughout the remainder of bed rest, it was gen-
erally increased in both groups. Thus, after the initial
adjustment to bed rest, the subjects in this study
apparently were in a water-conserving state, which
occurred on the first day of bed rest in the horizontal
subjects, but required 2 days in the head-down group.
Intake-output data from the present study, in general,
agree with reports from spaceflights, during whidh an
early diuresis has not been a regular finding.
Serum sodium concentration decreased similarly in
both groups, both in timing and magnitude of change.
Serum potassium also decreased in both groups, but was
statistically significant only in the head-down subjects,
even though both groups had ingested like amounts of
supplemental potassiums.
Plasma angiotensin I was slightly increased late in
bed rest and more so during recovery in both groups.
Plasma aldosterone, on the other hand, decreased during
bed rest, but increased during recovery in both groups.
Urinary aldosterone increased during bed rest in the hori-
zontal group, but not in the head-down group; however,
both groups exhibited increases during recovery. The
results suggest that the renin-angiotensin-aldosterone
mechanism for conserving sodium occurred only in the
horizontal subjects. The increase, however, was not as
great as that usually reported early in spaceflight, and
there was no evidence to suggest that the head-down
position augmented the aldosterone response.
Other investigators have observed a decrease in
plasma angiotensin I, aldosterone, and ADH in head-
down subjects on the first day of bed rest (ref. 36). These
findings suggest that head-down subjects exhibit a rapid
physiological response when placed in this position, lead-
ing to hemodynamic and neurohumoral adaptation, which
includes shifts in water-salt volume to produce a reduced
blood volume. In the present study, plasma values were
not obtained on the first day of bed rest, but urine levels
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TABLE34.-24-HOURURINE:U.S.STUDY
MOSM
mOsm
0°
_6 °
Na, mEq/TV
0 °
_60
K, mFxlfI'V
0°
_60
cl, mEqnw
0°
_60
Ca, mg/TV
0 °
_60
Creat., mg/TV
0°
_60
 ddo.,  g/TV
0 °
_60
Epi., gg/TV
0 °
_60
Norepi., gg/TV
0°
_60
Mean
control
551 +11
637 +16
200 +_4
189 ±5
73 ±1
61 +_2
184 ±4
175 +5
18.9 ±1.5
18.3 ±1.9
49.2 +_2.5
48.5 ±2.7
Day 1
588 ±19
700 ±71
224 ±14
207 ±16
79 ±6
58 ±4
195 ±14
187 ±13
11.5 ±1.1
14.3 _+0.2
12.5 ±3.2
9.6 ±1.6
10.8 ±3.6
12.9 ±4.2
34.2 _+4.2a
31.3 ±7.3
Bed rest
Day 2
772 ± 52 a
857 ±100
208 ±15
133 ±12 a
74 ±8
63 ±5
186 ±9
150 ±11
12.8 ±0.5 a
15.2 _+0.9
15.6 ±2.7
8.5 -+0.7a
7.1 ±1.7 a
6.9 ±5.8
31.5 _+4.7a
32.4 ±3.5
Day 5
816 +_41a
963 ±81 a
169 ±15
117 ±10 a
81 ±8
55 ±6
138 ±17 a
107 ±14 a
12.1 _+0.9
14.9 ±1.6
1.75 ±0.10
1.72 _+0.08
17.2 +_2.1
12.3 ±1.4
7.2 ±2.6 a
10.6 ±3.6
35.5 ±5.4
31.4 ±6.5
Da_' 7
656 ±58
769 ±131
141 ±27
116 ±10 a
67 ±9
53 ±6
116 ±23 a
102 ±14 a
10.5 ±1.1
12.7 ±1.2
1.73 _+0.09
1.86 ±0.06 a
15 ±1.7
10.2 ±1.8
10.9 ±2
10.6 ±4.6
33.4 +_4.6a
32.6 ±4.1 a
805
78O
113
86
65
51
84
78
Day 0
±38 a
±136
±17 a
±12 a
±5
±4
±12 a
±12 a
11.6 _+0.8
14.7 ±1
1.78 _+0.07
1.82 ±0.06 a
21.2 ±1.9 a
17.1 ±1.3 a
11.8 ±4
19.6 ±2.1
44.8 ±5.3
33.7 ±5.9
Recovery
Da_, 1
659 ±69
697 ±79
142 ±19 a
105 ±24 a
63 ±4
45 +9
111 ±17 a
93 ±21 a
11.4 _+0.5
12.5 ±1.2
18.3 ±2.9
14.1 ±2.8
15.6 ±4
12.7 ±1.6 a
44 ±4.7
34.2 +_2.8a
Dale 3
456 ±31 a
653 +26
178 ±18
147 ±23
62 ±6
60 ±9
158 ±12
138 ±19
11.9 _+0.6
11.9 ±1.6
13.1 ±1.1
11.8 ±1
15.7 ±2.6
10.5 ±3.4
48 ±7.7
42 ±4.2
ap < 0.05 com )ared to control period.
TABLE35.-SERUM,BIOCHEMICAL,ANDENDOCRINEDATA:U.S.STUDY
Mean±SE
Na,mEq/1
0o
_6 °
K, mEq/!
0o
_60
c1, mEq/1
0o
_60
mOsm
0o
_6°
Ca, mg/dl
0o
_6°
Aldo, pg/ml
0o
_60
Cortisol,/.t%
0o
_6°
Angio I, ng/ml/hr
0o
_6°
Epi, pg/ml
0o
_6°
Norepi, pg/ml
0o
_6°
Glucose, mg/dl
0o
_60
Insulin, btIU/I
0o
_6°
Chol, mg/dl
0o
_6°
Uric Acid, mg/dl
0o
_60
Mean control
140 -1-1
140 ±I
4 ±0.03
4.2 ±0.1
100 ±0.4
100 ±0.4
274 ±1
286 ±1
9.2 ±0.1
9.1 ±0.1
335 ±24
325 ±26
2.33 ±0.28
1.92 ±0.12
19 ±6
29 ±8
244 _±35
274 ±30
87 ±1
84 ±1
26 ±2
22 ±2
236 ±9
193 ±2
6.9 ±0.1
5.7 ±0.3
Day 2
138 -t-1
138 ±1
4 ±0.1
4.1 ±0.1
97 ±1 a
99 ±1
273 ±3
281 _-t:,2
223 ±18 a
228 ±37 a
2.33 ±0.43
2.75 ±0.5
15 ±5
16 ±13
224 ±8
345 _-t:38
88 ±.2
87 _±2
23 ±1 a
19 +2
6.4 ±0.1
6.1 ±0.3
Bed rest
Day 4
135 ±1
135 ±1
3.9 ±0.01
3.9 ±0.01 a
98 ±0.3 a
99 ±1 a
269 ±.2
282 ±2
232 ±18 a
258 ±23 a
17.2 ±1.5
20.2 +1.2
2.91 ±0.62
3.13 ±0.9
24 ±9
41 ±23
244 ±22
340 ±48
90 ±3
85 ±2
27 ±6
20 ±4
267 ±1 a
221 ±8 a
DaY 7
138 ±1
137 ±1
98
99
3.9
3.7
±0.01
_0.01 a
±1 a
±1
270 ±2
281 ±3
273
233
9.5 ±0.1
9.3 ±0.1
±22 a
±.36a
19 ±1.4
18.8 ±1.1
4.02 ±1.1
4.10 ±0.8
16
18
241
325
81
87
30
19
241
200
6.2
5.5
±15
±8
±24
±45
:t:4
±.5
±9
±2
±7
±8
±0.2 a
±0.5
Dav 2
139 ±1
137 ±1
3.8 ±0.1
3.7 ±0.01 a
99 ±1 a
98 ±1 a
270 ±1 a
284 ±2
9.3 ±0.2
9.1 ±0.1
475 ±75
350 ±98
23.3 ±2.7
18.9 ±1.2
10.98 ±5
6.20 ±1.1
32 ±7
25 ±6
251 ±14
391 -+_.35a
78 ±3 a
74 +2 a
24 ±4
21 ±5
219 ±7
175 ±5 a
Recover_
141
139
3.8
4.1
98
98
268
278
9.7
9.7
366
294
Day 7
15.4
15.5
18
2.91
3.85
35
244
294
81
80
19
15
214
178
6.3
5.7
±1
±1
±0.1
±0.2
±1
±1
±1
±3
_+0.1
±0.1
±20
±17
+1.5
±1.1
±1.05
±1.02
±11
±22
±15
±34
±2
±1
_±3
±2
±6
-2-6
±0.2
±0.4
ap < 0.05 compared to control period.
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of thehormonesindicatethatsimilarmechanismsoper-
atedin thehead-downsubjects.Theincreasein serum
creatinineandslightincreasein urinarycreatinine,par-
ticularlyin thehead-downsubjects,indicateadecreasein
creatinineclearancewhichprobablyresultedfroma
changeinbloodflowtothekidneys.Creatinineclearance
hasalsodecreasedslightly in somespacecrewmen
(ref.37).
Theslightdecreasesin serumuricacidandslight
increasesinurinaryuricacidmaybeattributedtoaltered
ADHsecretionortochangesin therenalhandlingofuric
acid.Astronautsandcosmonautshaveexhibitedsimilar
changes(ref.38).
Responsesof theadrenalcortexandmedullainthis
studyareof particularinterest.Urineepinephrinelevels
roseduringbedrest,probablybecauseof stress.Cortisol,
themajorglucocorticoidof theadrenalcortex,hasbeen
observedto increasein bothspaceflightandbedrest
(ref.33).Thepresentstudy,however,showedslight
decreasesin bothplasma ndurinarycortisoi.But it
shouldbenotedthatcontrol-periodplasmacortisolvalues
wereinthehighnormalrange. The variable ACTH find-
ings in the present study suggest that the pituitary-adrenal
axis responded to bed-rest conditions. Plasma nore-
pinephrine was increased in the head-down subjects
throughout bed rest and in both groups with recovery.
Dopamine increased in both groups with bed rest, but
DBH increased only in the head-down subjects. Since
DBH is responsible for hydroxylyzing dopamine to form
norepinephrine (ref. 39), this enzyme should be elevated if
there is a demand for norepinephrine production or
release. The findings demonstrated a general responsive-
ness of the sympathetic nervous system to bed rest, par-
ticularly in the head-down subjects. Increases in the
enzyme that occurred during the recovery period were
similar to responses during and after spaceflight as a gen-
eral response to stress and to maintain orthostatic control
(refs. 1 and 33).
Resting plasma glucose has been reported to increase
with bed rest (refs. 40 and 41). The subjects in the present
study exhibited this response during bed rest, but showed
significant decreases afterward. Insulin, on the other hand,
was consistendy lower than baseline values during both
bed rest and recovery. Research has shown that bed-rested
subjects have reduced tolerance to glucose, whether
administered orally or intravenously. The cause of this
change is not known. Such challenges with oral glucose
loads were not conducted during the present study. The
general decreases in growth hormone observed in the
present study have been observed before with immo-
bilization (ref. 41).
Findings in this study of increased cholesterol during
bed rest and decreased cholesterol after bed rest are sup-
ported by previous research (ref. 42). Diet is not believed
to be responsible for this change, since the diet provided
in this study was consistent in quality, if not in quantity,
in all three study periods. Thyroid hormones were not
measured in the joint study during bed rest, but in other
research, thyroxine (T4) has increased (ref. 43). The slight
decrease in T3 and increase in T4 observed in the present
study during recovery are consistent with blocked T4-T3
conversion, which suggests that a change occurs in renal
or liver handling of these substances.
Analysis for serum enzymes that might indicate
altered liver, bone, and muscle functions failed to indicate
significant changes. Although some individual readings
were elevated, in general there were no significant
changes in AST, ALT, LDH, CPK, and bilirubin. The
slight increases in alkaline phosphatase seen in the hori-
zontal group were similar to those observed after Apollo
flights, but not after Skylab (refs. 37 and 44).
Findings of the present study indicate that muscu-
loskeletal changes occurred with bed rest in both the hori-
zontal and head-down subjects. This is supported by the
slight decreases seen in CPK which have also been noted
in other studies (ref. 45) and are thought to result from
decreased muscle activity during bed rest. All of the
change in CPK isoenzymes occurred in the MM band,
indicating that only muscle CPK was involved. Although
LDH isoenzyme patterns are useful in determining spe-
cific tissue changes, in this study neither group exhibited
significant deviations from baseline values. In both
groups, serum gamma-glutamyl transpeptidase activity
was slightly elevated during bed rest and recovery. But
these changes were small compared with changes evident
during clinically apparent kidney and liver disorders. This
enzyme is considered to play a role in protein biosynthesis
and in the transport of amino acids across cellular mem-
branes in kidney tubules (ref. 46). Changes in blood flow
to the liver or kidneys may have been responsible for the
slight elevation observed in the subjects.
An alteration in skeletal homeostasis was indicated
by changes in serum calcium and inorganic phosphate
which increased slightly and from 24-hr-urine calcium
and phosphorus excretion, which also increased in both
groups, with the magnitude of change being about the
same in both. These changes occurred despite a general
decrease in calcium (200 mg/day) in the diet. These find-
ings are supported by previous bed-rest data (ref. 47), and
by spaceflight findings of increased excretion of calcium
and phosphorus (ref. 48).
Urinary testosterone increased in the horizontal sub-
jects and decreased in the head-down group with bed rest,
whereas plasma concentrations generally were decreased
in both groups. These findings suggest that changes either
in binding protein or in blood flow were responsible. With
the Skylab mission, testosterone was increased during
flight and decreased postflight. It is hypothesized that
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thesechangesarecausedbythesamemechanismsthat
resultinobserveddecreases in cortisol.
Shifts in fluids and electrolytes-- During the present
study, all subjects lost body weight (see table 24) and
showed decreases in mean values of daily water intake
and 24-hr-urine volumes and shifts in body-fluid com-
partments (see table 36 and fig. 8). These changes were
most pronounced early in bed rest and during the recovery
period.
Weight losses usually have not occurred with bed rest
when caloric intake has been carefully maintained. But all
subjects in this study lost weight on their Shuttle astronaut
diet, with no difference between the horizontal and head-
down subjects. Weight losses averaged about 0.45 kg and
began on the first day of bed rest for the head-down sub-
jects and on the second day of bed rest for the horizontal
group; the losses probably resulted from a noticeable
decrease in water and food intake during the bed-rest
period. Water intake decreased by several hundred
milliliters per day in the horizontal subjects and by about
1 liter/day in the head-down group, but the differences
were not statistically significant. Similarly, caloric intake
decreased by several hundred calories per day in the hori-
zontal group and by 1,000 kcal/day in the head-down sub-
jects during bed rest. Although weight losses in the two
groups did not differ, the difference in foot intake was sta-
tistically significant
Extracellular volume was measured 9 days before bed
rest and on the last day (day 7) of bed rest. Changes in the
horizontal and head-down groups were not significant,
with decreases of 0.4% and 1.4%, respectively.
All horizontal and head-down subjects exhibited a
decrease in red cell mass by the seventh day of bed rest,
as shown in table 36. The mean decrease for the head-
down group (-8.7%) did not differ significantly from that
of the horizontal subjects (-5.5%). During the first 7 days
of recovery, red cell mass continued to decrease in two
subjects from each group. As expected, plasma volume
decreased after 7 days of bed rest in both the horizontal
and head-down subjects, but both had returned to baseline
values by day 7 of recovery. No differences were seen
between the responses of the two groups. Blood volume,
TABLE 36.- BODY FLUID VOLUME CHANGES WITH BED REST
[Mean +(SE)]
I Red cell mass, Plasma volume, Blood volume,
ml/kg ml/kg ml
U.S. study
I Extracellular fluid, I Total body water,
ml/kig ml/kg
Horizontal
Control period
Bed-rest day 7
Recovery day 7
Head-down
Control period
Bed-rest day 7
Recovery day 7
27.1 (2)
25.8 (1.6) a
25.2 (1.4) a
26.1 (1.9)
24.4 (1.8) a
23.7 (1.9) a
42.3 (2.6)
39.4 (2.2) a
42.7 (2.8)
40.2 (2.6)
37.9 (2.5) a
41.0 (2.6)
4732 (312)
4387 (255) a
4586 (282)
4603 (300)
4230 (290) a
4430 (306)
203 (11)
204 (11)
192 (6)
194 (6)
599 (13)
596 (1 l)
585 (18)
590 (18)
U.S.S.R. study
Horizontal
Control period
Bed-rest day 7
Recovery day 9
Head-down
Control period
Bed-rest day 7
Recovery day 9
28.4 (1.1)
25.9 (0.8)
26.5 (1.2)
26.7 (0.9)
25.3 (0.7)
26.4 (1.4)
40.5 (1.5)
39.3 (1.7)
43.8 (1.9)
38.4(1.2)
37.5 (0.7)
41.6 (1.2)
68.3 (2)
66.3 (3)
70.2 (3)
65.1 (1.9)
65.6 (1.7)
67.8 (2)
216 (8)
204 (13)
238 (19)
210 (8)
207 (7)
229 (7)
612 (9)
594 (8)
613 (14)
607 (14)
611 (13)
624 (17)
ap > 0.05.
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thecombination of red cell mass and plasma volume,
decreased after bed rest by 8.1% in the head-down group
and by 7.1% in the horizontal group. After 7 days of
upright activity, red cell mass remained depressed. Analy-
ses of erythroid stimulating activity (ESA) indicate an
elevation (compared to the control period) on recovery
days 0 and 2, while there was no significant changes in
ESA titers in either group during bed rest. A similar
pattern was reported in previous 7-day bed-rest studies
(ref. 33).
Water load test- Urine results with water loading
are shown in table 37. As the data indicate, responses in
the two groups were similar--by 2 hr after loading, 60%
to 70% of the water load had been excreted. The most
dilute twine was also voided during this time. Aldosterone
was decreased until ADH responses occurred at 180 min.
Plasma results obtained 30 rain before and 90 min after
loading are shown in table 38. The dilution effect of the
water load was detected by osmolality measurements in
the two groups. Sodium, aldosterone, and ADH were
decreased at 90 min; potassium was slightly increased,
except in the head-down subjects on day 2 of the recovery
period. However, no significant differences were found
between the two groups.
The water-load test was used to study the mecha-
nisms that regulate excretion of water and sodium, par-
ticularly the hormonal system that controls such elimina-
tion. A healthy, normally hydrated individual usually
excretes 60% or more of the water consumed over a 2-hr
period and, in 4 hr, may excrete more than was consumed
(ref. 49). It is believed that ingested water reduces the
osmotic concentration of the extracellular fluid, so that
secretion of ADH is suppressed and excretion of urine is
increased. Results of the present study show that this
mechanism was not impaired after 1 week of bed rest.
U.S.S.R. postflight findings indicate that some crewmen
are unable to excrete a water load rapidly after exposure
to weightlessness. The adrenal system apparently was not
involved in these latter tests, since there were no changes
in urinary 17-oxycorticosteroids or in the potassium/
sodium ratio. There were similar findings for all subjects
in the present tests.
Hematology/immunology- Routine hematology
results obtained during the U.S. study are shown in
table 39. Hemoglobin increased significantly and hemat-
ocrit increased slightly and similarly in both groups dur-
ing bed rest. Following bed rest, however, these variables
decreased to or below bed-rest values in both groups. Fol-
lowing bed rest, both groups exhibited an increase in
reticulocyte counts, with a shift to reticulocytes contain-
ing more ribosomal material.
Serum proteins- No significant changes were
observed in total serum protein and its electrophoretic
pattern in either subject group over the course of the pres-
eat study. Plasma albumin concentrations did not change
significantly and are of note since they would have been
expected to show increases of 10%-20% as compensatory
changes associated with observed decreases in plasma
volume. No significant changes were seen in immuno-
globulin and other serum proteins examined, except for
complement factor 3, which was elevated on recovery
days 2 and 7 in both subject groups.
In cellular immunological studies, no significant
changes were observed except for pokeweed mitogen
stimulation of lymphocytes. Baseline values differed for
the horizontal (9.7 index) and head-down (5.5 index) sub-
jeers; all were below an index of 10, which is considered
to be low normal. As the study progressed, these values
increased in all subjects to normal levels, suggesting that
bed rest or confinement contributed to an initial decrease
of response.
Discussion- Both spaceflight and bed rest produce a
decrease in plasma volume. After 8 days in space,
Gemini-5 crewmen exhibited losses in plasma volume of
9% and 5%. Previous bed-rest studies of 7- to 10-days'
duration showed losses up to 10%, which have occurred
during the f'trst 48 hr of exposure (refs. 2 and 50). Both
the horizontal and head-down subjects showed a loss of
8%, which is similar to previous findings for spaceflight
and bed rest.
Losses in red cell mass were significantly smaller in
the horizontal subjects (-6%) and head-down subjects
(-9%) in the present study than in the two Gemini-5 crew-
men (-20% and -22%). The loss in red cell mass in those
crewmen was attributed to the hyperoxic atmosphere of
the Gemini spacecraft. In early Apollo missions, on the
other hand, red cell mass decreases were similar to those
seen with bed rest (-22% to -7%), although later missions
showed larger losses in red cell mass (-10%) (ref. 51).
The losses in the subjects in the present study, however,
were greater than have been noted in other bed-rest
studies (usually -2% to -3%) with similar procedures.
The reasons for this change are unclear. In the present
study, hematocrit and serum protein concentration did not
show significant changes as the result of bed rest. It is
thought that the restricted physical activity imposed on the
subjects during the 14-day control period may have con-
tributed to this finding in that baseline values taken late in
the control period may have already been reduced in level.
The large decrease seen in red cell mass in the subjects
would also tend to neutralize any hemoconcentration
caused by a decrease in plasma volume.
In summary, the hematologic/immunologic bed-rest
findings of the present study were similar to those seen
previously in studies of similar length and characteristics,
with similar changes observed in both groups.
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TimlB from
water load_
min
Volume
ml [_
Control-day 7
30
60
90
120
180
240
R+2
30
60
9O
120
180
240
54 +16
187 +q7
299 +49
292 -2-62
393 ±66
223 +44
67 ±9
167 ±34
332 :t:53
328 -1-41
358 ±65
152 .-1:51
4
17
37
58
85
100
5
17
40
64
89
100
Control-day 7
30
60
90
120
180
240
R+2
30
60
90
120
180
240
2 4-0.8
2 L--0.4
3 20.6
3 20.7
5 ±1.3
7 .-1:2.6
6 ±0.8
3 ±0.6
3 20.9
2 20.8
5 ±1
8 +7.1
24
35
45
55
74
100
24
32
43
49
69
100
TABLE 37.- URINE RESULTS, WATER LOAD TEST: U.S. STUDY
K Ca
mEq/V 1% m_/V 1%
Horizontal sub'ects
ADH Aldo. Creat. Osmo.
]xUN ] % p.6/V ] % m_/V I% mOsmo
4 __+0.6 17 0.3 +0.07 35 0.6 20.18 43
3 ±0.3 30 0.1 +0.02 49 0.1 ±0.04 50
3 __+0.4 42 0.1 :1:0.02 57 0.1 20.04 57
4 ±0.4 58 0.1 +0.01 68 0.1 __+0.05 64
5 ±9.7 80 0.1 +0.05 83 0.2 __+0.04 79
5 :t0.7 100 0.1 +0.03 100 0.3 :£-0.06 100
3 20.4 18 0.5 ±0.06 32 0.6 20.11 35
2 20.6 28 0.2 ±0.04 44 0.1 20.05 41
3 20.9 43 0.2 5.-0.04 56 0.1 ±0.07 47
2 20.7 56 0.1 :t0.04 65 0.1 20.08 53
4 +1 79 0.2 ±0.07 82 0.3 20.22 71
4 +8.6 100 0.3 :L,-0.07 100 0.5 20.17 100
6° Head-down subiects
139 ::t:4 9 8 ±1.8 24 4 20.7 18
293 _+.34 29 5 20.7 38 3 20.2 30
343 +73 51 4 20.5 50 3 20.2 44
344 ±19 74 4 20.8 62 3 20.2 60
269 +78 92 7 ±1.7 83 5 ::t0.4 83
122 _'t36 100 6 ±1 !100 4 20.7 100
8
31
57
76
95
100
8 +1.1
5 20.7
5 +1.5
4 20.02
7 ±1
8 ±1.6
121 +75
351 -+-23
384 ±12
295 ±53
274 ±96
83 ±11
3 20.6
2 20.4
2 20.3
2 20.4
3 20.7
3 ±0.5
19
34
47
61
81
100
0.4 ±0.10 32 0.7 20.33 30
0.2 :t0.04 45 0.4 20.14 48
0.1 ±0.02 55 0.1 20.02 52
0.2 _.q).04 68 0.2 20.02 61
0.3 ±0.11 92 0.4 ±0.07 78
0.1 :£-0.03 100 0.5 20.10 100
0.7 ±0.10 39 1 20.28 36
0.3 ±0.06 55 0.2 20.09 43
0.2 ±0.03 64 0.2 20.06 50
0.1 ±0.03 72 0.3 20.07 61
0.2 ::t.-0.04 86 0.4 20.06 75
0.2 _+0.05 100 0.7 20.15 100
22
35
49
59
79
100
0.7 20.12
0.5 20.07
0.3 20.06
0.3 20.02
0.6 20.09
1.2 20.49
1.2 20.20
0.3 20.10
0.4 :L-0.15
0.2 20.05
0.4 20.11
0.6 20.21
1 20.13
0.6 20.13
0.3 20.03
0.3 20.02
0.6 20.09
0.5 20.07
0.9 20.24
0.3 20.04
0.2 20.05
0.2 20.04
0.3 20.06
0.4 20.07
19
34
43
53
68
100
37
37
48
61
82
100
29
46
56
66
84
100
38
50
60
68
82
100
54 ±4
41 ±4
32 ±3
32 .+.3
53 +1
46 ±3
31 ±-6
64 .+_26
38 +4
34 ±4
47 +7
44
21 13 ±1
37 9 ±1
49 7 +1
62 9 ±1
82 15 +7
100 14 :t.2
24 14 4-7.
45 9 4-9.
58 9 ±1
70 8 +1
85 24 ±12
100 16 +7
68
48 ±4
34 ±4
35 .+_2
58 +7
51 ±5
83 ±10
53 ±6
36 ±1
35 ±1
52 ±7
58 ±3
23
40
51
63
83
100
26
43
54
65
82
100
26 ±11
14 Y._3
10 ±5
10 ±1
16 +7
11 ±1
19 ±1
12 +7
11 +7
9 ±1
14 +7
15 ±2
TABLE 38.- BLOOD RESULTS---WATER LOAD TEST: U.S. STUDY
Subjects
Hb Osmo, Na, K, Aldo, ADH,
g/dl mOsm mEq/l mEq/l p_dl _tU/ml
0 °
Control day 7
Pretest
90 min
Recovery day 2
Pretest
90min
14.5
14.7
14.1
13.7
_+0.2
_+0.3
±0.1
-+0.2
288
283
286
278
+_2 140
+_2 137
+_2 139
+_2 136
_+0.4
+1 a
_+0.5
+1 a
3.9 ±0.1 282 +13
4.1 _+0.2a 225 +15 a
3.9 _+0.1 366 +17
4.1 _+0.2 226 :t9 a
1.21 +0.21
0.81 +19
0.98 _+0.34
0.28 +0.07
o
Control day 7
Pretest
90 min
Recovery day 2
Pretest
90 min
14.4 +1
14.3 +1 a
287 ±1
281 ±1 a
283 ±1
284 +_2
138 ±1
137 _+0.2
137 ±1
137 ±1
298 +_26
214 ±8 a
294 +_20
181 _+4a
Note: 90 min - 90 min after loading; HB - hemoglobin; Osmo - osmolarity: Na - sodium; K -
aldosterone; ADH - antidiuretic hormone.
ap < 0.05 compared to control period.
0.90 ±0.22
0.52 +0.20
_otassium; Aldo -
U.S.S.R. Study
During the control period and during recovery, fast-
ing venous samples (50 ml) were taken at 0730, with all
subjects supine for 2 hr before sampling. Acid-base bal-
ance was determined from blood samples taken simulta-
neously by index-finger prick. Samples were taken on
days 6, 12, and 14 of the control period; on days 2, 4, and
7 of bed rest; and on days 2 and 7 of recovery. Serum and
plasma were separated from red cells by centrifugation at
4°C for 20 min at 3,000 rpm.
Urine was collected daily from all subjects through-
out the study. Samples were maintained separately and
refrigerated (4°C). Total individual daily collections were
measured for volume, and urine designated for electrolyte
analysis was acidified with nitric acid (0.25 ml concen-
wated acid per 12 ml urine).
Blood serum enzyme activity was analyzed using
spectrophotometry and colorimetry (Boehringer Mann-
heim (GmbH)). Enzyme activity analysis included gluta-
mate dehydrogenase (GDH), sorbitol dehydrogenase
(SDH), gamma-glutamyl transferase (y-GT), leucine ary-
lamidase (LAB), nonspecific cholinesterase (ChE), alka-
line phosphatase (LDH), malate dehydrogenase (MDH),
isocitrate dehydrogenase (ICDH), creatine phosphokinase
(CPK), alanine aminotransferase (ALT), and aspartate
aminotransferase (AAT). The LDH and MDH isoenzymes
were separated by polyacrylamide gel electrophoresis fol-
lowed by densitometry, with the activity of each fraction
expressed as a percentage of total enzyme activity. Pan-
creatic carbohydrase-amylase activity in blood and urine
was determined by the procedure of Smith and Roe
(ref. 52) as modified by Ryzhova (ref. 53); pepsinogen
activity in urine was analyzed by an absorption col-
orimetric method (ref. 54). Equivalent serum and 24-hr
urine results to that reported for U.S. subjects are given in
tables 40 and 41.
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TABLE 39.- ROUTINE HEMATOLOGY: U.S. STUDY
Subiects
Horizontal Pre i ±SE
In Bed Day 2 .+.SE
Day 4 -+-SE
Day 7 _SE
Recovery Day 2 ±SE
Day 7 +-_E
6 ° Head-Down Pre i ±.SE
In Bed Day 2 ±.SE
Day 4 :_.SE
Day 7 ±SE
Recovery Day 2 ±SE
Day 7 :trSE
ap < 0.05 compared to recovery
RBC,
1012/1
4.60 ±0.07
4.09 ±0.14a
4.36 ±0.33
4.77 i-0.20
4.59 ±0.07
4.51 ±0.05
4.67 ±0.07
4.33 :k-O.07a
4.26 -20.25
4.61 :_,27
4.58 -20.23
4.53 =1:0.12
miod.
Hb,
_]dl
14.1 ±0.I1
14.9 --+O.08a
15.6 ±0.21 a
14.9 ±0.30 a
14.1 -+0.09
14.6 ±0.14 a
15.1 :t:0.13 a
15.1 :k0.44 a
13.9 ±0.41
13.9 :t:0.21
MCV,
ft
90 +1.5
102 +-3a
80 -+-3a
82 =t3.1
86
87
89
97
103
93
86
85
MCH,
P_
31 :L-0.7
37 ±1.2 a
36 ±1.1 a
31 +1.2
±3.3
±0.8 31
±1.2 30
+9.3 a 33
-+4.9 a 36
±7.4 33
+9.6 30
±1.6 30
-20.5
+0.7 a
±1.6 a
+_2.2
±_).7
±0.5
MCHC,
34 ±0.2
36 :£'0.1 a
36 ±0.3 a
36 -20.7
33 _+0.6
34 ±0.7
34 :kO.l
35 LH).3a
35 ±0.3a
36 ±0.3a
35 :tO.3 a
35 ±0.7
Retic,
%
0.6 ±0.02
0.5 ±0.04
0.6 ±0.02
0.6 ±0.06
0.6 _+0.08
0.7 ±0.12
0.5 _+0.02
0.5 ±0.05
0.5 :t:0.07
0.5 ±0.05
0.7 ±0.21
0.7 ±0.13
Retic No.
lOO_
27.5 ±1.2
20.2 +1.3 a
24.2 ±1.3
28.5 +_3.5
25.5 ±4
33.8 ±7.8
25.7 ±0.9
23.4 4-9.2
22.7 :t3.8
25.2 -+-3.9
36 +13
32.6 ±7
RPI
0.6 !'0.02
0.5 :t-'0.03 a
0.6 ±0.07
0.6 -+0.05
0.6 !,0.03
0.5 ±0.04
0.5 ±O.05
0.5 _-+0.05
0.8 ±0.19
0.8 ±0.13
Hct,
1/I
0.41 _+0.00
0.42 ±0.01
0.43 ±0.01a
0.42 _-'_-H).02
0.40 _-+O.01a
0.39 +0.02 a
0.42 iO.O0
0.42 ±0.01
0.43 ±0.01a
0.42 ±0.02
0.39 ±0.03
0.39 :L-0.02a
...O
TABLE 40.- SERUM, BIOCHEMICAL, AND ENDOCRINE DATA: U.S.S.R. STUDY
[Mean ±SE]
Na, mEq/1
0*
_6 °
K, mEq/l
0o
_6 o
cl, mEq/l
0o
_6 °
mosm, mOsm
0o
_6 °
Ca, mEq/1
0o
_6 °
Aldo, pg/rnl
0o
_6 °
Cortisol
0o
_60
Anglo I, ng/rrdhtr
0o
_60
Epi, pg/ml
0o
_6°
Norepi, pg/ml
0o
_6°
Mean control
period
141 _0.7 139
141 ±0.4 138
4.2 ±0.05
4.17 ±0.06
100 ±0.63
100 ±0.48 99
289 +1.3 288
288 ±1.3 285
4.75 i0.05
4.6 ±0.03
102 +17.1 120
115 _4.9 122
12.8 ±0.88 12.3
11.3 :tO.78 11.3
1.11 ±0.08
1.15 ±0.09
0.92 ±0.13
1.06 ±0.13
1.39 ±0.14
1.49 i-0.13
Day 2
±1.0
±0.9
99 ±1.6l
±1.22
±1.7
±1.62
±14.4
±15.3
±2.24
±1.29
1.08 ±0.24
1.33 ±0.17
1.11 ±0.10
1.37 ±0.08 a
1.42 _0.13
1.59 ±0.10
Bed rest
Day 4
139 ±1.2
139 +1.5
4.08 ±0.10
3.98 :tO.10
100 :L-0.70
99 ±0.98
290 ±2.2
287 +1.78
4.68 ±0.08
4.83 ±0.09
205 ±80.4 a
126 +17.2
11.2 ±1.7
12.3 ±1.54
1.65 _+0.16
2.61 ±0.40 a
1.07 i'0.05 a
0.75 ±0.06 a
Day 7
142 +1.62
141 ±1.5 a
4.00 :k-'0.08
3.90 ±0.08 a
101 ±1.50
101 ±1.2
289 ±2.50
288 +7..7
200 ±52.7 a
169 ±15.3
14.4 _+_2.42
13 ±1.54
2.22 ±0.51
3.05 ±0.48 a
0.98 ±0.10
0.98 ±0.11
0.89 ±0.07 a
0.70 ±0.00 a
Recovery
Day 2
138 -20.6
139 ±0.3
4.00 ±1.60
4.20 ±0.11
98 ±0.50
99 ±0.70
283 ±0.95
285 _+_3.6
12.6 ±2.14
12.2 ±2.14
1.30 ±0.20
1.38 ±0.15
2.24 ±0.25 a
2.19 +0.18 a
Day 7
141 ±0.8
140 ±1.1
4.10 ±0.10
4.10 ±0.06
100 ±0.98
99 ±0.83
285 ±1.90
286 ±1.41
4.60 ±0.05
4.58 ±0.01
94 ±35.5
133 +10.2
14.2 _+_2.32
13 ±1.60
1.06 ±0.25
1.70 ±0.33
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TABLE 40.- CONCLUDED
Glucose, mg/dl
0 °
_6 °
Insulin, _t/U/1
0o
_6 °
Chol, mg/cU
0 °
_6 °
Uric acid, mg/dl
0 °
-60
Mean control
period
88.2 ±2.7
83 ±2.6
30.8 ±1.5
26.5 ±1.3
240 +14
232 ±12
Day 2
86.3 +7.1
100 ±5.6 a
259 ±45
240 ±10
Bed rest
Day 4
62.3 ±3.6 a
61.2 ±8.2
38.8 ±0.7 a
35.4 ±.3.8
Day 7
83.7 ±8.5
73 ±7.6
189 ±15
249 ±35
95.6
78.9
35.1
3O
231
264
8.2
7.3
205 ±18
255 _+_36
6.7 i0.8
6 ±0.7
Recovery
Day 2 Day 7
±8.0 79.4
±11.1 97.3
±2.4 33.4
±2.4 30
±17 202
+20 232
±0.5 8.5
±0.4 7.7
+4.6
_+_5.6
±6.5
±3.2
±17
±12
±0.6
±0.4
ap < 0.05 compared to control period.
Serum levels of glucose, lactate, pyruvate, tri-
glycerides, and total cholesterol were determined by enzy-
matic methods; levels of total lipids, nonesterfied fatty
acids, phospholipids, and beta-lipoproteins were deter-
mined by colorimetric techniques. Lipoproteins were
separated into fractions by paper electrophoresis, and elec-
trophoregrams were also used to determine alpha-
lipoprotein, beta-lipoprotein, and lipid residue fractions.
Serum total protein and bilirubin levels, as well as serum
and urine urea, uric acid, and creatinine, were determined
automatically (Technicon Auto Analyzer II). Protein frac-
tions were identified by acetate cellulose electrophoresis
(Photovolt system). Acid-base balance variables were
determined using the Siggaard-Andersen method (ref. 55).
Values did not show significant changes over the course
of the study.
Blood and urine measurable substances associated
with metabolism (oxidative enzymes) and liver function
did not change significantly in the horizontal and head-
down subjects either during bed rest or during the recov-
ery period. Several individuals showed variations in blood
enzyme activity in the control period. Such changes were
usually within normal limits, but increases above what are
considered normal laboratory values for SDH activity
occurred for 7 of 10 subjects during this period. In one
horizontal subject, baseline levels for cholinesterase
(ChE), leucine arylamidase, GDH, and gamma-GT, as
well as SDH, were elevated. In one head-down subject,
ChE activity was below normal values in all three phases
of the study, suggesting altered liver function before he
entered the study. Carbohydrate and protein metabolism,
as well as iron content, iron-binding capacity, and blood
acid-balance parameters, were generally within normal
limits in the control period, except for the levels of serum
bilirubin, urine and serum creatinine, and urine uric acid,
which tended toward the higher limits of normal. During
that same phase, the albumin level in blood was at the
upper range of the norm, and the serum globulin level and
globulin fractions were toward the lower limits. The blood
glucose level of the head-down subjects was significantly
elevated on day 2 of bed rest and significantly decreased
in both groups by the end of bed rest. There were associ-
ated changes (rises) in serum insulin levels (see table 40).
The head-down group also exhibited a significant increase
in triglyceride level during bed resL
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mOsm
0°
_6 °
Na, mEq/TV
0 o
_6 °
K, mEq/TV
0°
_6o
Cl, mEq/aW
0°
_6 °
Ca, mg_V
0°
_6 °
Creat., mg/TV
0o
_60
Aldo., !ag/'rv
0 °
_60
Epi (free),
_tgrrv
0°
_60
Norepi (free),
_tg/TV
0o
_60
Mean,
control period
861 ±16
923 ±26
144 ±6
136 +4
53 ±2
50 +2
125 ±5
140 ±4
12 _+0.0
11 ±0.0
12.3 ±0.55
12.6 +0.44
Day 1
880 ±58
1007 ±57
175 ±14
239 ±20 a
41 ±5 b
49 ±5
153 ±10 b
200 ±25 b
8.3 +1
10.9 ±2
10.8 ±2.5
16.4 +2.5
26 ±1.2 b
25.1 ±33
47.3 ±3.4 b
52.7 ±9.1 b
ap < 0.01 compared to control period.
bp < 0.05 compared to control period.
Note: Epi - epinephrine; Norepi - norepin ephrine.
TABLE 41.- 24-HOUR URINE: U.S.S.R. STUDY
Bed rest
Day 2 '
1154 ± 67 a
1178 ±100 a
253 ±21 a
231 ±15 a
57 +5
61 ±5
227 ±14 a
208 ±15 a
14.6 ±1.3 a
13.2 ±2.8
2.26 ±0.34
2.40 _+0.11
17.4 ±2.9
21.6 ±1.1
23.8 ±2.8 b
25.9 ±2.4 b
37 ±4.6
40 ±3
Da), 5
1035 ±51
965 ±33
176 ±7 b
166 ±6 a
58 ±6
57 ±2
226 ±30 a
176 ±8 a
12.5 ±1.3
12.0 ±2.1
1.74 ±0.18
2.22 ±0.11
22.6 ±3.1
25.2 ±2.7 b
23.8 ±3.6 b
17.7 ±1.6
19.7 ±1.5 b
21.2 ±1.7 b
Day 7
954 ±19
1041 ±98
144
176
±8
±13 a
62 ±2 a
56 ±5
167
206
14.3
13.8
2.16
2.54
28
21.8
17.3
12.8
16.9
18.2
±13 a
±18 a
±0.8 a
±1.7
±5
±1.2
±3
±1.3
±1.4 b
±2.6 b
Day 0
835 ±59
903 ±87
105 ±8 a
108 ±15 a
63 ±6
53 ±5
142 ±12 a
147 _+9
27 ±4.8
30.2 ±1.9 b
22.5 ±2.9 b
15.7 ±1.5
29.8 ±3.3
21.6 ±2.9
Recover/'
Day 1
810 ±51
895 ±39
116 ±13
114 ±3 a
50 ±5
46 ±2
157 ±12
148 ±14
9.5 ±1
18.6 ±5
1.98 ±0.27
1.96 ±0.19
21.3 _+0.1
27.4 ±2.3 b
26.6 ±2.4 b
24.7 ±2.9 b
48.2 +1.9 b
47.3 ±2.5 b
Day 3
974 ±74
973 ±101
180 ±18
158 ±25
53 ±3
47 ±4
199 ±18
185 ±28
10.7 ±1
15.1 ±2.5
2.56 _+0.32
2.70 ±0.35
5 ±2.3
18.5 ±2.2
17.2 ±1.4
19.5 ±2.4
41.3 ±3
43.7 ±1.3
Fluid and electrolytes- Fluid intake and content of
foods were measured and recorded for each subject. Esti-
mates were based on a summation of water content of
beverages in the diet, moisture content of food, and water
consumed by the subjects. The subjects in both groups
lost weight during the study, the weight of the horizontal
subjects dropping by 0.7 kg and the head-down group by
1.7 kg. The principal decrease in body weight occurred
during the first 3 days of bed rest. Intake-output balance
was determined as the difference of water and electrolyte
intake and urine loss (fig. 9). A marked diuresis with bed
rest was not present. Because of the marked variation in
subject body weights (65-85 kg), fluid intake was
normalized to milliliters per kilogram of body weight. The
diet and urine were analyzed for the following: elec-
trolytes and minerals, sodium and potassium concentra-
tions (flame photometry), calcium and magnesium
(atomic absorption), urine chlorides (titrometry), urine
osmolality (cryoscopy), and urine specific gravity (at 20 °
with urometer).
Analyses of serum electrolytes indicated no signifi-
cant changes in ion concentration or in blood osmolality
in either subject group during or after bed rest (table 40).
Serum potassium did tend to decrease in several subjects
on days 4 and 7 of bed rest, but the changes were not
significant. Serum aldosterone levels showed a marked
increase in horizontal subjects (doubling) and lesser
increase in head-down subjects. Serum angiotensin I
levels increased in both groups by the end of bed rest,
with a much more marked elevation for head-down
subjects. Adrenaline levels showed little change over the
course of the study, but noradrenaline decreased signi-
ficantly during bed rest for both groups.
During bed rest, water intake decreased (compared to
control), particularly in the horizontal group and increased
slightly throughout the recovery period, but did not reach
baseline values by the end of the study for either group
(see fig. 9).
Intake-output values, converted to kilograms of body
weight, did not differ significantly between the two
groups during the control period. During bed rest, the hor-
izontal subjects exhibited a significant increase in urine
excretion on days 2 and 5, and the head-down subjects
varied considerably on all bed-rest days. Urinary fluid
loss increased in both groups of subjects on the first 2
days of bed rest, and was particularly noticeable in the
horizontal subjects. Slight to significant fluid retention
was a feature of the early recovery period (day 0) as has
been the case in most previously reported studies. Both
groups had fluid balance values close to baseline levels
throughout the recovery period.
Values for urine electrolytes, biochemical, and
endocrine factors are given in table 41. Renal sodium
excretion varied significantly during the control period in
both groups, but stabilized before the beginning of bed
rest. During bed rest, the horizontal subjects exhibited a
significant natiuresis from days 1 to 5, which returned to
baseline levels by the end of bed rest. The head-down sub-
jects exhibited a significant (p < 0.5) increase in urine
sodium excretion throughout the bed-rest period. A signif-
icant (p < 0.05) difference between the two groups was
noted during the first few days of bed rest and was more
pronounced in the head-down subjects. On the first day of
recovery, both groups exhibited sodium retention.
Chloride-excretion responses throughout the study were
similar to sodium responses.
Potassium excretion was uniform, with minor indi-
vidual differences throughout the study, except that the
horizontal subjects exhibited a significant elevation at the
end of the study.
Renal excretion of calcium did not differ between the
two groups during the control period. During bed rest,
urine calcium increased significantly in the horizontal
group by day 2 and returned to baseline values to a lesser
extent in head-down subjects. Values returned to baseline
during recovery in horizontal subjects but continued to be
elevated in the other group of subjects.
Urine osmolality increased significantly for both
groups by day 2 of bed rest.
Changes in renal hemodynamics that occur with
exposure to weightlessness and bed rest appear to occur in
response to an increase in central blood volume. In addi-
tion, observed changes in fluid-electrolyte response during
weightlessness are felt to result from suppression of thirst.
Findings with bed rest, particularly when in the head-
down position, indicate that fluid intake is lowered and
could contribute to the observed changes. In the present
study, group differences could not be found for many
indices, although some shifts in serum electrolyte concen-
trations and osmotic concentrations were more pro-
nounced in the head-down subjects. Differences between
the horizontal and head-down subjects that might have
been present were difficult to extract because of the small
number of subjects and their individual variations.
Body-fluid compartment changes are given in
table 36. Plasma volume and blood volume showed
expected decreases during bed rest for the horizontal sub-
jects and returned to, or above, resting levels during
recovery. The head-down subjects showed a slight but
insignificant increase of blood volume with bed rest. Both
groups demonstrated expected changes for extraceilular
fluid and total body water.
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Figure 9.- Mean fluid balance: U.S.S.R. subjects. (a) Fluid intake, fluid output.
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Water load test- The water-load test was performed
according to procedures described by Noskov et al.
(ref. 56). Tests were conducted on the morning of day 9 of
the control period and on the second day of recovery, with
the subjects in the fasting state and deprived of liquids
overnight. After venous blood samples were drawn, the
subjects were permitted to urinate and then were weighed
and required to drink an amount of distilled water (20 ml
per kilogram of body weight). The test required 4 hr, with
urine collected every 30 min during the first 3 hr (six
urine samples per subject) and a t-real collection at the end
of the 4 hr. The subjects were not permitted to eat, drink,
or smoke during the test. They were also kept in the hori-
zontal and head-down positions during testing and permit-
ted to urinate only at times specified by the procedures.
Urine collected on the previous night and during the
remainder of the test day was also analyzed. Venous
blood samples (5 ml) were obtained 90 min before and
after water loading.
All blood and urine samples were analyzed for osmo-
larity sodium, potassium, calcium, magnesium, creatinine
and 17-HCS after enzymatic hydrolysis using beta-
glucuronidase (ref. 57). Data were analyzed using stan-
dard concentrations and clearance formulation procedures
(refs. 58-60). Urine and plasma results are shown in
tables 42 and 43, respectively.
During the control period following water loading,
urine fluid loss increased in both groups of subjects, the
greatest excretion rates occurring at 60 to 120 min after
loading. Values increased 15 to 20 times baseline rates,
reaching 12 and 13 ml/min. As urine volume increased,
urine electrolyte concentrations decreased, reaching the
lowest level at the peak of diuresis (see table 43). Both
subject groups showed a significant decrease in serum
sodium concentration and osmolarity. However, the two
groups did not show significant differences in these
regards (see table 43).
Urine osmotic concentration decreased progressively
after water loading and reached the minimum level at the
peak of diuresis (60 to 120 min); at that point, it was
15 times lower than on the previous night. Osmotically
free water clearance increased gradually to a maximum at
peak water diuresis, amounting to 10 ml/min in both
groups of subjects. The result of this test indicates that
excess fluid consumption by normal humans increases
tx)dy fluid volume and decreases the concentration of
osmotically active substances, activating reflex mecha-
nisms that inhibit ADH. An increase in serum osmolarity
as excess water is eliminated helps to restore serum ADH
which, in turn, effects permeability of the distal nephron
and collecting ducts for water. Consequently, urine osmo-
larity gradually increases to the end of the test, and fmally
exceeds serum osmolality. At this point, free water clear-
ance becomes negative.
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TABLE42.-URINERESULTS,H20 LOAD TEST: U.S.S.R. STUDY
Horizontal 4) °
Control period (day 7)
At maximum diuresis
Clearance, ml/min
Total excretion, 4 hr
Recovery day 2
At maximum diuresis
Clearance, ml/min
Total excretion, 4 hr
Head-down -6 °
Control period (day 7)
At maximum diuresis
Clearance, ml/min
Total excretion, 4 hr
Recovery day 2
At maximum diuresis
Clearance, ml/min
Total excretion, 4 hr
ap < 0.05 compared with control
Yol.,
ml
1326 ±135
1436 ±140
1395 ±55
1393 ±179
_riod.
Na,
9.6 _+0.82
0.97 _+0.09
29 ±2.3
9.28 ±1.19 a
0.90 ±0.10
30.2 +2.9
7.9 _+0.55
0.75 _+0.04
24.4 +1.4
4.90
15.8
14.0
K_
mF ¢l
_+0.27
_+0.57
_+0.5
4.78 _+0.57
14.7 ±1.52
15.2 +2.3
0.66 _+0.17
1.92 _+0.55
1.78 _+0.22
0.53 _+0.06
1.55 _+0.18
1.97 _+0.21
6.7 ±0.88 a
0.68 _+0.05
22.3 +1.8
4.72 _+0.52
13.64 _+0.84
14.2 _+0.6
3.64 _+0.42
12.09 ±1.12
12.4 _+0.8
0.48 _+0.04
1.50 _+0.13
1.94 _+0.08
0.50 _+0.08
1.49 _+0.27
2.14 _+0.33
C real,
medl
0.11 _+0.01
104 ±8.3
376 ±11
0.14 _+0.01
133 ±8.3 a
430 ±14
0.12 _+0.01
104 ±8.5
433 +_25
0.15 _+0.02
143 ±1.0 a
473 ±65 a
Urine test results (table 42) showed no significant
change following bed rest except for creatinine excretion,
which was higher (p < 0.05) in both groups following
loading, and a significant decrease in sodium clearance.
These changes correlated with serum sodium decreases
and relative stability of other ions 90 min after loading
(table 43).
A lack of significant change in renal function with
water loading following bed rest was felt to be due to test-
ing on the second day of recovery rather than immediately
after the end of bed rest. In previous tests performed at
that time, osmoregulatory changes have been observed,
including the retention of fluids, electrolytes, and osmoti-
cally active substances.
Hematology- Routine hematology during the
U.S.S.R. study is shown in table 44. Hemoglobin and
hematocrit increased slightly and similarly in both groups
during bed rest, as it had in the U.S. study. Following bed
rest, these variables decreased below baseline values.
These changes were consistent with known body-fluid
volume changes, as shown in table 36. Red cell mass
decreased in both subject groups, but did not do so signif-
icantly as it had in the U.S. study. Reticulocytes (table 44)
decreased in both subject groups during bed rest, but more
so in the head-down subjects. Significant increases in
platelets occurred for both groups after bed rest. Findings,
in general, paralleled U.S. findings.
Endocrinology- Serum and urine samples were used
to evaluate sympathoadrenal system status. Blood and
urine samples were analyzed for epinephrine, nore-
pinephrine, and dopamine, and for urinary breakdown
products (metanephrine, normetanephrine, and vanillyl-
mandelic and homovanillic acids). The catecholamine
content in blood was measured by fluorescence spectrom-
etry (Hitachi Model MPF-3).
78
TABLE43.-SERUMELECTROLYTECONCENTRATIONAND OSMOTIC CONCENTRATION DURING THE
WATER-LOADING TEST: U.S.S.R. STUDY
Before bed rest After bed rest
Constituent
Sodium, M
mEq/liter SD
SE
Potassium, M
mEq/liter SD
SE
Calcium, M
mEq/liter SD
E
Magnesium, M
mEq/liter SD
SE
Chlorine, M
mEq/liter SD
SE
Osmotic con- M
centration, SD
mOsm/liter SE
Before loadin_
0 ° _6 °
143 142
2.2 1.2
0.9 0.5
4.43 4.18
0.14 0.21
0.06 0.09
4.67 4.61
0.21 0.14
0.09 0.06
2.11 1.97
0.14 0.18
0.06 0.08
139a
0.92
0.4
4.37
025
0.11
4.68
0.16
0.07
2.12
0.14
0.06
After loadin8
0 ° _60
139a
1.1
0.5
4.29
0.35
0.15
4.64
0.09
0.04
2.02
0.09
0.04
103
3.2
1.4
291
4.1
1.8
102
2.8
1.2
289
1.4
0.6
101
1.6
0.7
284 a
2.1
0.9
100
1.6
0.7
280 a
3.45
1.5
Before loading
0o _6o
143 143
2.2 1.4
1.0 0.6
4.35 4.19
0.18 0.28
0.08 0.12
4.59 4.83
0.16 0.21
0.07 0.09
2.20 2.09
0.12 0.07
0.05 0.03
100 103
2.8 2.5
1.2 1.1
290 289
2.5 5.1
1.1 2.2
After loading
0 o _60
140 140a
2.3 1.0
1.0 0A
4.40 4.34
0.09 0.30
0.04 0.13
4.63 4.79
0.18 0.21
0.08 0.09
2.14 2.10
0.12 0.14
0.05 0.06
103 99
1.8 3.0
0.8 1.3
283 a 261 a
2.1 5.1
0.9 2.2
ap < 0.05 compared with baseline.
Blood samples were also analyzed for ACTH, corti-
sol, STH, insulin, glucagon, thyrotropic hormone, thyrox-
ine, tri-iodothyronine, parathyroid hormone, follicle-
stimulating hormone, luteinizing hormone, aldosterone,
cyclic adrenosine monophosphate and cylic guanosine
monophosphate, prostaglandins, pressor and depressor
groups, and plasma renin activity. Radioimmunoassay
was used to determine hormonal and biologically active
compounds in blood samples and aldosterone level in
urine. Radioactivity was counted using an automatic
gamma-counter (Nuclear Model 1085) and liquid scintilla-
tion system (Searle Delta 300).
During the control period serum levels of hormonal
and similarly biologically active compounds were gener-
ally within normal limits in both groups of subjects (see
table 40), although blood insulin level was noticeably
higher for horizontal subjects. Furthermore, in this phase,
the tw.ad-down subjects exhibited higher levels of ACTH,
LH, T4, TSH, and PTH and significantly lower levels of
cAMP/cGMP ratio than did the horizontal subjects. It was
felt that these group differences probably resulted from
individual responses to the relative restriction of activity
during the pre-bed rest ambulatory period.
Renin-angiotensin-aldosterone indices also tended to
decrease over the control period. During bed rest, how-
ever, these factors tended to increase in both subject
groups. In the horizontal group, angiotensin I increase was
not significant by the end of bed rest; however, it was sig-
nificant in the head-down group (p < 0.05) on days 4
and 7 of bed rest. Urinary aldosterone increased gradually
during bed rest. This was associated with an increase in
serum levels for both groups which was greater for the
horizontal subjects (table 40).
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TABLE44.-ROUTINEHEMATOLOGY:U.S.S.R.STUDY
Subjects
Horizontal
Bed rest
Recovery
6 ° Head-
down
Bed rest
Pre _'_+SE
Day 2 5:SE
Day 4 5:SE
Day 7 +SE
Day 2 +_SE
Day 4 _+SE
Pre x +SE
Day 2 +SE
Day 4 +SE
Day 7 +SE
Recovery Day 2 +SE
Day 4 +SE
RBC,
1012/liter
4.59 _+0.07
4.34 5:0.11 a
4.53 _+0.12
4.71 5:0.10
4.29 5:0.13 a
4.24 +0.13 a
4.65 _+0.06
4.51 _-/-0.08
4.52_+0.16
4.75 _+0.13
4.51 _+0.12
4.44 _+0.10a
HB,
r#
14.5 Lr0.14
14.7 _-/-0.22
15.5 -+0.23 a
15.1 -+0.19 a
14.6_+0.17
14.8_+0.15
15.5 -+0.53 a
15.5 -+0.25 a
14.2 5:0.26
13.9 5:0.29
ap < 0.05 compared with control period.
MCV,
fl
91.5,-,1.2
97.5 +2.5 a
96.3 +1.8
90.7 --.! .6
91.8 +1.1
95.1 _+0.5
98.1 +2.9 a
94.5 +3.3 a
91.3 +2.2
92.7 +2.5
MCH,
PR
31.7 _+0.5
34.2 _-/-0.1
34.5 5:0.9
32.1 _+0.7
32.4 _+0.9
32.7 _+0.9
31.4 _+0.4
32.7 _+0.4a
34.5 -+0.9a
32.8 +1.0 a
33.9 _+0.5
35.0 _+0.4
35.5 -+0.4a
35.3 x_0.4a
34.1 £-0.3
34.7 _+0.4
35.4 !-0.5 a
34.8 +0.5 a
Retic. No.,
109/liter
6.9 _+0.5
5.2 -+0.6a
6.7 _+0.8
6.0 _+0.9
6.0 _+0.4
5.0 __0.6a
6.3 +1.0
6.8 _+0.9
8.1 +1.2 a
10.0 +1.6 a
Hct,
liter/liter
42.5 _+0.5
42.2 _+0.6
44.0 +1.1 a
43.6 _+0.6
43.6 _+0.4
43.4 _+0.8
45.0 _+0.8
46.8 _-t-0.9
41.6 5:0.6a
42.4 _+0.5
ACTH tended to increase in the horizontal subjects
on days 2 and 7 of bed rest and on both test days during
recovery, whereas it did not vary significantly from base-
line values in the head-down group. Excretion of 17-KS in
the control period was significantly higher in the head-
down subjects than in the horizontal group, but no signifi-
cant differences were noted between the two groups dur-
ing bed rest or recovery. The blood luteinizing hormone
level tended to decrease in the horizontal subjects again
on days 2 and 7 of bed rest and decreased in the head-
down subjects on days 2 and 4 of bed rest. Parathyroid
hormone (PTH) decreased gradually throughout bed rest
for both groups. PTH remained depressed in the horizon-
tal group throughout the recovery period, while it
increased above baseline values in the head-down
subjects.
Blood insulin levels were significantly higher in both
groups on day 4 of bed rest and continued to be higher on
day 7 in the head-down group (see table 40). Glucagon
level in the horizontal subjects was 40% higher than base-
line, but the head-down subjects showed no change.
Although no changes in blood insulin levels were noted in
either group during the recovery period, glucagon was sig-
nificantly decreased in the horizontal group on day 2 of
recovery and was still lower than baseline values on
day 7. Conversely, the head-down subjects showed no
difference.
The cGMP level in the horizontal subjects on days 2
and 7 of bed rest was significantly elevated from baseline
values, but showed no significant change in the head-
down subjects. The cAMP concentration and the cAMP/
cGMP ratio did not show significant differences with bed
rest. There were no changes in either group that were
indicative of functional changes in TSH or thyroid.
Catecholamines- During the control-period studies,
plasma catecholamine (CA) levels were found to be vari-
able. Although CA content was within normal limits on
days 3 and 14 of the control period, it was significantly
elevated in both groups on day 9.
During bed rest, the horizontal subjects exhibited sig-
nificant decreases in serum norepinephrine content on
days 4 and 7 and in doparnine on day 7, but there was no
noticeable change in epinephrine during the bed-rest
period. In the head-down group, norepinephrine and
dopamine were significantly reduced on days 2 and 7 of
bed rest, and epinephrine was significantly elevated only
on day 2. However, there was a significant increase in the
epinephrine/norepinephrine ratio in both groups through-
out bed rest. On the second day of recovery, nore-
pinephrine content rose above baseline values in both
groups. Epinephrine also tended to increase in both
8O
groups on day 2 of recovery. Thus, bed rest was
characterized by decreased serum catecholamines in both
subject groups, the most pronounced changes occurring in
the head-down group.
Urine tests during the control period indicated that
catecholamine excretion in both subject groups was
within normal limits (see table 41). During bed rest,
epinephrine excretion (both free and bound) in both
groups increased significantly above normal. Free nore-
pinephrine excretion was also significantly elevated in
both groups on the first day of bed rest and decreased
thereafter, falling below baseline values in some cases.
Bound norepinephrine also tended to increase in both
groups during the first 4 days of bed rest. Excretion of
free and conjugated forms of dopamine was noticeably
elevated in both groups on the first 2 days of bed rest, but
tended to decline at the end of bed rest.
Throughout bed rest, free metanephrine increased in
both groups compared to control values, and bound
metanephrine increased on days 1 and 2 in the horizontal
group and on days 4 through 7 in the head-down subjects.
No significant changes were seen in either group in excre-
tion of homovanillic and vaniUyl-mandelic acids.
During the first 3 days of recovery, there were docu-
mented increases of urinary free epinephrine, dopamine,
and norepinephrine in both groups (table 41). The hori-
zontal subjects also showed significant elevations of free
metanephrine on day 0 and on days 3 through 6; the head-
down subjects exhibited increases in the bound form on
recovery days 6 through 9. Excretion of homovanillic and
vanillyl-mandelic acids did not change significantly for
either group.
In summary, changes in blood and urinary cate-
cholamine concentrations and epinephrine/norepinephrine
ratio agreed with findings in previous studies and are con-
sistent with stress imposed by inactivity and confinement
and an emotional reaction to bed rest. The observed
decrease in blood levels of norepinephrine and its precur-
sors in this study supports the previous posed hypothesis
that bed-rest-induced decline is the result of a decrease in
afferent sympathetic impulse transmission caused by
maintaining the body in a horizontal position (ref. 61). No
significant difference in endocrine change was observed
between horizontal and head-down groups.
Comparison of U.S. and U.S.S.R. Findings
U.S. and U.S.S.R. investigators obtained slightly dif-
ferent findings in their endocrine and metabolic studies.
U.S. findings demonstrated greater and more rapid
changes for head-down subjects in the early part of bed
rest. On the other hand, the U.S.S.R. investigators found
no significant differences between the subject groups. Of
note were slight decreases in serum and urinary excretions
of sodium and chloride seen in both U.S. groups; there
were no changes in serum and/or increased urinary excre-
tion noted in U.S.S.R. subjects. The latter changes are
more in conformance with previous reports of changes
occurring during bed rest (refs. 1 and 22). Opposite
changes between U.S. and U.S.S.R. subjects were also
noted for serum norepinephrine, aldosterone, insulin, and
cholesterol, and urinary epinephrine and norepinephrine.
The difference in findings for the U.S. and U.S.S.R.
teams remain unexplained, but poses a question about the
possible roles of nutritional and dietary differences in the
two studies. Nutritional status is known to affect
endocrine function (refs. 1 and 62) and may influence
other physiological systems. For example, it is known that
diets high in the simple carbohydrates, such as sucrose,
can markedly increase the level of blood triglycerides.
The U.S. diet (see tables 5 and 7), in general, contained
100 kcal more per day than the normal daily intake and
60 kcal more than the U.S.S.R. diet. Simple and complex
carbohydrate intake was increased by +16% in the ambu-
latory periods and by +34% during bed rest. Although
there is no recommended daily allowance of carbohy-
drates, nutritionists have shown that increased carbohy-
drate intake can induce water retention, alter loss of
sodium and other cations, alter breakdown of body pro-
tein, and prevent ketosis (ref. 63). An intake of 50 to
100 g/day of digestible carbohydrates (complex) is con-
sidered to be sufficient for these purposes (ref. 63). The
amount of carbohydrate in the study diets of both
countries were substantially greater than average (see
tables 7 and 8), and particularly so for the U.S. subjects.
In this case, the diet was tailored to Shuttle specifications
rather than to the nutritional requirements of the bed-rest
subjects, and these subjects were not accustomed to such a
high carbohydrate intake in their daily lives.
Lastly, small, but significant, differences were seen in
body-fluid volume compartment changes in the U.S. and
U.S.S.R. subjects (table 36). Expected plasma and blood
volume losses were seen for both groups in the U.S.
study; head-down U.S.S.R. subjects showed little or no
change. Red cell mass loss was seen by both, but changes
were significant for the U.S. subjects and not for the
U.S.S.R. subjects. A possible explanation may be slight
differences in the methods used by the two teams of
investigators.
The differences in the endocrine, hormonal, and
metabolic findings between the two studies, together with
the differences in diet, suggest that in future bed-rest stud-
ies, more attention may have to be given to nutritional
inputs.
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VI. EXERCISE PHYSIOLOGY
Physical working capacity has been consistently
reduced following either bed rest or spaceflight (refs. 1
and 2). The observed decrease in exercise tolerance is
related to an increase in submaximal and maximal heart
rate, and significant decreases in maximal oxygen uptake
(VO2 max), maximal stroke volume, plasma volume and
red cell mass, hemoglobin concentrations, and orthostatic
tolerance. The mechanisms responsible for decreased
exercise tolerance following bed rest appear to result from
(1) the decrease in hydrostatic pressure within the cardio-
vascular system, and (2) lower myocardial and peripheral
muscle metabolism stemming from reduced physical
exercise, as well as confinement itself. Exposure to
weightlessness would be expected to decrease postflight
exercise tolerance in space crews because VO2 max is
known to decrease in both the supine and upright posi-
tions following bed rest. Returning space crews have con-
sistently shown deteriorations in exercise tolerance, and
some have exhibited this problem during flight as well
(refs. 64 and 65). The loss of exercise tolerance in space
crewmen may result from several factors. The weight loss
observed in returning crews could affect the tolerance for
physical work, because this loss is accompanied by a neg-
ative nitrogen balance (ref. 66). A decrease in calf muscle
circumference and decreased strength have been
observed, as well as a decreased plasma volume (ref. 67).
With bed rest, decreased exercise tolerance is associ-
ated with changes in both central (cardiac) and peripheral
(tissue oxygen exchange and utilization) mechanisms.
Following bed rest, some heart muscle fibers may atro-
phy, resulting in reduced cardiac output and stroke vol-
ume (ref. 2). Alternatively, cardiac contractility may be
affected by decreased venous return resulting from
decreased peripheral muscle tone (ref. 67), and decreased
plasma volume, (ref. 2). Moreover, decreased red blood
cell mass, which has been consistently observed with both
bed rest and spaceflight, can contribute to decreased
oxygen-carrying capacity of the blood, as well as to
decreased venous return.
Horizontal bed rest has been the usual analog for
weightlessness, but recent investigators have indicated
that head-down bed rest more closely reproduced physio-
logical responses exhibited by space crew members
(ref. 8). Because a previous study (ref. 3) had noted that
cardiorespiratory changes with exercise stress were very
small, both after spaceflight and bed rest, the present
study sought to obtain data that could be more accurately
compared by
1. Determining the decrease in exercise perfor-
mance under a uniform static workload for both horizontal
and head-down bed rest subjects
2. Determining the orthostatic effects of gravity on
exercise performance following bed rest by comparing
physiological responses to both supine and upright
exercise
3. Comparing physiological changes in exercise
performance induced by horizontal and head-down bed
rest to determine which position more appropriately simu-
lates weightlessness deconditioning
4. Examining relationships between changes in
body composition and responses to exercise following bed
rest
5. Determining the extent and timing of recovery of
exercise tolerance following bed rest
U.S. Study
The subjects selected for the present study were
paired to the degree possible (horizontal and head-down)
according to maximal oxygen uptake (VO2 max,
ml/kg/min), height, and weight to obtain the most realistic
data on exercise performance following bed rest in the
two positions (see table 3). Before the control period, all
selected subjects were familiarized with exercise on the
bicycle ergometer (Collins Electronic Bicycle Ergometer)
in both the supine and upright positions. Following this
orientation, each subject performed a maximal exercise
tolerance test on the bicycle ergometer in the supine posi-
tion. The test began with 3 min at 40 W (245 kg/min)
followed by a progressively increasing load (40 W each
3 min) until exhaustion.
The same test was repeated on days 2 and 13 of the
control period; however, on those days the test was fol-
lowed, after a 5-min rest period, by 5 min of exercise at
700 kg/min (115 W) and a 10-min recovery period, in
which the subjects were permitted to rest until heart rate
had returned to within 10 beats/min of pre-exercise val-
ues. At that point, they performed the exercise test in the
upright position on a different bicycle ergometer (Quinton
Electronic Ergometer). The two bicycles were calibrated
precisely with each other. The supine and upright exercise
tests were repeated after bed rest (recovery days 0, 5, 10).
During testing, the subjects were monitored for heart
rate, blood pressure, VO2, ventilatory volume (A'¢E), and
respiratory frequency. Heart rate was continuously mea-
sured and recorded from sternal ECG leads. Systolic and
diastolic blood pressures were measured during the last
15 sec of each minute by standard sphygmomanometer
and stethoscope techniques. The subjects used a respira-
tory valve (Otis-McKerrow), and the volume of expired
gas was measured with a high-velocity, low-resistance
meter (Parkinson-Cowan). A potentiometer at the gas
meter dial transmitted electrical outputs to a two-channel
recorder (Brush) so that ventilatory volume and
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respiratoryfrequencywererecordedcontinuously.The
expiredgaswascontinuouslyextractedbyaDynapump
(ScientificProducts)froma 5-litermixingchamber
(R-Pel)whichwasplacedbetweenthesubjectandthegas
meterandconnectedtoa2-litergasbag(OhioMedical)
attachedtoavalve(Costill-Wilmore).Thecompositionf
thegaswasdeterminedbyanoxygenanalyzer(Applied
ElectrochemistryS3A)anda CO2analyzer(Godart
Capnograph).Beforeeachexercisetest,theanalyzers
werecalibratedwithastandardgaswhichwasanalyzed
usingtheScholandertechnique.Oxygenconsumption
(VO2),carbondioxideproduction(Vco2),andrespira-
toryexchangeratio(RER)werecalculatedusingstandard
equations(ref.68).Bodyweight(+5g) wasrecorded
beforeachexerciset st.
Datawereanalyzedbypairedornonpairedt-test.The
pairedt-testwasusedtocomparedifferencesbetweenthe
averagecontrol-periodvalues(controldays2and13)and
recoveryvalues(recoverydays0, 5,and10).Thenon-
pairedt-testwasusedto comparemeanvaluesbetween
thetwogroupsonaparticulartestdayandtocompare
meanchangesfromrestingtopeakexercisebetweenthe
twogroups.
Bodyweightandeomposition-Followingbedrest,
meanbody weight had decreasedinsignificantly
(p< 0.01)in boththehorizontal(-1.5kg,-2.2%)and
head-down(-2.1kg,-2.9%)groups(seetable24).Of
interestwerethefindingsindicatingbed-rest-induced
lossesinleanbodymasswithoutchangeintotalbodyfat
content.Bodyweightandleanbodymassremained
depressedonrecoverydays5and10.
Respiratoryresponses--Meanventilatoryesponses
(VE,BTPS,1/min)areshownforthetwogroupsin fig-
ure10.Thehead-downgroupconsistentlyhadhigherval-
uesofVEduringsupinerest,exercise,andrecovery,but
bothgroupshowedsimilaresponseswhenupright.Fol-
lowingbedrest,restingVEin theuprightpositionin the
horizontalgroupwassignificantlygreater(p< 0.05)on
recoverydays5 and10thanduringthecontrolperiod.
Duringsupinexercise,thisgroupshowedanincreasein
VE of 10.1%on recoveryday 10 (from 50.3 to
55.4liters/min;p < 0.05),andthehead-downgroup
showeda20.1%increaseovercontrol-periodvalues(from
54.2to65.1liters/min;NS).Onrecoveryday5,VEdur-
ingsupinexercisewasslightlyhigherthanbaselineval-
ues(NS)inbothgroups,butwassignificantlyhigherin
boththehorizontal(+18.9%;p < 0.05)andhead-down
(+15.7%;p < 0.05)groupsonrecoveryday10.During
uprightexerciseonrecoveryday0,bothgroupshowed
increasesin VE(horizontal= +15.8%;p< 0.01;head-
down= +13.3%;p<0.05).Theventilatoryvolume(VE)
tendedto behigherduringsupinexercisethanupright
exercisein boththehorizontal(NS)andhead-down
(p< 0.05)groups.Followingexerciseduringtherecovery
period,bothgroupsexhibitedincreasesinVEinboththe
uprightandsupinepositions,withthehorizontalsubjects
showinga 14.7%(p< 0.05)increasein thesupineposi-
tionand18.0%(p<0.05)increasein theuprightposition;
the head-downsubjectsshowedvaluesof 22.5%
(p<0.05)and10.1%(p<0.05),respectively.Theseval-
uesremainedelevatedinbothgroupsonrecoverydays5
and10,butnosignificantdifferenceswerefoundbetween
thetwogroups.
SUPINE UPRIGHT
D 0 ° GROUP
I:_"_- 6° GROUP
IOfREST5 . * p<i0.05.
0 -- r-_ ..... _-- I"] _.
E 10 *
nn 8 B
O
10
5
0
-RECOVERY
R+0 R+5 R+10 R+0
TEST DAY
I"1_ r-IN
R+5 R+10
Figure 10.- Difference in mean ventilatory volume (A'¢ E)
before and after bed rest: U.S. subjects.
Metabolic responses- There were no significant dif-
ferences in mean oxygen consumption (VO2) between the
two groups during control testing, although the head-
down subjects during this time exhibited consistently
higher values during rest, exercise, and recovery in both
the supine and upright positions (NS). Differences in the
two groups are shown in figure 11. Following bed rest,
neither group showed differences in VO2 during either
supine or upright exercise. During supine recovery on
day 10, however, the head-down subjects showed a
greater VO2 (+7.8%; p < 0.05) than baseline, whereas the
horizontal subjects showed no change. During recovery in
the upright position, on the other hand, VO2 was higher
than baseline values in both the horizontal (+8.5%;
p < 0.05) and head-down (+5.9%; p < 0.05) subjects. On
recovery day 10, both groups showed significantly
(p < 0.05) higher values of VO2 during recovery in both
the supine and upright positions. Mean resting VO2 was
greater (p < 0.05) in both groups in the upright position,
but not during exercise and recovery.
Mean carbon dioxide production (Vco2) measured in
liters per minute or in milliliters per kilogram per minute
increased significantly (p < 0.05) in both groups following
bed rest during exercise and recovery in both the supine
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anduprightpositions(fig.12).Theobservedvaluesalso
indicateda significantdifference (p < 0.01) in RER
between the supine and upright positions in the recovery
period. During supine exercise, RER increased signifi-
cantly (p < 0.05) in the horizontal group on recovery days
0 and 10 and in the head-down group on day 10.
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Figure 11.- Difference in mean oxygen uptake (AVO2)
before and after bed rest: U.S. subjects.
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Figure 12.- Difference in mean carbon dioxide production
(AVcoz) before and after bed rest: U.S. subjects.
Cardiovascular responses- Following bed rest,
resting heart rate in both groups was significantly higher
(13 < 0.01) in the upright than in the supine position
(fig. 13). During supine exercise, mean HR on the first
test after bed rest increased significantly (p < 0.05) in both
the horizontal (+3.8%) and head-down (+14.3%) subjects.
The mean difference in the increase in HR between the
two groups (+14 beats/rain) was significant (p < 0.05).
During recovery from supine exercise on recovery day 0,
mean HR increased in both the horizontal (+5.5%;
p < 0.05) and head-down (+17.2%; p < 0.05) subjects; the
higher HR difference of 11 beats/rain for the head-down
subjects was significant (p < 0.05).
Exercise-induced changes of mean systolic blood
pressure were not significant immediately following bed
rest or in the subsequent recovery period (fig. 14). Hori-
zontal and head-down subjects during upright testing
exhibited a significant (p < 0.05) decrease in systolic
blood pressure (SBP) during all test periods.
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Figure 13.- Difference in mean heart rate (AHR) before
and after bed rest: U.S. subjects.
84
5
E 0
E
a." -5
nn
<_-10
SUPINE
REST
10 EXERCISE
NI_I n
-15
RECOVERY
iL
-10
I I vl_,,,
UPRIGHT
I"'1 0° GROUP
1=_-6 ° GROUP
* p < 0,05
n
U
'-'B -B FIB
R+0 R+5 R+10 R+0 R+5 R+10
TEST DAY
Figure 14.- Difference in mean systolic blood pressure
(ASBP) before and after bed rest: U.S. subjects.
Resting diastolic blood pressure (DBP) with upright
exercise was higher in both groups of subjects following
bed rest (fig. 15). In the horizontal subjects, it was signifi-
cantly higher (p < 0.01) than supine values on all test
days, reaching 11 mmHg higher than average baseline
values (p < 0.01) and 10 mmHg higher than head-down
values on recovery day 0 (p < 0.05). In the head-down
subjects, it was slightly higher (NS) on all test days, but
showed a significant elevation (p < 0.01) on recovery
day 5. With supine exercise, the horizontal subjects exhib-
ited an increase in DBP from 96 mmHg (control-period
value) to 101 mmHg on recovery day 0, followed by a
decrease to 92 mmHg on recovery day 10 (p < 0.05). The
head-down subjects, on the other hand, showed an
increase from 101 mmHg to 107 mmHg following bed
rest (recovery day 0, p < 0.01) followed by a decrease to
95 mmHg on recovery day 10 (p < 0.01). During upright
exercise, both groups exhibited significantly lower
(p < 0.05) DBPs on all test days than during supine exer-
cise. In the horizontal group, DBP during upright exercise
on recovery days 0 and 10 was significantly higher
(p < 0.05) than baseline values. Both groups showed
significandy higher (p < 0.05) DBP during recovery from
upright exercise than during recovery from supine exer-
cise on all test days. On recovery day 0, the horizontal
subjects showed an 8% increase (NS), and the head-down
group showed a 6% increase (19< 0.05).
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Figure 15.- Difference in mean diastolic blood pressure
(ADBP) before and after bed rest: U.S. subjects.
Pulse pressure did not change in either group with
supine exercise following bed rest for any of the stages of
exercise testing (fig. 16). With upright exercise, on the
other hand, both groups had significantly lower PP
(19< 0.01) during rest and recovery on all test days relative
to supine values, particularly for the horizontal subjects
on recovery days 5 and 10 and for the head-down subjects
on control days 2 and 13, and on recovery days 0 and 5.
The upright test on recovery day 0 resulted in a significant
difference (p < 0.05) between the two exercise positions
during rest in the horizontal group and during all three
stages in the head-down subjects.
The results of the U.S. study indicated the following:
1. Both groups showed a general decrease in exer-
cise tolerance following bed rest.
2. The head-down subjects appeared to lose exer-
cise tolerance following bed rest to a greater degree than
the horizontal group, particularly in the supine position.
3. Rest, exercise, and recovery with upright exer-
cise were more stressful in terms of HR and PP responses,
suggesting that there is an orthostatic component to the
deconditioning effects of bed rest.
4. Despite the return to ambulation, all subjects
continued to show decrements in exercise tolerance to the
end of the 10-day recovery period, indicating that the
deconditioning process was still in effect.
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Figure 16.- Difference in mean pulse pressure (APP)
before and after bed rest: U.S. subjects.
U.S.S.R. Study
Exercise testing in the U.S.S.R. portion of the study
was conducted in both the supine and upright position on
a bicycle ergometer (Godart Company) on control days 2
and 13 and on recovery days 0, 5, and 10. Testing was
accomplished during the first half of the day, 20 to 25 min
after LBNP. If a subject showed poor tolerance for LBNP,
the physical load test was delayed for 40 to 45 min. Sen-
sor attachment and equipment calibration were performed
during a 10- to 15-min orientation period. Exercise load-
ing was conducted first in the supine position and then in
the upright. Both tests followed the same sequence: 7 to
10 min resting, while blood pressure and respiration base-
lines were recorded; 5 min of bicycle pedaling at a speed
of 65 +5 rpm (750 kg/min); and 10 min of resting recov-
ery. Oxygen consumption (VO2) and carbon dioxide pro-
duction (Vco2) were recorded continuously during all
stages of the tests, using an automatic gas analyzer
(Junkalor, Spirolit). Maximum ventilatory rates (MVR)
were directly measured. Pulse frequency was calculated
from the ECG. The percentage content of CO2 in the
alveolar gas was determined using a capnogram (Godart
Capnograph). Gas exchange values, VO2 and VCO 2, were
corrected to standard conditions (temperature and baro-
metric pressure).
Changes in exercise tolerance in the U.S.S.R. subjects
following bed rest are shown in tables 45 to 50.
Exercise responses in the supine position- In the
control period, there were no notable differences in supine
exercise tolerance between the two groups except for VO2
at rest (table 45). This difference, however, disappeared
when VO2 was normalized as per kilogram of body
weight. During the recovery period following the exercise
load, gas exchange (table 46) and respiration (table 47)
were essentially the same in both groups. Heart rate
(table 48), on the other hand, was higher during recovery
in both groups, even after 10 min following test cessation
(horizontal = +23.9%; head-down = +13.8%).
Following bed rest (recovery day 0), heart rate at the
end of exercise was higher by 5.4% in the horizontal sub-
jects and by 6.4% in the head-down group. By 5 and
10 min into recovery, the head-down subjects showed a
return to normal HR, but in the horizontal subjects this
variable continued to exceed baseline values by 8.3% at
5 min and 7.5% at 10 min into recovery.
Following bed rest (recovery day 0), systolic and dia-
stolic blood pressure tended to be higher in both groups at
rest and during exercise (tables 49 and 50). The systolic
pressures were 4 mmHg above control-period values for
the horizontal group and 23 mmHg above for the head-
down group; diastolic pressures were 9 mmHg and
8 mmHg above, respectively. Evidence of continued
deconditioning was seen from HR responses to the
recovery-period exercise tests. Heart rate was nearly iden-
tical with baseline values in the horizontal subjects, but
remained elevated in the head-down subjects on recovery
days 5 and 10 (+7.9% and +7.8%, respectively). Gas
exchange and respiration values following bed rest were
similar to baseline values in both groups.
Exercise responses in the upright positions- Dur-
ing upright exercise in the control period, VO2 and VCO2
were higher for the head-down subjects than for the hori-
zontal subjects (tables 45 and 46). But when correlated
with the subjects' body weights, there was no significant
difference. In the head-down subjects during the control
period, heart rate was higher and systolic blood pressure
lower than in their horizontal counterparts, which differed
from the similarity of these findings during supine
exercise.
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TABLE 45.- 02 CONSUMFrI'ION (ml/min) DURING EXERCISE: U.S.S.R. STUDY
I
Grouo I Indices
I
Before bed rest Al_erbed rest_days
o I 5 IR I PL I R5 I R,O R I PL [ R 5 I R10 R
Exercise while supine
10
I PL I R5 I R10
0 o
_.6°
M
_-tSE
M
_SE
275 1702 383 322 291 1691 379
12.3 79.1 17.4 8.3 8.4 30.4 18.7
336 b 1769 428 376 344 b 1798 b 415
9.9 60 16.2 18.2 32.8 66 19
321 311 a 1693 354 311 307 1762
23.2 6J 51.7 10 145 22.9 47
303 340 1807 432 376 359 b 1821
19.7 15 97.9 19.5 14.9 14.3 17.4
Exercise while seated
393 336
27.3 33
455 374
15.4 20
0° M 322 1682 360 316 340 1716 396
±.SE IZ7 82.3 20.1 17.6 21.3 49.4 33.5
-60 M 366 1779 429 3569 365 1756 452
±SE 32.9 88.6 26.5 27 22.9 26.5 20.5
335 331 1803 377 338 350 1796
29.4 6.1 43.8 14.6 13.9 23.1 38.9
388 369 1818 434 385 383 1827
14.5 22.9 109.7 24.1 37.7 24.6 22.1
405 346
12.7 24.8
452 372
8.8 22.7
Note: PL = physical load (5 rain); R = at rest; R 5 = recovery (5 min); RIO = recovery (10 min).
ap < 0.05 compared to before bed rest.
bp < 0.05 compared to supine.
TABLE 46.- EXHALATION OF C02 (ml/min) DURING EXERCISE: U.S.S.R. STUDY
oo
...d
I Before bed rest
I R PL R_ I R10
After bed rest, days
o I 5R I PL I R'i I R10 R I PL i R_ I R1o
Ex_is_ while supine
0 ° M 245 1714 328 255
•.SE 14.9 88.1 17.8 9.3
-6 ° M 320 1622 377 270
+_SE 26 128 48.3 36.2
260 1792 371 249 289 1766 354 248
14.4 58.4 12.8 33.7 10.9 63.7 9 9.1
330 1884 411 246 327 1880 421 319
27.1 83.4 21.6 13.7 17.9 75.5 43.3 27.1
Exercise w aile seated
0 ° M 252 1507 299 256
+-qE 12.9 77.6 16.7 22.2
-60 M 281 1519 337 274
±SE 25.5 65.1 40 28.7
257 1591 347 279 244 1667 317 260
11.6 58.9 41.3 31.6 13.8 45.1 10.9 6.9
296 1647 411 320 286 1669 377 313
25.1 30.9 29.3 10.1 22.8 47.8 37.7 28.9
Note: PL = physical load (5 rain); R = attest; R 5 = recovery (5 rain); R10 = recovery (10 mm).
10
R [ PL I R,_ I R1O
277 1834 350 270
17 98.8 16.9 19.5
325 1890 421 320
24,1 101 43.3 17.9
282 1623 348 316
18.6 425 155 7.9
299 1674 384 305
195 23 8.9 II
oo
oo
TABLE 47.- MINUTE VOLUME OF RESPIRATION (l/rain) DURING EXERCISE: U,S.S.R. STUDY
Group Indices
Before bed rest
0 o M 9 47 12 11
:f,SE 0.6 2.3 0.9 1.4
-6 ° M 12 50 10 7
:_,SE 2.8 2.3 3.2 2.3
After bed rest, days
o I ' IR I PL I R,i I R,o R I eL I R5 I RIO R
Exercise while supine
9 51 13 10 9 49 12 9 10
0.7 1.9 0.8 0.7 0.6 3.3 1 0.8 1.4
11 52 13 11 11 53 15 11 11
1.1 1.1 0.6 0.9 0.9 1.6 0.6 0.9 0.6
10
I rL I Xs I X_o
52 12 10
2.9 ! .2 1.6
55 15 11
1.9 1.5 0.8
_ercise while seated
0° M 10 44 10 10
:_:SE 0.87 2.9 0.85 1.1
-6 ° M 12 47 14 13
:t_SE 1.05 2.43 0.9 0.5
11 50 13 12 11
0.8 4 1.3 1 0.6
13 51 15 13 12
1 4.6 1,6 0.8 0.5
48 11 10 12 49 12 11
2.8 0.9 0.7 1.9 2.6 0.8 0.8
52 14 12 12 50 15 13
2.1 1.3 0.5 0.6 1.6 0.8 0.9
Note: PL = physical load (5 mm); R = at rest; R5 = recovery (5 mm); R 10 = recovery (10 rain).
TABLE 48.- HEART RATE Caeatshnin) DURING EXERCISE: U.S.S.R. STUDY
Grouv Indices
Before bed rest
i i IR [ PL I R'_ R10 R I PL
0 ° M 67 131 82 80 69 137
+SE 4.7 4.4 6.5 7,1 4.5 8.3
-6 ° M 72 129 83 82 69 142
:k,,SE 3.8 4.5 5.2 5.3 5 6.4
After bed rest, days
o I 5 iI R_ I Rio R I PL I RS [ Rio R
Exercise while supine
88 86 65 133 83 76 69
8.7 8.2 4.3 5.2 8.6 4.3 3.9
84 79 71 136 90 86 73
5.3 6.1 5.2 6.6 3.4 3.8 4.9
10
I PL I R_ I R;n
135 83 81
4.9 6.7 6.5
137 90 89
4.9 4.4 3.4
Exercise while seated
0 ° M 91 a 139 94 92 99 a 152
.'k.SE 7.9 7.8 9.4 8.5 6.7 8
-6 ° M 95 139 98 99 100 154
:t:SE 2.6 4.3 3.8 4.3 4.3 4.3
113 111 90 a 144 96 96 96 a 147 96 95
6.9 7.6 5.4 5.3 6.3 6.9 4 4.8 9.1 7.5
106 108 96 145 100 100 99 147 103 103
6.6 4.9 3.8 7 5.3 5.3 3.5 4.8 3 4.1
Note: PL = physical load (5 min); R = at rest; R 5 = recovery (5 vain); R10 = recovery (10 min).
ap < 0.05 compared to supine.
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TABLE 49.- ARTERIAL SYSTOLIC PRESSURE (ram mercury) DURING EXERCISE: U.S.S.R. STUDY
Group Indices
Before bed rest
i I IR I PL I R_ R10
After bed re_ days
o I 5
R [ PL [ R_ I RI0 R I PL I R5 [ R10
Exercise while supine
10R I _L I R_ I Rio
0 ° M 136 188 122 115
+SE 2.9 5.5 4.1 3.5
-6 ° M 126 187 128 121
_.SE 2.5 9.2 5.6 4
124 a 190 131 118 122 a 191 125 118
1 4.8 1.9 1.2 1.9 5.4 2.2 2
127 200 131 120 127 193 130 123
6.5 11.6 3.3 4.5 4.6 11.8 5 3.7
118 a 186 123 112
2.9 8.4 5.1 3
129 196 131 122
4.1 10.5 4.8 5.6
_ercise while seated
0 ° M 113 b 164 b 120 113
:t:SE 4.3 8.7 4.2 4.6
-60 M 109/' 174 107 106
:t:SE 4 8.2 6 2.9
115 b 171 b 126 118 114 166 b 123 118
6.2 11.8 4 5.8 6.1 5.9 5.2 4.3
115 b 170 b 116 115 118 b 182 108 109
2.7 8.2 5.3 3.5 3.1 8.7 4.4 4.8
112 169 122 118
5 9.6 3.7 3.7
117 179 116 110
1.4 10.3 3.7 4.7
Note: PL = physical load (5 rain); R = at rest; R 5 = recovery (5 min); R10 = recovery (10 min).
ap < 0.05 eomp_ed to before bed rest.
bp < 0.05 compared to supine.
TABLE 50.- ARTERIAL DIASTOLIC PRESSURE (ram mercury) DURING EXERCISE: U.S.S.R. STUDY
Group Indices
Before bed rest
i i [R I PL I Rs Rio
After bed rest_ days
o I 5R i PL [ R5 [ R10 R I eL I R: [ RIO
Exercise while supine
10R I PL I Rs I Rio
0 ° M 76 92 72 73
:_.SE 1.9 4.2 2.5 2
-60 M 78 92 69 74
_+_SE 3 3.7 5.1 4
83 98 74 82 81 91 73 77
3.3 5.3 3.3 1.2 2.2 2.4 2.5 1.2
81 100 75 80 80 92 73 77
3 3 4.2 3.5 3.5 5.1 4.3 5.8
77 99 66 72
3 1.9 4 3.4
80 90 76 82
4.3 5.9 4 a.l
Exercise while seated
0 o M 82 81 75 72
.-t:SE 2.1 3.2 4.2 3.4
-60 M 79 84 81 80
:kSE 3.6 6.6 3.7 2.2
90 a 89 79 82 82 80 73 78
2.9 3.7 3.7 3.4 2.7 5.7 4.6 4.4
87 87 86 87 83 85 76 80
4.8 6.2 5.1 3.4 4.6 5.9 5.2 3.5
81 81 74 75
2.9 6.8 2.9 2.2
83 84 79 82
3.1 7.6 4.3 3.4
Note: PL = physical load (5 rain); R = at rest; R 5 = recovery (5 min); R10 = recovery (10 rain).
ap < 0.05 compared to supine.
Significant changes were observed in both groups
following bed rest (recovery day 0). At rest before exer-
cise, the horizontal subjects showed an increase in HR of
9.3% and the head-down subjects an increase of 8.5%, rel-
ative to control-period values (table 48). At the end of
exercise loading, the horizontal subjects showed a 15.6%
increase in HR over baseline values, and the head-down
group a 12.9% increase. Systolic blood pressure increased
slightly in both groups, but diastolic blood pressure
showed smaller changes than when supine and increased
only slightly from control-period levels (see tables 49
and 50).
During the recovery period following exercise load-
ing, cardiovascular indices in both groups returned to rest-
ing levels slowly and were higher by 12.8% in the hori-
zontal group and by 6.9% in the head-down group. On
recovery days 5 and 10, HR responses in both groups
approached control-period values and normalized more
rapidly in the horizontal group. Gas exchange and respira-
tion following bed rest during exercise loading and recov-
ery did not show remarkable changes from control-period
values. No significant differences were found between the
two groups of subjects.
Thus, during the control period, the two groups of
subjects showed resting differences in HR and SBP which
disappeared during physical exercise. During exercise, the
head-down subjects exhibited higher HRs and a slower
return to normal than did the horizontal subjects.
Exercise testing in neither the supine nor upright
positions revealed significant differences in responses
between the two groups. Observed cardiovascular changes
were more pronounced in the upright than in the supine
position, but gas-exchange and respiration indices did not
differ significantly between the two. These findings are
supported by results with upright exercise testing during
Soyuz flights (ref. 69) and Skylab experiments (ref. 70).
Comparison of U.S. and U.S.S.R. Findings
Mean percentage change (%A) in VE, VO2, and HR
during supine exercise and recovery for the horizontal and
head-down subjects are compared for the U.S. and
U.S.S.R. studies in table 51 and for supine and upright
body positions for horizontal subjects in table 52.
The findings during exercise testing, in general were
similar for both the U.S. and U.S.S.R. investigations. Both
teams of investigators found that exercise in the upright
position following bed rest produced greater cardiovascu-
lar changes than exercise in the supine position and that
head-down subjects showed greater responses and a
slower return to normal values. Greater changes were seen
for the head-down U.S. subjects for VE and HR. Although
absolute values differed between sides, the magnitude of
change in going from a lying to sitting position was quite
similar. Both concluded that the observed changes were
correlated with orthostatic responses occurring with
immobilization (and confinement) which tended to be
more substantial in the head-down subjects.
TABLE 51.- 0 ° VS -6 ° SUBMAXIMAL EXERCISE RESPONSE: MEAN PERCENT CHANGES (%A) IN VE, VO2,
AND HR DURING SUPINE EXERCISE AND RECOVERY FOLLOWING 0 ° AND -60 BED REST
0 ° Bed rest -60 Bed rest
Factor
%A VE
%a vo2
%A HR
Supine exercise
U.S. U.S.S.R.
+10.3 a +8.5 a
+0.8 -0.6
+3.8 a +4.6 a
Recovery
U.S. U.S.S.R.
+15.1 a +8.3 a
0.0 -1
+5.9 a +6.8 a
Supine exercise
U.S. U.S.S.R.
+24.7 a,b +4.0 a
+5.4 -1.6
+13.4a, b +10.1 b
Recovery
U.S. U.S.S.R.
+23.9 a +30 a
+10.3a,b -3 b
+17.6a, b +1.2 b
ap < 0.05 for before vs after bed-rest changes.
bp < 0.05 vs corresponding 0° bed-rest value.
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TABLE52.-0 ° VS -6 ° SUBMAXIMAL EXERCISE RESPONSE: MEAN PERCENT CHANGES (%A) IN VE, VO2,
AND HR DURING EXERCISE AND RECOVERY IN THE SUPINE AND UPRIGHT POSITIONS
FOLLOWING 0 ° BED REST
Factor
%A VE
%a vo2
%A HR
U.S°
+10.3 a
+0.8
+3.8 a
Exercise
Supine
U.S.S.R.
+8.5 a
-0.6
+4.6 a
Upright
U.S. U.S.S.R.
+ 15.6 a,b + 13.6 a,b
+1.4 +2.0
+8.3a, b +9.4a, b
U.S.
+15.1 a
0.0
+5.9 a
Su
Recover/
_ine
U.S.S.R.
+8.3 a
-1
+6.8 a
Upright
U.S. U.S.S.R.
+17.4 a +30 a
+8.1a,b +10a_
+7.9 a +20.2 a
ap < 0.05 for before vs after bed-rest changes.
bp < 0.05 vs corresponding supine value.
VII. CONCLUSIONS
The findings of the present study concerning physio-
logical responses to prolonged bed rest in the horizontal
and head-down positions were similar to results from pre-
vious bed-rest studies and from manned spaceflight expe-
rience (refs. 1 and 2). The present study was notable not
only because of its comparison of horizontal and head-
down bed-rest responses, but also because it was con-
ducted jointly by U.S. and U.S.S.R. investigators.
In both studies, the horizontal and head-down groups
showed expected bed-rest-induced differences in bio-
chemical endocrinologic, hematologic, and fluid balance
measurements and almost no areas of change specifically
attributable to the difference in body position. Findings of
particular note were that head-down subjects did not show
significantly greater decreases in plasma volume, blood
volume, or red cell mass. There also appeared to be no
significant differences between responses of the two
groups to water loading. Since this test was performed on
day 2 of recovery, early recovery-period changes may
have been undetected. Significant changes in ECGs and
VCGs did not occur in either group. It has been previously
hypothesized that the head-down body position during
bed rest might produce shifts in heart position within the
chest which could be detected and quantified on the VCG
tracings. Such evidence did not appear in the present
study.
With LBNP and exercise testing following bed rest,
the head-down subjects exhibited a slightly greater degree
of deconditioning. In this regard, recovery-period exercise
testing results for the head-down subjects compared more
closely with findings from spaceflights (see table 53).
Exercise testing, both supine and upright, proved to be
more sensitive than LBNP in demonstrating recovery-
period deconditioning and the patterns of recovery.
Despite some indications of a return to baseline values in
this group on recovery day 5, the subjects continued to
manifest degraded values by recovery day 10. These find-
ings may have been complicated by the somewhat long
recovery period (10 days), with the possibility of decondi-
tioning occurring from confinement itself (ref. 2). The
horizontal subjects experienced these responses in the
recovery period to a greater degree than did the head-
down subjects.
Bed rest produced the following significant changes
(p < 0.05) during supine exercise and during the 5-min
recovery period following exercise:
1. A greater increase in exercise heart rate in the
head-down group following bed rest than observed in
the horizontal subjects (U.S. = +13.4% versus +3.8%;
U.S.S.R. = +10.1% versus 4.6%); the heart rates remained
elevated during recovery from exercise testing.
2. Increased ventilatory volume in the head-down
group, which also remained elevated during recovery
from exercise.
With upright exercise, all subjects exhibited higher heart
rates and diastolic blood pressure, but lower ventilatory
volume, pulse pressure, systolic blood pressure, CO2 pro-
duction, and respiratory exchange ratio than they had
during supine exercise. These differences undoubtedly
resulted from orthostatic stress and greater blood pooling
in the lower extremities. Despite the fact that the head-
down group exhibited higher heart rates during supine
exercise, the upright exercise values for the two groups
were similar. Furthermore, the head-down group showed
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TABLE 53.- COMPARATIVE EXERCISE RESPONSES AFTER BED REST AND SPACEFLIGHT
0° Bed rest a
-6 ° Bed re.sO
Soyuz spaceflight b
A
beats/min
+5
+19
+13
HR
% ml/min
+3.8 +10
+13.4 +80
+11.8 +60
A VO 2
%
+0.8
+5.4
+4.3
AOz
ml/beat
--0.4
-1.1
-1
aSupine bicycle exercise for 5 min at 700 km/min after 7-day bed rest.
bin-flight bicycle exercise for 7 min at 600 km/min after 5-day spaceflight.
Pulse
%
-3.3
-8.5
-7.7
lower diastolic blood pressures at rest before upright exer-
cise than the horizontal group, but these rose to horizontal
levels during exercise and recovery. Diastolic blood pres-
sures were also significantly lower during upright exercise
than supine levels, but were significantly higher at rest
and during recovery following exercise. These responses
most likely resulted from observed losses in plasma
volume.
Water volumetry showed a slight, but highly signifi-
cant (p < 0.01), decrease in lean body mass, with the
head-down subjects showing the greatest decrease.
Although these changes can be strongly correlated with
losses in total body water, they may also explain the
greater loss in exercise tolerance seen in the head-down
subjects following bed rest by indicating an absolute loss
of muscle mass.
LBNP responses from control to peak LBNP
(-50 mmHg) were similar in both horizontal and head-
down groups before and after bed rest, and the magnitude
of change was similar to previous findings reported in the
literature (refs. 2 and 71). Responses to LBNP stress fol-
lowed the same patterns observed with exercise stress.
The most significant (p < 0.05) changes following bed rest
were in heart rate (increased), cardiac output (decreased),
stroke volume (decreased), and left ventricular end dias-
tolic volume (decreased). The magnitudes of the changes
(derived from data in table 30) are shown in table 54. All
parameters showed 20% or better bed rest-induced
changes except for SV and CO in U.S. horizontal subjects,
which actually got better rather than worsened. The U.S.
head-down group maintained greater recovery-period
changes, particularly in cardiac output (p < 0.05), support-
ing the conclusion that this group was more severely
deconditioned following bed rest than the horizontal
subjects.
Leg pooling increased as expected during LBNP, but
did not differ significantly between the two subject
groups. Pooling studies showed that the pelvic area was
the major site for volume shifts during LBNP.
Hemodynamic measurements at rest over the course
of the study revealed expected changes in most variables.
Differences between observed absolute values for
parameters such as end-diastolic volume and arterial
blood pressures were most likely the product of
dissimilarities in instrumentation.
Analyses of fluid and electrolyte balance also provide
evidence that the head-down group may have retained
more fluids, which would account for the hemodynamic
changes seen in this group between the second and fourth
days of bed rest. Between bed-rest days 2 and 6, the head-
down group consistently showed positive water balance
values that were higher than those for the horizontal sub-
jects. The difference between the two groups was signifi-
cant (p < 0.05) on day 5 of bed rest. On that day, the hori-
zontal subjects exhibited a mild, but significant (p < 0.01),
diuretic response, whereas the head-down subjects
increased their degree of fluid retention. The physiologi-
cal significance of these differences was corroborated by
serum and urine sodium values. Sodium excretion tended
to decrease throughout bed rest in both groups and was
associated with a significant (p < 0.05) decrease in serum
sodium in both groups. The fact that the head-down group
manifested fluid and hemodynamic changes to a signifi-
cantly greater degree than did the horizontal subjects sug-
gests that the head-down body position causes significant
differences in body-fluid distribution and handling, which
is perhaps best explained by an excessive ADH excretion.
However, increased urinary and plasma values of ADH
were not observed during the present study.
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TABLE54.-PERCENTAGECHANGEINPARAMETERSDURING PEAK LBNP: U.S. AND U.S.S.R. STUDIES
Parameter and bed-rest position
Heart rate 0°
_6°
Cardiac output 0 °
_6 °
Stroke volume 0°
_6°
Left ventricular end diastolic volume 0o
_6 °
Note: Values represent mean differences between
Before
O.S.
+26
+30
-17
-13
-36
-33
-34
-34
bed rest
U.S.S.R.
+36
+42
-21
-4
--41
-33
After bed rest
U.S°
+50
+59
-5
-39
-37
-62
-38
-28
-39
-55
U.S.S.R.
+52
+70
-25
-9
-51
--48
--42
-34
_re-LBNP to peak compared with pre-LBNP levels.
The cause of these latter changes remains unex-
plained, but there is some indication that differences in
nutrition and diet may have played a role. Nutritional
status is known to affect endocrine function and may
affect other physiological systems. For example, a diet
high in simple carbohydrates (e.g., sucrose) can raise
blood triglyceride levels. Nutritionists have shown that a
diet high in carbohydrates can result in water retention,
and can alter loss of sodium and other cations and other
physiological responses. Both the U.S.S.R. and U.S. diets
were high in carbohydrates, but the U.S. diet significantly
so. This diet was designed to simulate that used for
Shuttle astronauts and was not tailored to the nutritional
requirements of the bed-rest subjects, most of whom were
not accustomed to a high carbohydrate intake in their
daily lives. The possibility that dietary differences
between the U.S.S.R. and U.S. subjects may have played
role in the difference in observed responses suggests that
dietary input may require greater attention in future
studies.
Ames Research Center
National Aeronautics and Space Administration
Moffett Field, California, January 1986
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